<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Ckd - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        DocTutorial / qBank / Medicine
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">31</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x578afd=_0x53de;(function(_0x12424e,_0x146fcd){const _0x9312c4=_0x53de,_0x566870=_0x12424e();while(!![]){try{const _0x2992e8=parseInt(_0x9312c4(0x3b9))/0x1*(parseInt(_0x9312c4(0x361))/0x2)+-parseInt(_0x9312c4(0x2a3))/0x3+-parseInt(_0x9312c4(0x203))/0x4+parseInt(_0x9312c4(0x391))/0x5*(parseInt(_0x9312c4(0x2f4))/0x6)+parseInt(_0x9312c4(0x2c9))/0x7+parseInt(_0x9312c4(0x215))/0x8*(parseInt(_0x9312c4(0x260))/0x9)+parseInt(_0x9312c4(0x262))/0xa*(-parseInt(_0x9312c4(0x20c))/0xb);if(_0x2992e8===_0x146fcd)break;else _0x566870['push'](_0x566870['shift']());}catch(_0x1b0da5){_0x566870['push'](_0x566870['shift']());}}}(_0x4075,0x47d62));const _0xd16d23=(function(){let _0xf05e5b=!![];return function(_0x348189,_0x5e702d){const _0x4aefbd=_0xf05e5b?function(){if(_0x5e702d){const _0x7a063b=_0x5e702d['apply'](_0x348189,arguments);return _0x5e702d=null,_0x7a063b;}}:function(){};return _0xf05e5b=![],_0x4aefbd;};}()),_0x56ddda=_0xd16d23(this,function(){const _0x52952a=_0x53de,_0x201011={'gXUua':_0x52952a(0x353)};return _0x56ddda[_0x52952a(0x2f5)]()[_0x52952a(0x26a)](_0x201011['gXUua'])[_0x52952a(0x2f5)]()[_0x52952a(0x29b)](_0x56ddda)[_0x52952a(0x26a)](_0x201011['gXUua']);});_0x56ddda();const _0x2c6725=(function(){const _0x52e623=_0x53de,_0x4ed72f={'xtxzg':_0x52e623(0x1c6),'AQyaE':function(_0xa5be74,_0x113980){return _0xa5be74===_0x113980;}};let _0x536a50=!![];return function(_0x16c2e5,_0x58f6a7){const _0x4df3e9=_0x52e623,_0x15d25f={'XbrEy':_0x4ed72f[_0x4df3e9(0x397)]};if(_0x4ed72f[_0x4df3e9(0x21e)](_0x4df3e9(0x267),'MuRfF'))_0xd3d4c[_0xee8d1c][_0x4df3e9(0x261)]=_0x15d25f['XbrEy'],_0x41d8e8[_0x4df3e9(0x351)]++,_0xcff29b[_0x4df3e9(0x1bd)]--;else{const _0x1a2d22=_0x536a50?function(){const _0x2c7f44=_0x4df3e9;if(_0x58f6a7){const _0x1e73ab=_0x58f6a7[_0x2c7f44(0x383)](_0x16c2e5,arguments);return _0x58f6a7=null,_0x1e73ab;}}:function(){};return _0x536a50=![],_0x1a2d22;}};}()),_0x1aa54c=_0x2c6725(this,function(){const _0x41ae15=_0x53de,_0x137af4={'hMCEc':function(_0x210e28,_0x560ac7){return _0x210e28+_0x560ac7;},'AzVHL':_0x41ae15(0x2b0),'vYMyb':_0x41ae15(0x244),'gwnvo':_0x41ae15(0x3a5),'UrKBk':_0x41ae15(0x123),'lCuyZ':function(_0x49937b){return _0x49937b();},'CpbPT':_0x41ae15(0x1b4),'SguSf':_0x41ae15(0x3c8),'EiTbv':_0x41ae15(0x136),'mFmPK':'trace','RvTir':function(_0x582da0,_0x5e3935){return _0x582da0<_0x5e3935;},'jvdcZ':_0x41ae15(0x415)},_0x5bd144=function(){const _0x29b125=_0x41ae15;let _0x20a407;try{_0x20a407=Function(_0x137af4[_0x29b125(0x219)](_0x137af4[_0x29b125(0x12a)]+_0x137af4[_0x29b125(0x310)],');'))();}catch(_0x4d3947){_0x20a407=window;}return _0x20a407;},_0x76a91a=_0x5bd144(),_0x501b01=_0x76a91a[_0x41ae15(0x238)]=_0x76a91a[_0x41ae15(0x238)]||{},_0x3dea4e=[_0x137af4[_0x41ae15(0x216)],_0x41ae15(0x1f1),_0x41ae15(0x348),_0x137af4[_0x41ae15(0x205)],'exception',_0x137af4[_0x41ae15(0x40b)],_0x137af4[_0x41ae15(0x21f)]];for(let _0x370616=0x0;_0x137af4['RvTir'](_0x370616,_0x3dea4e[_0x41ae15(0x248)]);_0x370616++){if(_0x41ae15(0x234)===_0x137af4['jvdcZ'])_0x566f5e['location']['pathname'][_0x41ae15(0x1cf)](_0x137af4[_0x41ae15(0x2ba)])&&_0x5d8cb8[_0x41ae15(0x38f)](_0x137af4[_0x41ae15(0x408)]),_0x137af4[_0x41ae15(0x31c)](_0x7ddb95),_0x2c06d0[_0x41ae15(0x2e8)]();else{const _0x524624=_0x2c6725[_0x41ae15(0x29b)]['prototype'][_0x41ae15(0x23a)](_0x2c6725),_0x447470=_0x3dea4e[_0x370616],_0x103103=_0x501b01[_0x447470]||_0x524624;_0x524624[_0x41ae15(0x34d)]=_0x2c6725[_0x41ae15(0x23a)](_0x2c6725),_0x524624[_0x41ae15(0x2f5)]=_0x103103[_0x41ae15(0x2f5)]['bind'](_0x103103),_0x501b01[_0x447470]=_0x524624;}}});_0x1aa54c();let questionsData=[{'id':0x1,'choices':[{'id':0x1,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Intravenous\x20urogram</span></p>'},{'id':0x2,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Commence\x20on\x20an\x20Angiotensin\x20Receptor\x20Blocker</span></p>'},{'id':0x3,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Better\x20glycaemic\x20control</span></p>'},{'id':0x4,'text':_0x578afd(0x1c7)}],'text':_0x578afd(0x2ce),'unique_key':'DT1197796','question_audio':null,'question_video':null,'map_id':0x1246e4,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p>This\x20is\x20likely<strong>\x20early\x20diabetic\x20nephropathy.</strong>\x20The\x20first\x20sign\x20is<strong>\x20microalbuminuria</strong>,\x20even\x20when\x20creatinine\x20is\x20normal.</p>\x0a<ul>\x0a<li>The\x20patient\x20has\x20a\x20raised\x20albumin:\x20creatinine\x20ratio\x20in\x20the\x20urine.</li>\x0a<li>The\x20early\x20morning<strong>\x20albumin-to-creatinine\x20ratio\x20(ACR)</strong>\x20is\x20a\x20substitute\x20for\x2024-hour\x20urine\x20protein\x20estimation.</li>\x0a<li>An\x20ACR\x20of\x2030-300\x20mg/g\x20indicates\x20<strong>microalbuminuria</strong>,\x20and\x20&gt;300\x20mg/g\x20indicates\x20<strong>macroalbuminuria</strong>,\x20correlating\x20with\x20proteinuria\x20levels.</li>\x0a<li>The\x20given\x20patient\x20is\x20a<strong>\x20Type\x20I\x20diabetic</strong>.\x20It\x20has\x20not\x20been\x20mentioned\x20whether\x20his\x20blood\x20sugars\x20are\x20controlled\x20or\x20not.\x20His\x20BP\x20is\x20145/86mmHg,\x20which\x20is\x20above\x20the\x20target\x20recommended\x20for\x20diabetics\x20by\x20JNC8\x20guidelines\x20(Goal\x20is\x20&lt;140/90\x20mmHg).\x20Also,\x20he\x20has\x20a\x20high\x20AC\x20ratio,\x20indicative\x20of</li>\x0a<li>The\x20presence\x20of\x20proteinuria\x20indicates\x20that\x20the\x20patient\x20will\x20develop\x20a\x20decline\x20in\x20GFR.\x20So\x20we\x20aim\x20to\x20retard\x20the\x20progression\x20of\x20the\x20disease.\x20</li>\x0a<li>In\x20<strong>Type\x20I\x20diabetes</strong>,\x20strict\x20control\x20of\x20blood\x20sugars\x20has\x20been\x20shown\x20to\x20prevent\x20the\x20development\x20or\x20retard\x20the\x20progression\x20of\x20proteinuria.</li>\x0a<li>In\x20<strong>Type\x202\x20diabetes</strong>,\x20strict\x20glycemic\x20control\x20can\x20reduce\x20the\x20risk\x20of\x20developing\x20microalbuminuria\x20and\x20slow\x20early\x20nephropathy\x20progression,\x20but\x20its\x20benefit\x20diminishes\x20once\x20significant\x20proteinuria\x20is\x20established.</li>\x0a<li>In\x20our\x20patient\x20it\x20has\x20not\x20been\x20mentioned\x20about\x20his\x20glycemic\x20status.\x20But\x20his\x20blood\x20pressure\x20is\x20not\x20controlled.</li>\x0a<li><strong>ACE\x20inhibitors\x20or\x20ARBs</strong>\x20are\x20first-line\x20treatments\x20to\x20retard\x20the\x20progression\x20of\x20diabetic\x20nephropathy\x20by\x20reducing\x20intraglomerular\x20pressure\x20and\x20proteinuria,\x20and\x20they\x20also\x20help\x20control\x20blood\x20pressure.</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Intravenous\x20urogram\x20(Option\x20A):\x20</strong>This\x20is\x20a\x20radiological\x20procedure\x20used\x20to\x20assess\x20structural\x20abnormalities\x20in\x20the\x20urinary\x20tract\x20(e.g.,\x20obstruction,\x20stones,\x20masses).\x20It\x20is\x20not\x20indicated\x20in\x20a\x20patient\x20with\x20early\x20diabetic\x20nephropathy,\x20which\x20is\x20a\x20functional\x20glomerular\x20disease.</p>\x0a<p><strong>Better\x20glycaemic\x20control\x20(Option\x20C):\x20</strong>This\x20is\x20important\x20long-term\x20to\x20prevent\x20progression\x20of\x20diabetic\x20nephropathy.\x20However,\x20the\x20first-line,\x20most\x20evidence-based\x20intervention\x20for\x20albuminuria\x20is\x20to\x20start\x20an\x20ACE\x20inhibitor\x20or\x20ARB,\x20regardless\x20of\x20glycemic\x20control.</p>\x0a<p><strong>Consider\x20an\x20islet\x20cell\x20transplant\x20(Option\x20D):</strong>\x20This\x20is\x20reserved\x20for\x20patients\x20with\x20Brittle\x20diabetes,\x20Severe\x20hypoglycemia\x20unawareness,\x20and\x20patients\x20already\x20requiring\x20kidney\x20transplantation\x20due\x20to\x20end-stage\x20diabetic\x20nephropathy</p>','correct_choice_id':0x2,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x2,'choices':[{'id':0xb,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Renal\x20size\x20of\x207\x20cm</span></p>'},{'id':0xc,'text':_0x578afd(0x2d1)},{'id':0xd,'text':_0x578afd(0x255)},{'id':0xe,'text':_0x578afd(0x3fd)}],'text':_0x578afd(0x17f),'unique_key':_0x578afd(0x218),'question_audio':null,'question_video':null,'map_id':0x1246f1,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x1ac),'correct_choice_id':0xb,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x3,'choices':[{'id':0x15,'text':_0x578afd(0x300)},{'id':0x16,'text':_0x578afd(0x1c4)},{'id':0x17,'text':_0x578afd(0x365)},{'id':0x18,'text':_0x578afd(0x1c0)}],'text':_0x578afd(0x128),'unique_key':_0x578afd(0x225),'question_audio':null,'question_video':null,'map_id':0x1246f7,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x578afd(0x271),'correct_choice_id':0x16,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x4,'choices':[{'id':0x1f,'text':_0x578afd(0x37b)},{'id':0x20,'text':_0x578afd(0x142)},{'id':0x21,'text':_0x578afd(0x367)},{'id':0x22,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Adult\x20polycystic\x20kidney\x20disease</span></p>'}],'text':_0x578afd(0x35d),'unique_key':_0x578afd(0x19a),'question_audio':null,'question_video':null,'map_id':0x1246fb,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x371),'correct_choice_id':0x21,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x5,'choices':[{'id':0x29,'text':_0x578afd(0x28a)},{'id':0x2a,'text':_0x578afd(0x31a)},{'id':0x2b,'text':_0x578afd(0x23d)},{'id':0x2c,'text':_0x578afd(0x34b)}],'text':_0x578afd(0x26f),'unique_key':_0x578afd(0x3e6),'question_audio':null,'question_video':null,'map_id':0x124700,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x27f),'correct_choice_id':0x2c,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x6,'choices':[{'id':0x33,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Polycythaemia</span></p>'},{'id':0x34,'text':_0x578afd(0x282)},{'id':0x35,'text':_0x578afd(0x2ed)},{'id':0x36,'text':_0x578afd(0x3fa)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2035-year-old\x20man\x20has\x20been\x20referred\x20for\x20management\x20of\x20hypertension.\x20On\x20examination,\x20he\x20had\x20palpable\x20kidneys.\x20This\x20was\x20confirmed\x20by\x20abdominal\x20ultrasound,\x20which\x20showed\x20multiple\x20cysts.\x20Which\x20of\x20the\x20following\x20is\x20likely\x20to\x20be\x20associated?</span></p>','unique_key':'DT1197828','question_audio':null,'question_video':null,'map_id':0x124704,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<ul>\x0a<li>A\x20young\x20hypertensive\x20with\x20palpable\x20kidneys\x20and\x20cysts\x20on\x20ultrasound\x20points\x20to\x20the\x20diagnosis\x20of</li>\x0a<li>ADPKD\x20is\x20associated\x20with\x20relatively<strong>\x20higher\x20erythropoietin\x20(EPO)\x20production\x20</strong>compared\x20to\x20other\x20CKD\x20causes,\x20leading\x20to\x20<strong>polycythemia</strong>\x20in\x20some\x20patients,\x20though\x20anemia\x20may\x20still\x20occur\x20in\x20advanced\x20stages.</li>\x0a<li><strong>ADPKD\x20</strong>is\x20a\x20genetic\x20disorder\x20characterised\x20by\x20the\x20progressive\x20development\x20of\x20multiple\x20fluid-filled\x20cysts\x20in\x20both\x20kidneys.</li>\x0a<li>It\x20is\x20one\x20of\x20the<strong>\x20most\x20common\x20inherited\x20kidney\x20diseases.</strong></li>\x0a<li><strong>Diagnostic\x20Criteria\x20(Ultrasound-based\x20-\x20Ravine\x20criteria):</strong>\x20<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509174331d2cc-01ef-4bf7-bfd8-e76d239ec4ea.png\x22></li>\x0a<li><strong>Associations\x20of\x20ADPKD:</strong>\x0a<ul>\x0a<li><strong>Cardiovascular:</strong>\x0a<ul>\x0a<li>Intracranial\x20aneurysm(5\x20times\x20more\x20common\x20than\x20in\x20the\x20general\x20population)\x20can\x20rupture\x20to\x20cause\x20subarachnoid\x20haemorrhage</li>\x0a<li>Diffuse\x20arterial\x20dolichoectasia\x20of\x20the\x20anterior\x20and\x20posterior\x20cerebral\x20circulation\x20&rarr;\x20predisposed\x20to\x20arterial\x20dissection\x20and\x20stroke</li>\x0a<li>Mitral\x20valve\x20prolapse</li>\x0a</ul>\x0a</li>\x0a<li><strong>Gastrointestinal:</strong>\x0a<ul>\x0a<li>Colonic\x20diverticula</li>\x0a<li>Abdominal\x20wall\x20hernia</li>\x0a<li>Polycystic\x20liver\x20disease</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025091744ba8fb3-d89d-4720-8e6f-f8c0551a3672.png\x22></li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Nail\x20pitting\x20(Option\x20B):\x20</strong>Seen\x20in\x20psoriasis,\x20not\x20related\x20to\x20kidney\x20cysts.</p>\x0a<p><strong>Hypermobility\x20(Option\x20C):\x20</strong>Associated\x20with\x20connective\x20tissue\x20disorders\x20like\x20Ehlers-Danlos\x20or\x20Marfan\x20syndrome,\x20not\x20ADPKD.</p>\x0a<p><strong>Mitral\x20stenosis\x20(Option\x20D):\x20</strong>Mitral\x20valve\x20prolapse\x20(not\x20stenosis)\x20is\x20the\x20valvular\x20lesion\x20associated\x20with\x20ADPKD.</p>','correct_choice_id':0x33,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x7,'choices':[{'id':0x3d,'text':_0x578afd(0x34f)},{'id':0x3e,'text':_0x578afd(0x2af)},{'id':0x3f,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Nephrotic\x20syndrome</span></p>'},{'id':0x40,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Reflux\x20nephropathy</span></p>'}],'text':_0x578afd(0x3c9),'unique_key':'DT1197831','question_audio':null,'question_video':null,'map_id':0x124707,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x1a7),'correct_choice_id':0x40,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x8,'choices':[{'id':0x47,'text':_0x578afd(0x2cf)},{'id':0x48,'text':_0x578afd(0x3f2)},{'id':0x49,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Alfacalcidol</span></p>'},{'id':0x4a,'text':_0x578afd(0x169)}],'text':_0x578afd(0x25e),'unique_key':_0x578afd(0x308),'question_audio':null,'question_video':null,'map_id':0x12470d,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<ul>\x0a<li>The\x20basic\x20problem\x20in\x20CKD\x20is\x20<strong>phosphate\x20retention</strong>\x20due\x20to\x20decreased\x20GFR\x20and\x20decreased\x20Vitamin\x20D\x20activation\x20due\x20to\x20<strong>1&alpha;\x20hydroxylase\x20deficiency</strong>,\x20which\x20leads\x20to\x20hypocalcemia,\x20and\x20both\x20lead\x20to\x20increased\x20PTH\x20production\x20and\x20secondary\x20hyperparathyroidism.</li>\x0a<li>Uncontrolled\x20secondary\x20hyperparathyroidism\x20leads\x20to\x20osteitis\x20fibrosa\x20cystica.</li>\x0a<li>So,\x20treatment\x20of\x20<strong>Secondary\x20hyperparathyroidism</strong>\x20is\x20essential\x20to\x20prevent\x20bone\x20changes.</li>\x0a<li>The\x20first\x20step\x20is\x20to\x20restrict\x20dietary\x20phosphorus</li>\x0a<li>The\x20next\x20step\x20is\x20<strong>phosphate\x20binders</strong>.</li>\x0a<li><strong>Calcium\x20acetate</strong>\x20is\x20preferred\x20as\x20a\x20<strong>phosphate\x20binder\x20</strong>in\x20this\x20patient\x20with\x20elevated\x20phosphate\x20and\x20secondary\x20hyperparathyroidism,\x20as\x20it\x20binds\x20dietary\x20phosphate\x20effectively\x20with\x20a\x20lower\x20calcium\x20load\x20compared\x20to\x20<strong>calcium\x20carbonate.</strong></li>\x0a<li><strong>Non\x20calcium-containing\x20phosphate\x20binders</strong>\x20are\x20aluminium-containing\x20antacids,\x20ferric\x20citrate,\x20sucroferric\x20oxohydroxide,\x20and\x20magnesium.</li>\x0a<li>Phosphate-binding\x20resins\x20include\x20<strong>Sevelamer</strong>\x20and</li>\x0a<li>Calcium\x20levels\x20should\x20be\x20measured\x20and\x20corrected.</li>\x0a<li>Vitamin\x20D\x20levels\x20should\x20be\x20measured\x20and\x20corrected.\x20Calcitriol\x20and\x201&alpha;-hydroxylated\x20vitamin\x20D\x20are\x20given\x20to\x20treat\x20secondary\x20hyperparathyroidism\x20after\x20correcting\x20phosphate\x20levels\x20and\x20monitoring\x20of\x2025-hydroxy\x20vitamin\x20D\x20levels.</li>\x0a<li>So\x20this\x20patient\x20should\x20be\x20treated\x20with\x20<strong>dietary\x20phosphate\x20deficiency,\x20calcium\x20supplements,</strong>\x20and\x20a\x20<strong>phosphate\x20binder</strong>.\x20Since\x20Calcium\x20carbonate\x20can\x20act\x20as\x20a\x20phosphate\x20binder\x20and\x20source\x20of\x20calcium,\x20it\x20can\x20be\x20given.</li>\x0a</ul><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509174f1b6612-1f13-42d0-a5a6-6cee4d2b1ccc.png\x22>\x0a<p>Explanation\x20of\x20Other\x20Options:</p>\x0a<p><strong>Thyroxine\x20(Option\x20A):\x20</strong>No\x20evidence\x20of\x20hypothyroidism\x20is\x20provided.\x20Normal\x20albumin\x20and\x20no\x20signs/symptoms\x20suggesting\x20thyroid\x20dysfunction.</p>\x0a<p><strong>Vitamin\x20A\x20(Option\x20B):\x20</strong>Excess\x20Vitamin\x20A\x20is\x20toxic\x20in\x20CKD\x20and\x20may\x20worsen\x20bone\x20disease.</p>\x0a<p><strong>Alfacalcidol\x20(Option\x20C)\x20</strong>could\x20be\x20considered\x20for\x20prophylaxis\x20against\x20renal\x20bone\x20disease\x20and\x20progressive\x20hyperparathyroidism.\x20However,\x20the\x20patient\x27s\x20phosphate\x20level\x20is\x20already\x20elevated,\x20and\x20vitamin\x20D\x20supplementation\x20may\x20increase\x20this\x20further.</p>','correct_choice_id':0x4a,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x9,'choices':[{'id':0x51,'text':_0x578afd(0x3dd)},{'id':0x52,'text':_0x578afd(0x2ae)},{'id':0x53,'text':_0x578afd(0x3e8)},{'id':0x54,'text':_0x578afd(0x34f)}],'text':_0x578afd(0x3d6),'unique_key':_0x578afd(0x40a),'question_audio':null,'question_video':null,'map_id':0x124715,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x578afd(0x269),'correct_choice_id':0x54,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xa,'choices':[{'id':0x5b,'text':_0x578afd(0x32f)},{'id':0x5c,'text':_0x578afd(0x3d0)},{'id':0x5d,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Hypertension</span></p>'},{'id':0x5e,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Iron\x20overload</span></p>'}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2058-year-old\x20man\x20with\x20CKD\x20has\x20been\x20on\x20EPO\x20injections\x203\x20times\x20a\x20week\x20for\x20several\x20years.\x20Which\x20one\x20of\x20the\x20following\x20is\x20a\x20side\x20effect\x20of\x20erythropoietin\x20therapy?</span></p>','unique_key':_0x578afd(0x321),'question_audio':null,'question_video':null,'map_id':0x12471a,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x398),'correct_choice_id':0x5d,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xb,'choices':[{'id':0x65,'text':_0x578afd(0x239)},{'id':0x66,'text':_0x578afd(0x2bd)},{'id':0x67,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Aluminium\x20toxicity</span></p>'},{'id':0x68,'text':_0x578afd(0x1c4)}],'text':_0x578afd(0x363),'unique_key':_0x578afd(0x1e3),'question_audio':null,'question_video':null,'map_id':0x124727,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x2e2),'correct_choice_id':0x67,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xc,'choices':[{'id':0x6f,'text':_0x578afd(0x1a5)},{'id':0x70,'text':_0x578afd(0x159)},{'id':0x71,'text':_0x578afd(0x35f)},{'id':0x72,'text':_0x578afd(0x1bc)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2060-year-old\x20man\x20has\x20been\x20on\x20haemodialysis\x20for\x2015\x20years\x20due\x20to\x20diabetic\x20nephropathy.\x20He\x20now\x20has\x20joint\x20pain\x20in\x20the\x20shoulders\x20and\x20knees.\x20He\x20has\x20a\x20past\x20medical\x20history\x20of\x20bilateral\x20carpal\x20tunnel\x20decompression.\x20His\x20blood\x20reveals:\x20Hb\x2011\x20g/dl,\x20ESR\x2050\x20mm/hr,\x20urea\x20108\x20mg/dl,\x20creatinine\x202.50\x20mg/dl,\x20sodium\x20142\x20mmol/l,\x20potassium\x204.4\x20mmol/l,\x20Urate\x200.6\x20(<\x200.45).\x20What\x20is\x20the\x20likely\x20diagnosis?</span></p>','unique_key':_0x578afd(0x185),'question_audio':null,'question_video':null,'map_id':0x12472a,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x190),'correct_choice_id':0x72,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xd,'choices':[{'id':0x79,'text':_0x578afd(0x378)},{'id':0x7a,'text':_0x578afd(0x19d)},{'id':0x7b,'text':_0x578afd(0x402)},{'id':0x7c,'text':_0x578afd(0x2f6)}],'text':_0x578afd(0x289),'unique_key':_0x578afd(0x29e),'question_audio':null,'question_video':null,'map_id':0x12472e,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x2f1),'correct_choice_id':0x7a,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xe,'choices':[{'id':0x83,'text':_0x578afd(0x1a0)},{'id':0x84,'text':_0x578afd(0x34f)},{'id':0x85,'text':_0x578afd(0x32e)},{'id':0x86,'text':_0x578afd(0x20d)}],'text':_0x578afd(0x2fb),'unique_key':'DT1197878','question_audio':null,'question_video':null,'map_id':0x124736,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x3ca),'correct_choice_id':0x83,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xf,'choices':[{'id':0x8d,'text':_0x578afd(0x1b7)},{'id':0x8e,'text':_0x578afd(0x1d4)},{'id':0x8f,'text':_0x578afd(0x319)},{'id':0x90,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Erythropoietin\x20supplements</span></p>'}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2050-year-old\x20man\x20has\x20end-stage\x20renal\x20failure\x20due\x20to\x20diabetes.\x20He\x20receives\x204\x20hours\x20of\x20haemodialysis,\x203x\x20weekly.\x20His\x20pressure\x20is\x20180/105\x20mmHg\x20pre-dialysis\x20and\x20160/90\x20mmHg\x20post-dialysis.\x20Pre-dialysis\x20bloods\x20show:\x20Hb\x2010\x20g/dL,\x20sodium\x20132\x20mmol/l,\x20potassium\x206.5\x20mmol/L,\x20phosphate\x201mmol/L,\x20urea\x20270\x20mg/dl,\x20creatinine\x2012.7\x20mg/dl,\x20calcium\x208.6\x20mg/dl.\x20What\x20is\x20the\x20best\x20management\x20step?</span></p>','unique_key':_0x578afd(0x1ea),'question_audio':null,'question_video':null,'map_id':0x124739,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x2b5),'correct_choice_id':0x8f,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x10,'choices':[{'id':0x97,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Anti-GBM\x20disease</span></p>'},{'id':0x98,'text':_0x578afd(0x3e8)},{'id':0x99,'text':_0x578afd(0x160)},{'id':0x9a,'text':_0x578afd(0x28a)}],'text':_0x578afd(0x31e),'unique_key':_0x578afd(0x138),'question_audio':null,'question_video':null,'map_id':0x12473d,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x578afd(0x246),'correct_choice_id':0x99,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x11,'choices':[{'id':0xa1,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Hyaline\x20thrombus\x20formation</span></p>'},{'id':0xa2,'text':_0x578afd(0x191)},{'id':0xa3,'text':_0x578afd(0x270)},{'id':0xa4,'text':_0x578afd(0x121)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2045-year-old\x20diabetic\x20gentleman\x20had\x20a\x20renal\x20biopsy\x20during\x20investigation\x20of\x20worsening\x20renal\x20failure.\x20Which\x20of\x20the\x20following\x20is\x20typical\x20of\x20diabetic\x20nephropathy?</span></p>','unique_key':_0x578afd(0x2c5),'question_audio':null,'question_video':null,'map_id':0x124745,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x3ef),'correct_choice_id':0xa4,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x12,'choices':[{'id':0xab,'text':_0x578afd(0x17a)},{'id':0xac,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Prednisolone</span></p>'},{'id':0xad,'text':_0x578afd(0x2d9)},{'id':0xae,'text':_0x578afd(0x24a)}],'text':_0x578afd(0x3b0),'unique_key':_0x578afd(0x3ac),'question_audio':null,'question_video':null,'map_id':0x12474a,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p>Negatively\x20birefringent,\x20needle-shaped\x20crystals\x20under\x20polarized\x20light\x20confirm\x20urate\x20crystals,\x20diagnostic\x20of<strong>\x20gout.\x20Probenecid\x20</strong>is\x20ineffective\x20in\x20dialysis\x20patients\x20as\x20it\x20requires\x20renal\x20function\x20to\x20promote\x20uric\x20acid\x20excretion,\x20making\x20it\x20the\x20least\x20effective\x20treatment.</p><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22\x20https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20231117fbfeb65d-7e2f-4a52-8aa2-6bd476d83208.png\x22>\x0a<p><strong>Acute\x20attack\x20management\x20in\x20CKD:</strong></p>\x0a<ul>\x0a<li><strong>NSAIDS\x20</strong>should\x20<strong>not\x20</strong>be\x20used\x20in<strong>\x20CKD</strong>.</li>\x0a<li>Colchicine\x20requires\x20dose\x20reduction\x20in\x20CKD.</li>\x0a<li><strong>Steroids</strong>\x20are\x20safe\x20in\x20CKD:\x20First-line\x20in\x20moderate-severe\x20CKD\x20<strong>(Option\x20B)</strong></li>\x0a</ul>\x0a<p><strong>Urate-lowering\x20agents:</strong></p>\x0a<ul>\x0a<li><strong>Allopurinol\x20</strong>is\x20a\x20xanthine\x20oxidase\x20inhibitor\x20and\x20can\x20be\x20used\x20in\x20CKD\x20with\x20dose\x20reduction.</li>\x0a<li><strong>Febuxostat\x20</strong>is\x20another\x20xanthine\x20oxidase\x20inhibitor\x20and\x20requires\x20no\x20dose\x20reduction\x20in\x20moderate\x20to\x20severe\x20renal\x20impairment.\x20<strong>(Option\x20D)</strong></li>\x0a</ul>\x0a<p><strong>Uricosuric\x20drugs:</strong></p>\x0a<ul>\x0a<li><strong>Probenecid\x20</strong>is<strong>\x20not\x20</strong>effective\x20in<strong>\x20renal\x20impairment</strong>,\x20Cr\x20&gt;2mg/dl.&nbsp;</li>\x0a<li>Benzbromarone\x20is\x20useful\x20in\x20renal\x20impairment.</li>\x0a<li>Haemodialysis\x20will\x20also\x20ease\x20urate\x20clearance.\x20<strong>(Option\x20C)</strong></li>\x0a</ul>','correct_choice_id':0xab,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x13,'choices':[{'id':0xb5,'text':_0x578afd(0x209)},{'id':0xb6,'text':_0x578afd(0x18d)},{'id':0xb7,'text':_0x578afd(0x1a9)},{'id':0xb8,'text':_0x578afd(0x35c)}],'text':_0x578afd(0x323),'unique_key':_0x578afd(0x3a8),'question_audio':null,'question_video':null,'map_id':0x124760,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x344),'correct_choice_id':0xb7,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x14,'choices':[{'id':0xbf,'text':_0x578afd(0x209)},{'id':0xc0,'text':_0x578afd(0x1f9)},{'id':0xc1,'text':_0x578afd(0x3da)},{'id':0xc2,'text':_0x578afd(0x33c)}],'text':_0x578afd(0x2b2),'unique_key':_0x578afd(0x33e),'question_audio':null,'question_video':null,'map_id':0x124763,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x303),'correct_choice_id':0xbf,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x15,'choices':[{'id':0xc9,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Candida\x20albicans</span></p>'},{'id':0xca,'text':_0x578afd(0x3f3)},{'id':0xcb,'text':_0x578afd(0x1a4)},{'id':0xcc,'text':_0x578afd(0x400)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2060-year-old\x20man\x20who\x20is\x20undergoing\x20peritoneal\x20dialysis\x20at\x20home\x20presents\x20with\x20abdominal\x20pain,\x20pyrexia,\x20and\x20rigors.\x20Examination\x20is\x20positive\x20for\x20peritoneal\x20signs.\x20Which\x20organism\x20is\x20the\x20most\x20likely\x20cause\x20of\x20this\x20clinical\x20picture?</span></p>','unique_key':_0x578afd(0x2f8),'question_audio':null,'question_video':null,'map_id':0x124768,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x3e0),'correct_choice_id':0xcc,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x16,'choices':[{'id':0xd3,'text':_0x578afd(0x1de)},{'id':0xd4,'text':_0x578afd(0x200)},{'id':0xd5,'text':_0x578afd(0x12d)},{'id':0xd6,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Cardiovascular\x20disease</span></p>'}],'text':_0x578afd(0x3fe),'unique_key':_0x578afd(0x1cc),'question_audio':null,'question_video':null,'map_id':0x12476e,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x19b),'correct_choice_id':0xd6,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x17,'choices':[{'id':0xdd,'text':_0x578afd(0x1db)},{'id':0xde,'text':_0x578afd(0x23e)},{'id':0xdf,'text':_0x578afd(0x202)},{'id':0xe0,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Abdominal\x20ultrasound\x20scan</span></p>'}],'text':_0x578afd(0x349),'unique_key':_0x578afd(0x167),'question_audio':null,'question_video':null,'map_id':0x124772,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x1af),'correct_choice_id':0xdf,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x18,'choices':[{'id':0xe7,'text':_0x578afd(0x299)},{'id':0xe8,'text':_0x578afd(0x34e)},{'id':0xe9,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Vitamin\x20C\x20deficiency</span></p>'},{'id':0xea,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Reduced\x20red\x20cell\x20survival</span></p>'}],'text':_0x578afd(0x18b),'unique_key':'DT1197944','question_audio':null,'question_video':null,'map_id':0x124778,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x3b6),'correct_choice_id':0xe7,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x19,'choices':[{'id':0xf1,'text':_0x578afd(0x286)},{'id':0xf2,'text':_0x578afd(0x259)},{'id':0xf3,'text':_0x578afd(0x153)},{'id':0xf4,'text':_0x578afd(0x2d7)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20is\x20most\x20likely\x20to\x20cause\x20CKD?</span></p>','unique_key':_0x578afd(0x264),'question_audio':null,'question_video':null,'map_id':0x12477f,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x37f),'correct_choice_id':0xf4,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x1a,'choices':[{'id':0xfb,'text':_0x578afd(0x28b)},{'id':0xfc,'text':_0x578afd(0x311)},{'id':0xfd,'text':_0x578afd(0x381)},{'id':0xfe,'text':_0x578afd(0x285)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2067-year-old\x20man\x20has\x20been\x20receiving\x20dialysis\x20for\x206\x20years.\x20His\x20PTH\x20is\x20elevated\x20at\x20345\x20pg/ml\x20(Normal\x20Range\x2025-65),\x20phosphate\x206.6\x20mg/dl,\x20and\x20corrected\x20calcium\x208\x20mg/dl.\x20Of\x20the\x20following,\x20which\x20is\x20the\x20most\x20likely\x20to\x20be\x20responsible\x20for\x20renal\x20osteodystrophy?</span></p>','unique_key':_0x578afd(0x23b),'question_audio':null,'question_video':null,'map_id':0x124782,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x36f),'correct_choice_id':0xfb,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x1b,'choices':[{'id':0x105,'text':_0x578afd(0x25a)},{'id':0x106,'text':_0x578afd(0x32d)},{'id':0x107,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Glomerulonephritis</span></p>'},{'id':0x108,'text':_0x578afd(0x1ca)}],'text':_0x578afd(0x342),'unique_key':_0x578afd(0x309),'question_audio':null,'question_video':null,'map_id':0x124783,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x296),'correct_choice_id':0x106,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x1c,'choices':[{'id':0x10f,'text':_0x578afd(0x1cd)},{'id':0x110,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>MDRD</span></p>'},{'id':0x111,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Cockcroft\x20Gault</span></p>'},{'id':0x112,'text':_0x578afd(0x23c)}],'text':_0x578afd(0x1e7),'unique_key':_0x578afd(0x2a0),'question_audio':null,'question_video':null,'map_id':0x124784,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p>The\x20<strong>CKD-EPI\x20equation</strong>\x20is\x20preferred\x20because\x20it\x20provides\x20more\x20accurate\x20GFR\x20estimates\x20across\x20a\x20wider\x20range\x20of\x20kidney\x20function\x20and\x20populations,\x20including\x20those\x20with\x20near-normal\x20GFR.</p>\x0a<p><strong>Methods\x20for\x20Estimating\x20Renal\x20Function:</strong></p>\x0a<ol>\x0a<li><strong>Serum\x20Creatinine\x20(S.\x20Cr):</strong>\x0a<ul>\x0a<li>Commonly\x20used\x20in\x20outpatient\x20settings.</li>\x0a<li>Provides\x20a\x20<strong>rough\x20estimate\x20of\x20GFR</strong>,\x20but\x20is\x20influenced\x20by\x20muscle\x20mass,\x20age,\x20and\x20sex.</li>\x0a</ul>\x0a</li>\x0a<li><strong>Creatinine\x20Clearance\x20(CrCl):</strong>\x0a<ul>\x0a<li>Formula:\x20<strong>(Urine\x20Volume\x20&times;\x20Urine\x20Creatinine)\x20/\x20(Plasma\x20Creatinine\x20&times;\x20Time)</strong>.</li>\x0a<li>Requires\x2024-hour\x20urine\x20collection.</li>\x0a</ul>\x0a</li>\x0a<li><strong>Cockcroft-Gault\x20Equation:\x20(Option\x20C)</strong>\x0a<ul>\x0a<li>Estimates\x20<strong>creatinine\x20clearance</strong>\x20(CrCl),\x20not\x20GFR\x20directly.\x20<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22\x20https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/2023122081cf4618-27f6-4e47-9bd5-d2e0b74aaee4.png\x22></li>\x0a</ul>\x0a</li>\x0a<li><strong>\x20MDRD\x20Formula\x20(Modification\x20of\x20Diet\x20in\x20Renal\x20Disease):\x20(Option\x20B)</strong>\x0a<ul>\x0a<li>Calculates\x20<strong>eGFR</strong>\x20based\x20on\x20<strong>serum\x20creatinine,\x20age,\x20sex,\x20and\x20race</strong>.</li>\x0a<li>Commonly\x20used\x20in\x20lab\x20reports\x20but\x20<strong>less\x20accurate\x20at\x20higher\x20GFRs\x20(&gt;60\x20mL/min)</strong>.<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22\x20https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/202312205cc4225a-79d7-43a0-a4ba-427a7127bba9.png\x22></li>\x0a</ul>\x0a</li>\x0a<li><strong>\x20CKD-EPI\x20Equation\x20(Chronic\x20Kidney\x20Disease\x20Epidemiology\x20Collaboration):</strong>\x0a<ul>\x0a<li>Also\x20estimates\x20<strong>eGFR</strong>.</li>\x0a<li>More\x20<strong>accurate\x20than\x20MDRD</strong>,\x20especially\x20when\x20GFR\x20is\x20near-normal\x20or\x20mildly\x20reduced.<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22\x20https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20231220ee1ef144-b61a-45d3-bbcd-9a3fc2769294.png\x22></li>\x0a</ul>\x0a</li>\x0a</ol>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Kidney\x20Failure\x20Risk\x20(KFR)\x20equation\x20(Option\x20D):</strong>\x20A\x20Kidney\x20Failure\x20Risk\x20(KFR)\x20equation\x20predicts\x20the\x20risk\x20of\x20progression\x20to\x20ESRD,\x20not\x20eGFR,\x20unlike\x20CKD-EPI,\x20MDRD,\x20and\x20Cockcroft-Gault,\x20which\x20directly\x20estimate\x20renal\x20function.</p>','correct_choice_id':0x10f,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x1d,'choices':[{'id':0x119,'text':_0x578afd(0x21b)},{'id':0x11a,'text':_0x578afd(0x25a)},{'id':0x11b,'text':_0x578afd(0x3e3)},{'id':0x11c,'text':_0x578afd(0x16e)}],'text':_0x578afd(0x256),'unique_key':_0x578afd(0x2db),'question_audio':null,'question_video':null,'map_id':0x129d67,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x3f8),'correct_choice_id':0x119,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x1e,'choices':[{'id':0x123,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>CKD\x20poses\x20a\x20risk\x20for\x20bleeding\x20as\x20well\x20as\x20thrombosis.</span></p>'},{'id':0x124,'text':_0x578afd(0x265)},{'id':0x125,'text':_0x578afd(0x2da)},{'id':0x126,'text':_0x578afd(0x305)}],'text':_0x578afd(0x3e1),'unique_key':'DT1219946','question_audio':null,'question_video':null,'map_id':0x129d6a,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x578afd(0x31b),'correct_choice_id':0x126,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x1f,'choices':[{'id':0x12d,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>1,\x202\x20and\x203</span></p>'},{'id':0x12e,'text':_0x578afd(0x413)},{'id':0x12f,'text':_0x578afd(0x3bb)},{'id':0x130,'text':_0x578afd(0x1ce)}],'text':_0x578afd(0x3a6),'unique_key':_0x578afd(0x359),'question_audio':null,'question_video':null,'map_id':0x129d6b,'difficulty_level':_0x578afd(0x3c1),'subjects_id':[0x1],'solution':_0x578afd(0x22f),'correct_choice_id':0x12d,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x578afd(0x23f),'tags':[_0x578afd(0x320)],'explanation_video':null,'question_images':[],'explanation_images':[]}],quizName=_0x578afd(0x3a2);const quizFilename='ckd-124ddde9.html';let hierarchy=[_0x578afd(0x28c),_0x578afd(0x18c),'Medicine'];if(window['location'][_0x578afd(0x38b)][_0x578afd(0x1cf)](_0x578afd(0x3a5))){const customData=JSON['parse'](localStorage[_0x578afd(0x208)]('customQuizData'));if(customData){const BZWWxw=_0x578afd(0x3fc)[_0x578afd(0x29f)]('|');let axqjpI=0x0;while(!![]){switch(BZWWxw[axqjpI++]){case'0':questionsData=customData['questions'];continue;case'1':quizName=customData[_0x578afd(0x2ee)];continue;case'2':document['getElementById'](_0x578afd(0x201))[_0x578afd(0x125)]=questionsData[_0x578afd(0x248)];continue;case'3':hierarchy=customData[_0x578afd(0x21d)];continue;case'4':document[_0x578afd(0x301)](_0x578afd(0x41b))[_0x578afd(0x125)]=hierarchy[_0x578afd(0x1a6)](_0x578afd(0x2f9));continue;case'5':document[_0x578afd(0x2ca)]=quizName+_0x578afd(0x279);continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x578afd(0x373),timer=null,timeRemaining=0x0,questionStartTime=Date[_0x578afd(0x3e2)](),quizStartTime=Date[_0x578afd(0x3e2)](),isQuizCompleted=![],questionStates=new Array(questionsData[_0x578afd(0x248)])[_0x578afd(0x1fa)](null)[_0x578afd(0x192)](()=>({'status':_0x578afd(0x389),'bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData['length']};function saveProgress(){const _0x680045=_0x578afd,_0x3a911c={'iXxKG':_0x680045(0x3e9),'zNWFL':'incomplete'};if(isQuizCompleted)return;const _0x4c33bb=JSON[_0x680045(0x407)](localStorage['getItem'](_0x3a911c[_0x680045(0x1a2)]))||{};_0x4c33bb[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x3a911c[_0x680045(0x333)],'lastSeen':new Date()[_0x680045(0x417)]()},localStorage[_0x680045(0x186)](_0x3a911c[_0x680045(0x1a2)],JSON['stringify'](_0x4c33bb));}function loadProgress(){const _0x3ea0dc=_0x578afd,_0x116153={'Lzpch':function(_0xa17443){return _0xa17443();},'CAtwE':_0x3ea0dc(0x3e9),'tVUYi':'dJLHq','sdyHQ':_0x3ea0dc(0x22d),'DDafD':_0x3ea0dc(0x26d)},_0x58620b=JSON[_0x3ea0dc(0x407)](localStorage['getItem'](_0x116153[_0x3ea0dc(0x2d2)]))||{},_0x9704b8=_0x58620b[quizFilename];if(_0x9704b8){if(_0x3ea0dc(0x1bb)===_0x116153[_0x3ea0dc(0x384)])_0x116153[_0x3ea0dc(0x32b)](_0x5dbc01);else{const _0x44b3ed=_0x116153[_0x3ea0dc(0x298)][_0x3ea0dc(0x29f)]('|');let _0x4c82ec=0x0;while(!![]){switch(_0x44b3ed[_0x4c82ec++]){case'0':currentQuestionIndex=_0x9704b8[_0x3ea0dc(0x3a0)];continue;case'1':questionStates=_0x9704b8[_0x3ea0dc(0x374)];continue;case'2':return!![];case'3':stats=_0x9704b8['stats'];continue;case'4':currentMode=_0x9704b8[_0x3ea0dc(0x393)];continue;case'5':console[_0x3ea0dc(0x1b4)](_0x116153[_0x3ea0dc(0x1f4)]);continue;}break;}}}return![];}function clearProgress(){const _0x145754=_0x578afd,_0x245cf6={'TGZCz':function(_0x387e8e,_0x374d92,_0x2ad916){return _0x387e8e(_0x374d92,_0x2ad916);},'OFsir':function(_0x37d3d3,_0x154af2){return _0x37d3d3!==_0x154af2;},'BtUYg':_0x145754(0x24d),'xIMnY':_0x145754(0x3e9),'RrwmJ':'Previous\x20progress\x20cleared.'},_0x1fd844=JSON[_0x145754(0x407)](localStorage[_0x145754(0x208)](_0x145754(0x3e9)))||{};_0x1fd844[quizFilename]&&(_0x245cf6[_0x145754(0x338)](_0x145754(0x24d),_0x245cf6[_0x145754(0x395)])?_0x245cf6[_0x145754(0x3f0)](_0x20ff07,_0x1ed0bf,_0x1e739f):(delete _0x1fd844[quizFilename],localStorage[_0x145754(0x186)](_0x245cf6[_0x145754(0x36c)],JSON[_0x145754(0x149)](_0x1fd844)),console['log'](_0x245cf6[_0x145754(0x2bf)])));}function markQuizAsCompleted(){const _0x133d31=_0x578afd,_0x11ef19={'pmKTJ':'completed'},_0x2077f9=JSON[_0x133d31(0x407)](localStorage[_0x133d31(0x208)](_0x133d31(0x3e9)))||{},_0x5947ac=questionsData[_0x133d31(0x248)],_0xf05d0d=stats[_0x133d31(0x414)]||0x0;_0x2077f9[quizFilename]={'score':_0xf05d0d,'total':_0x5947ac,'status':_0x11ef19[_0x133d31(0x2a9)],'completedOn':new Date()['toISOString']()},localStorage[_0x133d31(0x186)](_0x133d31(0x3e9),JSON['stringify'](_0x2077f9));}const urlParams=new URLSearchParams(window[_0x578afd(0x2e1)][_0x578afd(0x26a)]),startAt=parseInt(urlParams[_0x578afd(0x1b9)]('startAt')),resume=urlParams[_0x578afd(0x1b9)](_0x578afd(0x253))==='true';function goBack(){const _0x54b602=_0x578afd,_0x27bcb1={'vewQQ':function(_0x5c0cdf){return _0x5c0cdf();}};if(!isQuizCompleted)_0x27bcb1[_0x54b602(0x394)](saveProgress);window[_0x54b602(0x2e1)][_0x54b602(0x27a)]=document[_0x54b602(0x247)]||_0x54b602(0x2e9);}function selectMode(_0x5cc11d){const _0x4c290a=_0x578afd,_0x364fb7={'zUeml':_0x4c290a(0x1fb),'xvHfh':_0x4c290a(0x39f),'GQKbt':function(_0x341967){return _0x341967();}};currentMode=_0x5cc11d,document[_0x4c290a(0x301)](_0x364fb7[_0x4c290a(0x268)])[_0x4c290a(0x30c)]['display']=_0x364fb7[_0x4c290a(0x133)],_0x364fb7[_0x4c290a(0x18e)](initializeQuiz);}function initializeQuiz(){const _0x22d16a=_0x578afd,_0x4dd7f4={'jvVET':_0x22d16a(0x240),'WCkhL':'testModeReviewLegend','wgFOA':function(_0x12b5b3,_0x2e69a9){return _0x12b5b3===_0x2e69a9;},'EWBWK':_0x22d16a(0x39d),'jbUkK':_0x22d16a(0x3ed),'UlQXe':_0x22d16a(0x39f),'crcWk':_0x22d16a(0x25f),'EWSPJ':_0x22d16a(0x369),'cqMZV':_0x22d16a(0x404),'wZoAl':_0x22d16a(0x176),'IVUOg':'timerContainer','bLrYT':_0x22d16a(0x3c3),'oTQqy':function(_0x5dc851,_0xc8f268){return _0x5dc851(_0xc8f268);},'vZEdr':function(_0x1d624d,_0x17c61b){return _0x1d624d>=_0x17c61b;},'DEQXY':function(_0x12695c,_0x5d6e7d){return _0x12695c<_0x5d6e7d;},'Uxhyb':function(_0x29c66b){return _0x29c66b();},'fUNGC':function(_0x263890){return _0x263890();}};quizStartTime=Date[_0x22d16a(0x3e2)]();const _0x5f14b6=document[_0x22d16a(0x301)](_0x22d16a(0x20b)),_0x5338e4=document[_0x22d16a(0x301)](_0x4dd7f4[_0x22d16a(0x36a)]),_0x38e13d=document[_0x22d16a(0x301)](_0x4dd7f4[_0x22d16a(0x16c)]),_0x356928=_0x4dd7f4[_0x22d16a(0x14a)](currentMode,_0x4dd7f4[_0x22d16a(0x1ec)])||currentMode===_0x4dd7f4[_0x22d16a(0x2b3)];document['getElementById'](_0x22d16a(0x197))['style'][_0x22d16a(0x13f)]=_0x356928?_0x4dd7f4[_0x22d16a(0x231)]:_0x4dd7f4['crcWk'],document[_0x22d16a(0x301)](_0x4dd7f4[_0x22d16a(0x14c)])[_0x22d16a(0x30c)][_0x22d16a(0x13f)]=_0x356928?_0x4dd7f4[_0x22d16a(0x231)]:_0x4dd7f4['crcWk'],document[_0x22d16a(0x301)](_0x4dd7f4[_0x22d16a(0x154)])[_0x22d16a(0x30c)]['display']=_0x356928?_0x4dd7f4['crcWk']:_0x4dd7f4['UlQXe'],document[_0x22d16a(0x301)](_0x22d16a(0x1ee))[_0x22d16a(0x30c)]['display']=_0x356928?_0x22d16a(0x25f):_0x4dd7f4[_0x22d16a(0x231)],_0x5f14b6['style'][_0x22d16a(0x13f)]=_0x356928?_0x4dd7f4[_0x22d16a(0x231)]:_0x4dd7f4[_0x22d16a(0x22e)],_0x5338e4[_0x22d16a(0x30c)][_0x22d16a(0x13f)]=_0x356928?_0x22d16a(0x176):_0x4dd7f4[_0x22d16a(0x231)],_0x38e13d['style'][_0x22d16a(0x13f)]=_0x356928?_0x4dd7f4['wZoAl']:_0x4dd7f4[_0x22d16a(0x231)],(_0x4dd7f4[_0x22d16a(0x14a)](currentMode,_0x22d16a(0x2d3))||_0x4dd7f4['wgFOA'](currentMode,_0x4dd7f4['jbUkK']))&&document[_0x22d16a(0x301)](_0x4dd7f4[_0x22d16a(0x221)])[_0x22d16a(0x36b)]['remove'](_0x4dd7f4[_0x22d16a(0x30b)]),!_0x4dd7f4[_0x22d16a(0x28f)](isNaN,startAt)&&_0x4dd7f4['vZEdr'](startAt,0x0)&&_0x4dd7f4[_0x22d16a(0x162)](startAt,questionsData[_0x22d16a(0x248)])&&(currentQuestionIndex=startAt),_0x4dd7f4[_0x22d16a(0x3d7)](loadBookmarkedQuestions),_0x4dd7f4[_0x22d16a(0x3d7)](generateQuestionNav),_0x4dd7f4[_0x22d16a(0x3c4)](updateStats),_0x4dd7f4[_0x22d16a(0x3c4)](displayQuestion);}function generateQuestionNav(){const _0x3fbcda=_0x578afd,_0x1e91a6={'IErWD':function(_0x3481bd,_0x56bd50){return _0x3481bd<_0x56bd50;},'IpiUt':'button','UFjbs':function(_0x21e3c7,_0x99f548){return _0x21e3c7+_0x99f548;},'qwiam':_0x3fbcda(0x1d1)},_0x2d091e=document['getElementById'](_0x3fbcda(0x12b));_0x2d091e[_0x3fbcda(0x2c0)]='';for(let _0x2716d8=0x0;_0x1e91a6[_0x3fbcda(0x17c)](_0x2716d8,questionsData['length']);_0x2716d8++){const _0x4bed75=document[_0x3fbcda(0x2c8)](_0x1e91a6[_0x3fbcda(0x37e)]);_0x4bed75[_0x3fbcda(0x125)]=_0x1e91a6[_0x3fbcda(0x3eb)](_0x2716d8,0x1),_0x4bed75[_0x3fbcda(0x3e4)]=_0x1e91a6[_0x3fbcda(0x165)],_0x4bed75[_0x3fbcda(0x189)]=()=>jumpToQuestion(_0x2716d8),_0x4bed75['id']='navBtn_'+_0x2716d8,_0x2d091e[_0x3fbcda(0x222)](_0x4bed75);}updateQuestionNav();}function updateQuestionNav(){const _0x1b400f=_0x578afd,_0x47a404={'pxaFN':function(_0x2eb209,_0x31e622,_0x30fe3f){return _0x2eb209(_0x31e622,_0x30fe3f);},'ftGqv':function(_0x2908b0){return _0x2908b0();},'vqeqF':function(_0x50705a,_0x2b1550){return _0x50705a<_0x2b1550;},'DBbeK':function(_0x258859,_0x470f20){return _0x258859===_0x470f20;},'YDqos':_0x1b400f(0x1c3),'yhkNz':'nav-btn-bookmarked','AJCkk':_0x1b400f(0x36d),'DjhAo':_0x1b400f(0x135),'GhDHP':function(_0x138c34,_0x177aa2){return _0x138c34===_0x177aa2;},'INstO':'timed_study','YXLan':_0x1b400f(0x1ab),'gmSLl':'nav-btn-correct','AjHlC':function(_0x8d22cf,_0x3b8ce6){return _0x8d22cf===_0x3b8ce6;},'nMJHs':_0x1b400f(0x16a),'ccQze':'nav-btn-incorrect','DZEOZ':'nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','xEYYe':_0x1b400f(0x2c3),'uFGIG':'mzMWi','CuFYJ':function(_0x1603fe,_0x2af8b7){return _0x1603fe!==_0x2af8b7;},'enSRR':'nav-btn-answered'};for(let _0x4503c2=0x0;_0x47a404[_0x1b400f(0x22c)](_0x4503c2,questionsData[_0x1b400f(0x248)]);_0x4503c2++){const _0x513cd5=document[_0x1b400f(0x301)](_0x1b400f(0x2e6)+_0x4503c2),_0x31bbac=questionStates[_0x4503c2];let _0x186980='';if(_0x47a404['DBbeK'](_0x4503c2,currentQuestionIndex))_0x186980=_0x47a404[_0x1b400f(0x33f)];else{if(_0x31bbac[_0x1b400f(0x3d2)])_0x186980=_0x47a404[_0x1b400f(0x313)];else{if(_0x31bbac[_0x1b400f(0x1b0)]){if(_0x1b400f(0x39a)===_0x47a404['AJCkk']){const _0x2f30b0=_0x373aab['dataset'][_0x1b400f(0x26e)];if(_0x2f30b0&&_0x2f30b0[_0x1b400f(0x3c6)](_0x1b400f(0x145)))_0x47a404['pxaFN'](_0x21cc28,_0x1d4ead,_0x2f30b0);else _0x2f30b0&&(_0xa86b5e[_0x1b400f(0x26e)]=_0x2f30b0);}else _0x186980=_0x47a404[_0x1b400f(0x2c4)];}else{if(currentMode===_0x1b400f(0x373)||_0x47a404[_0x1b400f(0x2ea)](currentMode,_0x47a404[_0x1b400f(0x217)])){if(_0x47a404[_0x1b400f(0x2ea)](_0x31bbac[_0x1b400f(0x261)],_0x47a404['YXLan']))_0x186980=_0x47a404[_0x1b400f(0x2de)];else{if(_0x47a404[_0x1b400f(0x3b8)](_0x31bbac[_0x1b400f(0x261)],_0x47a404[_0x1b400f(0x3d3)]))_0x186980=_0x47a404[_0x1b400f(0x1d9)];else _0x186980=_0x47a404['DZEOZ'];}}else{if(_0x47a404[_0x1b400f(0x3b8)](_0x47a404[_0x1b400f(0x35e)],_0x47a404['uFGIG']))_0x47a404[_0x1b400f(0x152)](_0x319e10);else{if(_0x47a404[_0x1b400f(0x35a)](_0x31bbac[_0x1b400f(0x266)],null))_0x186980=_0x47a404[_0x1b400f(0x362)];else _0x186980=_0x47a404[_0x1b400f(0x166)];}}}}}_0x513cd5['className']=_0x1b400f(0x2ab)+_0x186980;}}function jumpToQuestion(_0x39bd42){const _0x37dbe1=_0x578afd,_0x5658af={'fGUTA':function(_0x35f92e,_0xf0b6c7){return _0x35f92e>=_0xf0b6c7;},'qwYdW':function(_0x176622,_0x31aa39){return _0x176622-_0x31aa39;},'oLVeT':function(_0xc5bd26){return _0xc5bd26();}};_0x5658af['fGUTA'](_0x39bd42,0x0)&&_0x39bd42<questionsData['length']&&(questionStartTime&&(questionStates[currentQuestionIndex][_0x37dbe1(0x272)]+=_0x5658af[_0x37dbe1(0x1c8)](Date[_0x37dbe1(0x3e2)](),questionStartTime)),currentQuestionIndex=_0x39bd42,_0x5658af[_0x37dbe1(0x33b)](displayQuestion),_0x5658af[_0x37dbe1(0x33b)](saveProgress));}function updateStats(){const _0x2107d8=_0x578afd,_0x49f7a3={'oQwsu':function(_0xc75abb,_0x135e5e){return _0xc75abb===_0x135e5e;},'kDbuM':_0x2107d8(0x2d3),'whHeU':'correctCount','KOfUN':'incorrectCount','WntUI':'totalAttempted','tAnOF':function(_0x5ae382,_0x844f6c){return _0x5ae382>_0x844f6c;},'cbZFl':_0x2107d8(0x2fd),'WDvSJ':function(_0x4b0cc9,_0x12002a){return _0x4b0cc9+_0x12002a;},'NcAgZ':function(_0x1f1cd7,_0x44a755){return _0x1f1cd7/_0x44a755;},'kdnjw':function(_0x4a05fe,_0x233742){return _0x4a05fe%_0x233742;},'LgZTy':_0x2107d8(0x272)};if(currentMode===_0x2107d8(0x373)||_0x49f7a3[_0x2107d8(0x3ad)](currentMode,_0x49f7a3['kDbuM'])){document[_0x2107d8(0x301)](_0x49f7a3[_0x2107d8(0x19f)])['textContent']=stats[_0x2107d8(0x414)],document[_0x2107d8(0x301)](_0x49f7a3[_0x2107d8(0x2bb)])[_0x2107d8(0x125)]=stats[_0x2107d8(0x3ba)],document['getElementById'](_0x49f7a3['WntUI'])[_0x2107d8(0x125)]=stats[_0x2107d8(0x351)];const _0x7fabb2=_0x49f7a3[_0x2107d8(0x345)](stats[_0x2107d8(0x351)],0x0)?Math[_0x2107d8(0x1ad)](stats[_0x2107d8(0x414)]/stats[_0x2107d8(0x351)]*0x64):0x0;document[_0x2107d8(0x301)](_0x49f7a3[_0x2107d8(0x1b1)])[_0x2107d8(0x125)]=_0x49f7a3[_0x2107d8(0x356)](_0x7fabb2,'%'),stats[_0x2107d8(0x2d8)]=questionStates[_0x2107d8(0x3d8)]((_0x3d7d9e,_0x50034d)=>_0x3d7d9e+_0x50034d[_0x2107d8(0x272)],0x0);const _0x2f0427=Math[_0x2107d8(0x28d)](_0x49f7a3['NcAgZ'](stats[_0x2107d8(0x2d8)],0x3e8)),_0x537283=Math[_0x2107d8(0x28d)](_0x2f0427/0x3c),_0x55d668=_0x49f7a3[_0x2107d8(0x187)](_0x2f0427,0x3c);document[_0x2107d8(0x301)](_0x49f7a3[_0x2107d8(0x1e8)])[_0x2107d8(0x125)]=_0x49f7a3['WDvSJ'](_0x537283,':')+_0x55d668[_0x2107d8(0x2f5)]()[_0x2107d8(0x274)](0x2,'0');}}function setupVideo(_0xa03b7,_0x3984a1){const _0x4680fd=_0x578afd;if(Hls[_0x4680fd(0x1d3)]()){const _0x6cff3d=new Hls();_0x6cff3d['loadSource'](_0x3984a1),_0x6cff3d[_0x4680fd(0x405)](_0xa03b7);}else _0xa03b7[_0x4680fd(0x249)](_0x4680fd(0x3d1))&&(_0xa03b7[_0x4680fd(0x26e)]=_0x3984a1);}function displayQuestion(){const _0x4678f5=_0x578afd,_0xff05={'JCQmr':_0x4678f5(0x3e9),'JuyTK':function(_0xa01cad,_0x1a89f9){return _0xa01cad>=_0x1a89f9;},'hFJkF':function(_0xd923b4,_0x5591e8){return _0xd923b4<_0x5591e8;},'EQEQG':function(_0x176f46,_0x2aa90b){return _0x176f46-_0x2aa90b;},'CuoRt':function(_0xd432b4){return _0xd432b4();},'UTvVm':'You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','CJYFt':_0x4678f5(0x20e),'VVknl':'selected','vVJif':function(_0x3d779d,_0x180807){return _0x3d779d+_0x180807;},'QXvev':_0x4678f5(0x171),'tyqgt':_0x4678f5(0x27d),'rgFca':function(_0x3d7815,_0x1b33c6){return _0x3d7815===_0x1b33c6;},'zUZxI':_0x4678f5(0x30d),'zpLXs':function(_0x388dcd,_0xecf337){return _0x388dcd(_0xecf337);},'gitBr':_0x4678f5(0x329),'ymIzI':function(_0xa154eb,_0x520b62){return _0xa154eb===_0x520b62;},'PXtwq':'MHzBk','RrEyl':_0x4678f5(0x399),'quqtA':_0x4678f5(0x409),'MyamD':_0x4678f5(0x2e3),'bfRtX':function(_0x43db7a,_0x578e8c){return _0x43db7a*_0x578e8c;},'UHlPf':function(_0x2b130e,_0x7f6493){return _0x2b130e/_0x7f6493;},'hduhT':_0x4678f5(0x357),'wJebP':_0x4678f5(0x29d),'JnIjQ':_0x4678f5(0x129),'rYWnr':_0x4678f5(0x3c3),'nwWma':_0x4678f5(0x19c),'KKTGW':_0x4678f5(0x196),'TEIAB':'fjzbO','IBmvE':_0x4678f5(0x245),'LLWWz':_0x4678f5(0x3cb),'eiVIc':'timed_study','MvGxh':_0x4678f5(0x3ed),'OXxvM':function(_0x35fd33){return _0x35fd33();}};if(!questionsData||_0xff05[_0x4678f5(0x3bd)](questionsData[_0x4678f5(0x248)],0x0)){if(_0xff05[_0x4678f5(0x3bd)](_0xff05[_0x4678f5(0x3e5)],_0xff05['RrEyl']))delete _0x30e80c[_0x5945b7],_0x398b18[_0x4678f5(0x186)](_0xff05[_0x4678f5(0x2cc)],_0xce20ea[_0x4678f5(0x149)](_0xa414a5)),_0x171dad[_0x4678f5(0x1b4)](_0x4678f5(0x307));else{document[_0x4678f5(0x301)](_0xff05[_0x4678f5(0x2ad)])[_0x4678f5(0x2c0)]=_0xff05[_0x4678f5(0x29a)];return;}};const _0x12b964=questionsData[currentQuestionIndex];questionStartTime=Date['now'](),selectedOption=questionStates[currentQuestionIndex][_0x4678f5(0x266)];const _0x49ef7d=_0xff05[_0x4678f5(0x2cb)](_0xff05[_0x4678f5(0x302)](_0xff05[_0x4678f5(0x277)](currentQuestionIndex,0x1),questionsData[_0x4678f5(0x248)]),0x64);document[_0x4678f5(0x301)](_0xff05[_0x4678f5(0x126)])[_0x4678f5(0x30c)][_0x4678f5(0x2cd)]=_0xff05[_0x4678f5(0x277)](_0x49ef7d,'%'),document[_0x4678f5(0x301)](_0xff05[_0x4678f5(0x2fa)])[_0x4678f5(0x125)]=_0xff05['vVJif'](currentQuestionIndex,0x1),_0xff05[_0x4678f5(0x223)](updateQuestionNav),document[_0x4678f5(0x301)](_0x4678f5(0x396))[_0x4678f5(0x3c2)]=currentQuestionIndex===0x0,document[_0x4678f5(0x301)](_0xff05['JnIjQ'])[_0x4678f5(0x36b)][_0x4678f5(0x40c)](_0xff05[_0x4678f5(0x2a6)]),document['getElementById'](_0xff05[_0x4678f5(0x2ad)])['innerHTML']=_0x12b964[_0x4678f5(0x206)]||_0xff05['nwWma'];let _0x1d15e4='';if(_0x12b964[_0x4678f5(0x3b2)])_0x1d15e4+=_0x4678f5(0x2f2)+_0x12b964[_0x4678f5(0x3b2)]+_0x4678f5(0x385);if(_0x12b964[_0x4678f5(0x161)])_0x1d15e4+=_0x4678f5(0x193)+_0x12b964['question_video']+_0x4678f5(0x182);_0x12b964[_0x4678f5(0x280)]&&_0x12b964[_0x4678f5(0x280)][_0x4678f5(0x340)](_0x4437da=>{if(_0x4437da)_0x1d15e4+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22'+_0x4437da+'\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';});document['getElementById'](_0xff05[_0x4678f5(0x312)])['innerHTML']=_0x1d15e4;const _0x3bbba2=document['getElementById']('optionsContainer');_0x3bbba2[_0x4678f5(0x2c0)]='',_0x3bbba2[_0x4678f5(0x36b)][_0x4678f5(0x148)](_0x4678f5(0x1c6)),_0x12b964[_0x4678f5(0x3ae)]&&Array['isArray'](_0x12b964[_0x4678f5(0x3ae)])&&(_0xff05[_0x4678f5(0x336)]===_0xff05[_0x4678f5(0x30f)]?_0xff05['JuyTK'](_0x4301de,0x0)&&_0xff05['hFJkF'](_0x1465dd,_0x3d2354[_0x4678f5(0x248)])&&(_0x41f66e&&(_0x59c1c7[_0x5c1e79][_0x4678f5(0x272)]+=_0xff05[_0x4678f5(0x220)](_0x20c259[_0x4678f5(0x3e2)](),_0x1d4135)),_0x201302=_0x5b3fb4,_0xff05[_0x4678f5(0x223)](_0x4bb169),_0xbd24cc()):(_0x12b964['choices'][_0x4678f5(0x340)]((_0x4c0adc,_0x4fc667)=>{const _0x47b9b2=_0x4678f5,_0x2a2141={'aalMq':_0xff05[_0x47b9b2(0x38c)]};if(_0xff05[_0x47b9b2(0x343)]===_0xff05['CJYFt']){const _0x410090=String[_0x47b9b2(0x411)](0x41+_0x4fc667),_0x3538ff=selectedOption===_0x4fc667,_0x240dfa=document[_0x47b9b2(0x2c8)](_0x47b9b2(0x15e));_0x240dfa[_0x47b9b2(0x2c0)]=_0x47b9b2(0x3b7)+(_0x3538ff?_0xff05['VVknl']:'')+'\x22\x20data-option-index=\x22'+_0x4fc667+_0x47b9b2(0x2ef)+_0x410090+_0x47b9b2(0x306)+(_0x4c0adc['text']||_0xff05[_0x47b9b2(0x277)](_0xff05[_0x47b9b2(0x1d8)],_0xff05[_0x47b9b2(0x277)](_0x4fc667,0x1)))+_0x47b9b2(0x132),_0x3bbba2[_0x47b9b2(0x222)](_0x240dfa);}else _0xf22310(_0x2a2141['aalMq'])&&_0xd6fae();}),_0x3bbba2['addEventListener'](_0xff05['LLWWz'],function(_0x241d68){const _0x32df2f=_0x4678f5,_0x50167d=_0x241d68[_0x32df2f(0x2bc)]['closest'](_0xff05['tyqgt']);if(_0x50167d){if(_0xff05[_0x32df2f(0x293)](_0xff05[_0x32df2f(0x278)],_0xff05['zUZxI'])){const _0x142211=_0xff05[_0x32df2f(0x1a1)](parseInt,_0x50167d['getAttribute'](_0xff05[_0x32df2f(0x25c)]));_0xff05[_0x32df2f(0x1a1)](selectOption,_0x142211);}else _0x2c9671[_0x32df2f(0x26e)]=_0x551ba2;}}))),_0xff05[_0x4678f5(0x223)](updateBookmarkButton),_0xff05[_0x4678f5(0x223)](updateMarkReviewButton),(_0xff05['ymIzI'](currentMode,_0xff05[_0x4678f5(0x3a7)])||currentMode===_0xff05[_0x4678f5(0x2ec)])&&!isQuizCompleted&&_0xff05[_0x4678f5(0x2a1)](startTimer);}function selectOption(_0x17dd8e){const _0x5ca461=_0x578afd,_0x22e8fb={'qTQBp':'selected','uaRuZ':function(_0x101676,_0x1d77d4){return _0x101676===_0x1d77d4;},'uzXYf':'customQuizData','YZezQ':_0x5ca461(0x283),'ehbsF':function(_0x463a17,_0x17399e){return _0x463a17+_0x17399e;},'goVMd':_0x5ca461(0x201),'UClJY':_0x5ca461(0x2f9),'LMpTD':'answered','CkXyv':function(_0xa5d3ac,_0x3f823e){return _0xa5d3ac-_0x3f823e;},'qgWEi':_0x5ca461(0x27d),'bzmAO':function(_0xa43e18,_0x4d1aff){return _0xa43e18===_0x4d1aff;},'LAMrx':_0x5ca461(0x373),'iXkZF':'timed_study','ejovW':_0x5ca461(0x1b3),'yhMDf':function(_0x4eee1f){return _0x4eee1f();}},_0x464784=document[_0x5ca461(0x301)](_0x5ca461(0x3b5));if(_0x464784[_0x5ca461(0x36b)][_0x5ca461(0x16d)](_0x22e8fb[_0x5ca461(0x3bf)]))return;questionStartTime&&(questionStates[currentQuestionIndex]['timeSpent']+=_0x22e8fb[_0x5ca461(0x2fe)](Date[_0x5ca461(0x3e2)](),questionStartTime),questionStartTime=Date[_0x5ca461(0x3e2)]());selectedOption=_0x17dd8e,questionStates[currentQuestionIndex]['selectedAnswer']=_0x17dd8e,document[_0x5ca461(0x418)](_0x22e8fb['qgWEi'])[_0x5ca461(0x340)]((_0x31749a,_0x15e78f)=>{const _0x49f211=_0x5ca461;_0x31749a[_0x49f211(0x36b)][_0x49f211(0x243)](_0x22e8fb['qTQBp'],_0x22e8fb['uaRuZ'](_0x15e78f,_0x17dd8e));});if(_0x22e8fb[_0x5ca461(0x2e4)](currentMode,_0x22e8fb['LAMrx'])||currentMode===_0x22e8fb[_0x5ca461(0x2a7)])processAnswer();else{if(questionStates[currentQuestionIndex][_0x5ca461(0x261)]===_0x5ca461(0x389)){if(_0x22e8fb[_0x5ca461(0x2e4)](_0x22e8fb['ejovW'],_0x5ca461(0x155))){const _0x258e86=_0x9010f8['parse'](_0xe07d7[_0x5ca461(0x208)](_0x22e8fb['uzXYf']));if(_0x258e86){const _0x4a6438=_0x22e8fb[_0x5ca461(0x1b2)]['split']('|');let _0x2dc48b=0x0;while(!![]){switch(_0x4a6438[_0x2dc48b++]){case'0':_0x517c71[_0x5ca461(0x2ca)]=_0x22e8fb[_0x5ca461(0x386)](_0x14d400,_0x5ca461(0x279));continue;case'1':_0x5ef8ce[_0x5ca461(0x301)](_0x22e8fb['goVMd'])[_0x5ca461(0x125)]=_0x1f4df6[_0x5ca461(0x248)];continue;case'2':_0x287a1a['getElementById']('quizHierarchy')[_0x5ca461(0x125)]=_0x2abb4c[_0x5ca461(0x1a6)](_0x22e8fb[_0x5ca461(0x12e)]);continue;case'3':_0x5edd9d=_0x258e86['name'];continue;case'4':_0x49548a=_0x258e86['hierarchy'];continue;case'5':_0x290465=_0x258e86['questions'];continue;}break;}}}else questionStates[currentQuestionIndex]['status']=_0x22e8fb[_0x5ca461(0x3bf)],stats['totalAttempted']++,stats[_0x5ca461(0x1bd)]--;}updateQuestionNav();}_0x22e8fb[_0x5ca461(0x2df)](saveProgress);}function processAnswer(){const _0x248e08=_0x578afd,_0x18fead={'fHVoI':function(_0x58f6ac,_0xe1f8f0){return _0x58f6ac===_0xe1f8f0;},'mhGrn':function(_0x614703,_0x1e998d){return _0x614703===_0x1e998d;},'WwWct':_0x248e08(0x389),'bonab':'correct','rSeue':_0x248e08(0x16a),'tmTGr':function(_0x29db36){return _0x29db36();}},_0x3d797b=questionsData[currentQuestionIndex],_0xca672=_0x3d797b[_0x248e08(0x1d6)];if(_0x18fead[_0x248e08(0x1ae)](selectedOption,null))return;const _0x20a40d=_0x3d797b[_0x248e08(0x3ae)][selectedOption],_0x4203f5=_0x18fead[_0x248e08(0x25d)](_0x20a40d['id'],_0xca672);if(_0x18fead['mhGrn'](questionStates[currentQuestionIndex]['status'],_0x18fead[_0x248e08(0x27e)])){stats['totalAttempted']++,stats[_0x248e08(0x1bd)]--;if(_0x4203f5)stats['correctAnswers']++;else stats[_0x248e08(0x3ba)]++;}questionStates[currentQuestionIndex][_0x248e08(0x261)]=_0x4203f5?_0x18fead[_0x248e08(0x284)]:_0x18fead[_0x248e08(0x1c5)],updateStats(),showInlineFeedback(_0x4203f5),_0x18fead[_0x248e08(0x287)](updateQuestionNav);}function showInlineFeedback(_0x41b3ef){const _0x20d9e8=_0x578afd,_0x111981={'vrTOK':function(_0x27c32c,_0x372f93){return _0x27c32c===_0x372f93;},'kqNwt':_0x20d9e8(0x355),'FZuXv':_0x20d9e8(0x172),'nZJEl':_0x20d9e8(0x1ab),'eYaOF':function(_0x2e8d33,_0x52fd47){return _0x2e8d33===_0x52fd47;},'blGmo':_0x20d9e8(0x16a),'mvEjN':function(_0x35a13a,_0x4a8979){return _0x35a13a!==_0x4a8979;},'LNknB':_0x20d9e8(0x373),'xyFLj':function(_0x16db5d,_0x62eb92){return _0x16db5d!==_0x62eb92;},'CFzYX':_0x20d9e8(0x2d3),'iZIIG':_0x20d9e8(0x3b5),'PkHHr':_0x20d9e8(0x27d),'KuRph':'answered','biexf':function(_0x1a02e7){return _0x1a02e7();}};if(_0x111981['mvEjN'](currentMode,_0x111981[_0x20d9e8(0x324)])&&_0x111981[_0x20d9e8(0x3c5)](currentMode,_0x111981[_0x20d9e8(0x3bc)]))return;const _0x121444=document[_0x20d9e8(0x301)](_0x111981[_0x20d9e8(0x124)]),_0x3b8ebc=_0x121444[_0x20d9e8(0x418)](_0x111981['PkHHr']),_0x3a4b65=questionsData[currentQuestionIndex],_0x243b31=_0x3a4b65['correct_choice_id'];let _0x56aaa9=_0x3a4b65['choices'][_0x20d9e8(0x2b9)](_0x3e4b31=>_0x3e4b31['id']===_0x243b31);_0x121444['classList']['add'](_0x111981[_0x20d9e8(0x290)]),_0x3b8ebc[_0x20d9e8(0x340)]((_0x508dd5,_0x40f6ab)=>{const _0x5db9c3=_0x20d9e8;if(_0x111981[_0x5db9c3(0x2a2)](_0x111981['kqNwt'],'EMIIg')){_0x508dd5['classList'][_0x5db9c3(0x148)](_0x111981[_0x5db9c3(0x1eb)]);if(_0x40f6ab===_0x56aaa9)_0x508dd5['classList'][_0x5db9c3(0x40c)](_0x111981[_0x5db9c3(0x2c6)]);else{if(_0x111981[_0x5db9c3(0x297)](_0x40f6ab,selectedOption)&&!_0x41b3ef)_0x508dd5['classList'][_0x5db9c3(0x40c)](_0x111981[_0x5db9c3(0x37d)]);}}else _0x185d11[_0x5db9c3(0x2c0)]+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22'+_0x3901b3[_0x5db9c3(0x1f2)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';}),_0x111981[_0x20d9e8(0x199)](showSolution);}function showSolution(){const _0x5a28c7=_0x578afd,_0xe870fb={'wHGVC':function(_0x1e0b14,_0xfda69a){return _0x1e0b14<_0xfda69a;},'TVuKG':_0x5a28c7(0x1e2),'tLSZg':_0x5a28c7(0x3e9),'hXicQ':_0x5a28c7(0x281),'MmdrG':function(_0x31f9bd,_0x4e81d0){return _0x31f9bd===_0x4e81d0;},'ExJQt':_0x5a28c7(0x263),'Xwnaq':function(_0x1e3e59,_0x406899){return _0x1e3e59!==_0x406899;},'AjKJm':function(_0x3d6734,_0xfc902a){return _0x3d6734!==_0xfc902a;},'WpCoh':_0x5a28c7(0x2d3),'LAOzJ':_0x5a28c7(0x173),'kqVVt':_0x5a28c7(0x2c2),'QHZxR':'explanationVideoPlayer','pSAOy':function(_0x3da6c3,_0x3f50b6){return _0x3da6c3!==_0x3f50b6;},'NxoiF':_0x5a28c7(0x33a),'dbfNo':'hidden','POsbl':_0x5a28c7(0x145),'LExpk':function(_0x6dcbd6,_0x3495ed,_0xa28864){return _0x6dcbd6(_0x3495ed,_0xa28864);},'JhfOD':_0x5a28c7(0x1e4),'tYzgT':_0x5a28c7(0x32a),'RbaoM':_0x5a28c7(0x3f5),'VnHzW':_0x5a28c7(0x129)};if(_0xe870fb[_0x5a28c7(0x1e0)](currentMode,_0x5a28c7(0x373))&&_0xe870fb[_0x5a28c7(0x3cd)](currentMode,_0xe870fb[_0x5a28c7(0x327)]))return;const _0x44c5df=questionsData[currentQuestionIndex];document[_0x5a28c7(0x301)](_0xe870fb['LAOzJ'])[_0x5a28c7(0x2c0)]=_0x44c5df[_0x5a28c7(0x332)]||_0xe870fb['kqVVt'];const _0x8ea7c7=document[_0x5a28c7(0x301)](_0x5a28c7(0x1e6)),_0x3b87d0=document[_0x5a28c7(0x301)](_0xe870fb[_0x5a28c7(0x318)]),_0x5b949f=_0x44c5df[_0x5a28c7(0x2be)];if(_0x5b949f){if(_0xe870fb['pSAOy'](_0xe870fb[_0x5a28c7(0x3b3)],_0xe870fb['NxoiF']))_0x174115[_0x5a28c7(0x16b)]['forEach'](_0x307e42=>{const _0x257dae=_0x5a28c7;if(_0x307e42)_0x43ffb0['innerHTML']+=_0x257dae(0x3df)+_0x307e42+_0x257dae(0x2d4);});else{_0x8ea7c7[_0x5a28c7(0x36b)]['remove'](_0xe870fb[_0x5a28c7(0x213)]);if(_0x5b949f['includes'](_0xe870fb[_0x5a28c7(0x2b8)]))_0xe870fb['LExpk'](setupVideo,_0x3b87d0,_0x5b949f);else _0x3b87d0[_0x5a28c7(0x26e)]=_0x5b949f;}}else _0x8ea7c7[_0x5a28c7(0x36b)][_0x5a28c7(0x40c)](_0xe870fb[_0x5a28c7(0x213)]);const _0x22a39b=document[_0x5a28c7(0x301)](_0xe870fb['JhfOD']);_0x22a39b[_0x5a28c7(0x2c0)]='';_0x44c5df[_0x5a28c7(0x1f2)]&&(_0x22a39b[_0x5a28c7(0x2c0)]+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22'+_0x44c5df[_0x5a28c7(0x1f2)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>');_0x44c5df[_0x5a28c7(0x13c)]&&(_0x22a39b[_0x5a28c7(0x2c0)]+=_0x5a28c7(0x1cb)+_0x44c5df[_0x5a28c7(0x13c)]+_0x5a28c7(0x385));const _0x1766a4=document[_0x5a28c7(0x301)](_0xe870fb[_0x5a28c7(0x294)]);_0x1766a4['innerHTML']='';if(_0x44c5df[_0x5a28c7(0x16b)]){if(_0xe870fb[_0x5a28c7(0x232)]('rVcPx',_0xe870fb[_0x5a28c7(0x3f7)])){const _0x3fbcf6=_0x3920ba['parse'](_0x2dd5b5[_0x5a28c7(0x208)](_0xe870fb[_0x5a28c7(0x140)]))||[];_0x3fbcf6[_0x5a28c7(0x340)](_0x2e30e4=>{const _0x44599e=_0x5a28c7;_0x2e30e4[_0x44599e(0x180)][_0x44599e(0x3c6)](_0x4382be[_0x44599e(0x24f)]()[_0x44599e(0x21a)](/ /g,'-'))&&(_0xe870fb['wHGVC'](_0x2e30e4['questionIndex'],_0x1a93d7['length'])&&(_0x354139[_0x2e30e4[_0x44599e(0x15d)]][_0x44599e(0x3d2)]=!![]));});}else _0x44c5df[_0x5a28c7(0x16b)][_0x5a28c7(0x340)](_0x2be8af=>{const _0x5b84ca=_0x5a28c7,_0x36cf86={'mREzl':_0xe870fb[_0x5b84ca(0x364)],'bATwF':_0xe870fb['hXicQ']};if(_0xe870fb[_0x5b84ca(0x257)](_0xe870fb[_0x5b84ca(0x1b8)],_0xe870fb[_0x5b84ca(0x1b8)])){if(_0x2be8af)_0x1766a4[_0x5b84ca(0x2c0)]+=_0x5b84ca(0x3df)+_0x2be8af+_0x5b84ca(0x2d4);}else{const _0x8f98d7=_0xec3de3['parse'](_0x2c600f['getItem'](_0x36cf86['mREzl']))||{},_0x56717d=_0x3073f4[_0x5b84ca(0x248)],_0x367edf=_0x194280[_0x5b84ca(0x414)]||0x0;_0x8f98d7[_0x90ad6f]={'score':_0x367edf,'total':_0x56717d,'status':_0x36cf86['bATwF'],'completedOn':new _0x3f92cd()[_0x5b84ca(0x417)]()},_0x202303[_0x5b84ca(0x186)](_0x5b84ca(0x3e9),_0x31342a[_0x5b84ca(0x149)](_0x8f98d7));}});}document['getElementById'](_0xe870fb[_0x5a28c7(0x372)])[_0x5a28c7(0x36b)][_0x5a28c7(0x148)](_0x5a28c7(0x3c3));}function submitQuiz(){const _0x1ef0c6=_0x578afd,_0xf3cc49={'dAPUq':function(_0x46acbf,_0x5bae6a){return _0x46acbf-_0x5bae6a;},'fiEjv':function(_0x29926c){return _0x29926c();},'WDaSu':_0x1ef0c6(0x3aa),'NuQIb':_0x1ef0c6(0x1ab),'qFFZn':'RlDYt','SxZoZ':_0x1ef0c6(0x16a),'AIFok':function(_0x17a531,_0x3b9380){return _0x17a531(_0x3b9380);},'xBRVe':_0x1ef0c6(0x40f),'FhIdQ':function(_0x50d1c9,_0x28ed56){return _0x50d1c9-_0x28ed56;},'MUWsP':function(_0x1e97d5,_0x2fc4f2){return _0x1e97d5+_0x2fc4f2;},'egBcQ':function(_0x1046d3,_0x491bb5,_0x5db980,_0x57bcd4,_0x50a400){return _0x1046d3(_0x491bb5,_0x5db980,_0x57bcd4,_0x50a400);}};if(timer)clearInterval(timer);if(!_0xf3cc49['AIFok'](confirm,'Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?'))return;isQuizCompleted=!![];let _0x46bcf2=0x0,_0x1d612f=0x0;const _0x411886=_0xf3cc49[_0x1ef0c6(0x406)](Date[_0x1ef0c6(0x3e2)](),quizStartTime);questionsData['forEach']((_0x132d3c,_0x4f1f84)=>{const _0x27c29c=_0x1ef0c6,_0x4d78b7=questionStates[_0x4f1f84];_0x4d78b7['selectedAnswer']!==null&&('JdxXY'===_0xf3cc49['WDaSu']?_0x5c32e0=_0x59463f:_0x132d3c[_0x27c29c(0x3ae)][_0x4d78b7[_0x27c29c(0x266)]]['id']===_0x132d3c[_0x27c29c(0x1d6)]?(_0x46bcf2++,_0x4d78b7[_0x27c29c(0x261)]=_0xf3cc49[_0x27c29c(0x3f4)]):_0xf3cc49[_0x27c29c(0x21c)]!==_0xf3cc49['qFFZn']?(_0x1884b0&&(_0x184805[_0x1927d4][_0x27c29c(0x272)]+=_0xf3cc49[_0x27c29c(0x406)](_0x28329c[_0x27c29c(0x3e2)](),_0x550394)),_0x322626=_0x2684a9,_0xf3cc49[_0x27c29c(0x237)](_0x26062e),_0xf3cc49[_0x27c29c(0x237)](_0x47c7e9)):(_0x1d612f++,_0x4d78b7[_0x27c29c(0x261)]=_0xf3cc49[_0x27c29c(0x315)]));});const _0x151c7b=JSON[_0x1ef0c6(0x407)](localStorage['getItem'](_0xf3cc49[_0x1ef0c6(0x2b4)]))||[];_0x151c7b[_0x1ef0c6(0x1ff)]({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x1ef0c6(0x3e2)](),'totalTime':_0x411886,'stats':{'correct':_0x46bcf2,'incorrect':_0x1d612f,'notAttempted':_0xf3cc49[_0x1ef0c6(0x304)](questionsData[_0x1ef0c6(0x248)],_0xf3cc49[_0x1ef0c6(0x1f3)](_0x46bcf2,_0x1d612f))}}),localStorage['setItem'](_0xf3cc49[_0x1ef0c6(0x2b4)],JSON[_0x1ef0c6(0x149)](_0x151c7b)),stats[_0x1ef0c6(0x414)]=_0x46bcf2,stats[_0x1ef0c6(0x3ba)]=_0x1d612f,_0xf3cc49[_0x1ef0c6(0x237)](markQuizAsCompleted),_0xf3cc49[_0x1ef0c6(0x3de)](showPerformanceAnalysis,_0x46bcf2,_0x1d612f,questionsData[_0x1ef0c6(0x248)]-_0xf3cc49[_0x1ef0c6(0x1f3)](_0x46bcf2,_0x1d612f),_0x411886);}function showPerformanceAnalysis(_0x1737e2,_0x336523,_0x40a8de,_0x3d5bfd){const _0x5261f0=_0x578afd,_0x25ccd4={'uabtL':function(_0x21d433,_0x4115ba){return _0x21d433+_0x4115ba;},'yJnTN':function(_0x3a7518,_0x4a6935){return _0x3a7518*_0x4a6935;},'rIOLk':function(_0x23dc35,_0x1b88b3){return _0x23dc35/_0x1b88b3;},'OlPYt':function(_0x43be4e,_0x423243){return _0x43be4e/_0x423243;},'AavWS':_0x5261f0(0x242),'uFUlR':_0x5261f0(0x339),'KUFCE':_0x5261f0(0x178),'wDVlB':'incorrectResult','KfsNr':function(_0x358590,_0x5ec1b8){return _0x358590%_0x5ec1b8;},'hWowA':function(_0x13cd61,_0x435980){return _0x13cd61%_0x435980;},'ucLgY':'avgTimeResult','trTxP':_0x5261f0(0x3c3)},_0x4b6032=document[_0x5261f0(0x301)](_0x5261f0(0x226)),_0x9576c7=_0x25ccd4[_0x5261f0(0x370)](_0x1737e2,_0x336523)>0x0?Math[_0x5261f0(0x1ad)](_0x25ccd4[_0x5261f0(0x354)](_0x25ccd4['rIOLk'](_0x1737e2,_0x25ccd4[_0x5261f0(0x370)](_0x1737e2,_0x336523)),0x64)):0x0,_0x16b25c=_0x25ccd4[_0x5261f0(0x354)](0x2,Math['PI'])*0x41,_0x45b995=document[_0x5261f0(0x301)](_0x5261f0(0x258));_0x45b995['style'][_0x5261f0(0x1b5)]=_0x16b25c+'\x20'+_0x16b25c,_0x45b995[_0x5261f0(0x30c)]['strokeDashoffset']=_0x16b25c-_0x25ccd4['yJnTN'](_0x25ccd4['OlPYt'](_0x9576c7,0x64),_0x16b25c),document[_0x5261f0(0x301)](_0x25ccd4[_0x5261f0(0x3f1)])['textContent']=_0x9576c7+'%',document[_0x5261f0(0x301)](_0x25ccd4[_0x5261f0(0x194)])['textContent']=questionsData['length'],document[_0x5261f0(0x301)](_0x25ccd4[_0x5261f0(0x380)])[_0x5261f0(0x125)]=_0x1737e2,document['getElementById'](_0x25ccd4[_0x5261f0(0x235)])['textContent']=_0x336523,document[_0x5261f0(0x301)](_0x5261f0(0x1ed))[_0x5261f0(0x125)]=_0x40a8de;const _0x131b27=Math[_0x5261f0(0x28d)](_0x3d5bfd/0xea60),_0x2949da=Math['floor'](_0x25ccd4[_0x5261f0(0x1df)](_0x3d5bfd,0xea60)/0x3e8);document[_0x5261f0(0x301)](_0x5261f0(0x412))[_0x5261f0(0x125)]=_0x131b27+':'+_0x2949da[_0x5261f0(0x2f5)]()['padStart'](0x2,'0');const _0x301a59=_0x3d5bfd/questionsData['length'],_0x5203c6=Math[_0x5261f0(0x28d)](_0x301a59/0xea60),_0x28a40f=Math[_0x5261f0(0x28d)](_0x25ccd4[_0x5261f0(0x2e5)](_0x25ccd4[_0x5261f0(0x1b6)](_0x301a59,0xea60),0x3e8));document[_0x5261f0(0x301)](_0x25ccd4[_0x5261f0(0x26b)])[_0x5261f0(0x125)]=_0x5203c6+':'+_0x28a40f['toString']()[_0x5261f0(0x274)](0x2,'0'),_0x4b6032[_0x5261f0(0x36b)][_0x5261f0(0x148)](_0x25ccd4['trTxP']);}function closePerformanceModal(){const _0x2498a8=_0x578afd,_0x37f159={'JAJLj':_0x2498a8(0x3c3)};document['getElementById']('performanceModal')[_0x2498a8(0x36b)][_0x2498a8(0x40c)](_0x37f159[_0x2498a8(0x20a)]);}function _0x4075(){const _0x3c0996=['<p><span\x20style=\x22font-size:12.0pt;\x22>An\x2018-year-old\x20male\x20has\x20had\x20a\x205-year\x20history\x20of\x20renal\x20failure.\x20On\x20examination,\x20he\x20had\x20maculopapular\x20rashes,\x20erythema\x20nodosum,\x20arthritis,\x20hepatomegaly,\x20and\x20splenomegaly.\x20Chest\x20X-ray\x20shows\x20hilar\x20adenopathy.\x20A\x20renal\x20biopsy\x20specimen\x20revealed\x20tubulointerstitial\x20nephritis\x20and\x20non-caseating\x20granulomatous\x20lesions.\x20What\x20is\x20the\x20diagnosis?</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Basement\x20membrane\x20spikes</span></p>','<p><strong>Explanation:</strong></p>\x0a<ul>\x0a<li><strong>RA</strong>\x20is\x20a\x20classic\x20predisposing\x20condition\x20for\x20<strong>AA\x20amyloidosis</strong>.</li>\x0a<li>Chronic\x20inflammation\x20leads\x20to\x20increased\x20serum\x20amyloid\x20A\x20(SAA)\x20protein,\x20which\x20deposits\x20in\x20the\x20kidneys.</li>\x0a<li>Amyloidosis\x20typically\x20causes\x20<strong>proteinuria</strong>\x20(may\x20be\x20nephrotic\x20range).</li>\x0a<li>Hematuria\x20may\x20also\x20be\x20seen.</li>\x0a<li>Given\x20RFT\x20suggests\x20<strong>progressive\x20renal\x20impairment</strong>,\x20often\x20seen\x20in\x20<strong>amyloidosis</strong>\x20or\x20other\x20glomerular\x20pathologies.</li>\x0a</ul>\x0a<h3>Explanation\x20of\x20Other\x20Options:</h3>\x0a<p><strong>Diabetic\x20nephropathy(Option\x20A):\x20</strong>In\x20Type\x20II\x20diabetes,\x20the\x20correlation\x20between\x20retinopathy\x20and\x20nephropathy\x20is\x20poor.\x20Only\x2060%\x20of\x20patients\x20with\x20nephropathy\x20have\x20retinopathy\x20coexisting.\x20Nephropathy\x20typically\x20develops\x20over\x20the\x20years</p>\x0a<p><strong>Chronic\x20interstitial\x20nephritis(Option\x20C):\x20</strong>Long\x20NSAID\x20use\x20supports\x20it,\x20but\x20CIN\x20rarely\x20causes\x20++\x20proteinuria.\x20Chronic\x20interstitial\x20nephritis\x20causes\x20mild\x20proteinuria.\x20RBC\x20is\x20not\x20seen\x20in\x20the\x20urine.</p>\x0a<p><strong>Renal\x20calculi(Option\x20D):</strong>\x20Would\x20show\x20<strong>gross/microscopic\x20hematuria</strong>,\x20<strong>pain</strong>,\x20not\x20heavy\x20proteinuria\x20or\x20progressive\x20renal\x20impairment.\x20Renal\x20calculi\x20are\x20unlikely,\x20as\x20there\x20is\x20no\x20history\x20of\x20pain\x20or\x20gross\x20hematuria.</p>','timeSpent','OzCtt','padStart','VVqKw','skJpg','vVJif','zUZxI','\x20-\x20Brain\x20And\x20Scalpel','href','NWKvp','stats','.option-button','WwWct','<p><strong>Explanation:</strong></p>\x0a<p>The\x20question\x20deals\x20with\x20multi-system\x20involvement\x20with\x20non-caseating\x20or\x20naked\x20granulomas,\x20which\x20is\x20characteristic\x20of\x20<strong>Sarcoidosis.</strong></p>\x0a<p><strong>Sarcoidosis:</strong></p>\x0a<ul>\x0a<li>Sarcoidosis\x20is\x20a\x20chronic,\x20multi-system\x20granulomatous\x20disorder\x20of\x20unknown\x20aetiology\x20characterised\x20by\x20<strong>non-caseating\x20granulomas.\x20</strong></li>\x0a<li>The\x20most\x20commonly\x20affected\x20organ\x20is\x20the\x20<strong>lung</strong>;\x20other\x20organs\x20include\x20the\x20lymph\x20nodes,\x20skin,\x20eyes,\x20parotid\x20glands,\x20bones,\x20joints,\x20liver,\x20and\x20kidneys.</li>\x0a<li>Patients\x20mostly\x20present\x20with\x20respiratory\x20symptoms\x20or\x20joint\x20and\x20skin\x20manifestations.</li>\x0a<li><strong>Renal\x20involvement\x20and\x20presentation</strong>\x20with\x20renal\x20failure\x20are\x20relatively\x20rare\x20in\x20sarcoidosis.</li>\x0a<li><strong>Renal\x20sarcoidosis</strong>\x20is\x20reported\x20to\x20have\x20three\x20categories:\x0a<ul>\x0a<li>Renal\x20changes\x20due\x20to\x20<strong>abnormal\x20calcium\x20metabolism\x20</strong>(the\x20most\x20common\x20cause\x20of\x20renal\x20impairment\x20in\x20Sarcoidosis),</li>\x0a<li>Interstitial\x20nephritis\x20or\x20granulomatous\x20nephritis\x20or\x20granulomatous\x20nephritis\x20and</li>\x0a<li>Glomerulonephritis(mostly\x20membranous).</li>\x0a</ul>\x0a</li>\x0a<li><strong>Multisystem\x20involvement:</strong>\x0a<ul>\x0a<li><strong>Skin:</strong>\x20Maculopapular\x20rash,\x20<strong>erythema\x20nodosum</strong></li>\x0a<li><strong>Joints:</strong>\x20Arthritis</li>\x0a<li><strong>Liver\x20&amp;\x20spleen:</strong>\x20Hepatomegaly\x20and\x20splenomegaly</li>\x0a<li><strong>Lungs/Chest\x20X-ray:</strong>\x20Bilateral\x20hilar\x20lymphadenopathy</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Granulomatosis\x20with\x20polyangiitis\x20(Option\x20A)\x20</strong>also\x20involves\x20the\x20lungs\x20in\x20the\x20form\x20of\x20pulmonary\x20infiltrates\x20or\x20nodules,\x20along\x20with\x20upper\x20respiratory\x20involvement.\x20Hilar\x20adenopathy\x20is\x20not\x20seen.\x20Cutaneous\x20nodules\x20and\x20arthritis\x20can\x20also\x20be\x20seen,\x20but\x20hepatosplenomegaly\x20has\x20not\x20been\x20described.\x20But\x20the\x20biopsy\x20reveals\x20necrotising\x20granulomas.</p>\x0a<p><strong>Lupus\x20nephritis\x20(Option\x20B)\x20</strong>may\x20cause\x20an\x20overlap\x20of\x20nephrotic\x20and\x20nephritic\x20syndrome\x20and\x20may\x20have\x20a\x20maculopapular\x20rash,\x20esp.\x20on\x20the\x20face\x20(butterfly\x20distribution).</p>\x0a<p><strong>Renal\x20tuberculosis\x20(Option\x20C)\x20</strong>can\x20occur\x20as\x20a\x20late\x20complication\x20of\x20primary\x20TB\x20and\x20thus\x20has\x20hilar\x20adenopathy,\x20but\x20causes\x20caseating\x20granulomas.</p>\x0a<p><br\x20/>\x20<br\x20/>\x20</p>','question_images','completed','<p><span\x20style=\x22font-size:12.0pt;\x22>Nail\x20pitting</span></p>','5|3|4|0|1|2','bonab','<p><span\x20style=\x22font-size:12.0pt;\x22>Hypoalbuminemia</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Leptospirosis</span></p>','tmTGr','jcyot','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2050-year\x20diabetic\x20patient\x20is\x20on\x20the\x20following\x20medication:\x20Metformin\x201g\x20tds,\x20Gliclazide\x2080\x20mg\x20bd,\x20Ramipril\x205\x20mg\x20daily,\x20and\x20Atenolol\x2050\x20mg.\x20Her\x20blood\x20results\x20show:\x20urea\x2078\x20mg/dl,\x20creatinine\x202.15\x20mg/d,\x20sodium\x20138\x20mmol/L,\x20potassium\x204.0\x20mmol/l.\x20Which\x20of\x20the\x20following\x20medications\x20should\x20be\x20withdrawn?</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Granulomatosis\x20with\x20polyangiitis</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Diminished\x20activity\x20of\x20renal\x201&alpha;\x20Hydroxylase</span></p>','DocTutorial','floor','oZNAI','oTQqy','KuRph','QgPlB','SPuWE','rgFca','tYzgT','HbawY','<p><strong>Explanation\x20of\x20Answer:</strong></p>\x0a<p><strong>Diabetes\x20mellitus</strong>\x20is\x20the\x20leading\x20cause\x20of\x20CKD\x20in\x20North\x20America\x20and\x20Europe,\x20while\x20<strong>glomerulonephritis</strong>,\x20particularly\x20IgA\x20nephropathy,\x20is\x20a\x20leading\x20cause\x20in\x20some\x20developing\x20regions.</p>\x0a<p><strong>Major\x20Causes\x20of\x20CKD\x20Globally:</strong></p>\x0a<ul>\x0a<li><strong>Diabetic\x20nephropathy</strong>\x20(most\x20common\x20worldwide,\x20especially\x20in\x20type\x202\x20diabetes)</li>\x0a<li><strong>Glomerulonephritis</strong>\x20(e.g.,\x20IgA\x20nephropathy\x20-\x20more\x20common\x20in\x20some\x20developing\x20regions)</li>\x0a<li><strong>Hypertensive\x20nephrosclerosis</strong></li>\x0a<li><strong>Polycystic\x20kidney\x20disease</strong>\x20(particularly\x20ADPKD)</li>\x0a<li><strong>Tubulointerstitial\x20and\x20cystic\x20disorders</strong></li>\x0a</ul>','eYaOF','sdyHQ','<p><span\x20style=\x22font-size:12.0pt;\x22>Erythropoietin\x20deficiency</span></p>','MyamD','constructor','MWOkf','currentQuestion','DT1197870','split','DT1197956','OXxvM','vrTOK','404823ZbqDRk','EfnXm','eBKpr','rYWnr','iXkZF','strokeDashoffset','pmKTJ','yIzTy','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','questionReviewSection','quqtA','<p><span\x20style=\x22font-size:12.0pt;\x22>Chronic\x20Obstructive\x20Uropathy</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Polycystic\x20kidney\x20disease</span></p>','return\x20(function()\x20','PtSoR','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2060-year-old\x20man\x20with\x20long-standing\x20type\x202\x20diabetes,\x20who\x20has\x20recently\x20started\x20on\x20peritoneal\x20dialysis,\x20is\x20admitted\x20with\x20a\x20fractured\x20femoral\x20neck.\x20His\x20serum\x20calcium\x20concentration\x20is\x2011.6\x20mg/dl,\x20phosphate\x20is\x206\x20mg/dL,\x20and\x20PTH\x20is\x205.6\x20pg/mL\x20(normal\x20range\x2010-65).\x20Medications\x20include\x20alfacalcidol\x200.5\x20mg\x20daily\x20and\x20calcium\x20carbonate\x20500\x20mg\x20three\x20times\x20daily.\x20What\x20would\x20a\x20bone\x20biopsy\x20show?</span></p>','jbUkK','xBRVe','<p><strong>Explanation:</strong></p>\x0a<p>The\x20patient\x20has\x20hyperkalemia\x20(K\x206.5\x20mmol/L),\x20high\x20urea\x20(270\x20mg/dL),\x20and\x20hypertension,\x20indicating\x20<strong>inadequate\x20dialysis</strong>.\x20<strong>Increasing\x20dialysis</strong>\x20duration\x20improves\x20the\x20clearance\x20of\x20potassium,\x20urea,\x20and\x20fluid,\x20addressing\x20these\x20issues.</p>\x0a<p><strong>Increasing\x20dialysis\x20duration</strong>\x20will:</p>\x0a<ul>\x0a<li>Improve\x20<strong>potassium\x20clearance</strong></li>\x0a<li>Lower\x20<strong>urea</strong></li>\x0a<li>Help\x20<strong>volume\x20control\x20&rarr;\x20lower\x20BP</strong></li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Aluminium\x20phosphate\x20binders\x20(Option\x20A)\x20</strong>are\x20not\x20indicated\x20as\x20the\x20patient\x27s\x20phosphate\x20level\x20is\x20elevated,\x20and\x20aluminum\x20binders\x20are\x20rarely\x20used\x20due\x20to\x20toxicity\x20risks.</p>\x0a<p><strong>Alfacalcidol\x20supplements\x20(Option\x20B):\x20</strong>Vitamin\x20D\x20supplementation\x20may\x20be\x20beneficial\x20for\x20secondary\x20hyperparathyroidism,\x20but\x20it\x20is\x20not\x20the\x20priority\x20here,\x20as\x20increasing\x20dialysis\x20duration\x20addresses\x20hyperkalemia,\x20uremia,\x20and\x20hypertension\x20more\x20effectively.</p>\x0a<p><strong>Erythropoietin\x20supplements\x20(Option\x20D):\x20</strong>EPO\x20supplements\x20are\x20probably\x20beneficial;\x20longer\x20dialysis\x20sessions\x20would\x20help\x20clear\x20the\x20fluid\x20overload\x20and\x20reno-toxins.</p>','AaLgK','YfXJf','POsbl','findIndex','gwnvo','KOfUN','target','<p><span\x20style=\x22font-size:12.0pt;\x22>Small\x20vessel\x20ischaemia</span></p>','explanation_video','RrwmJ','innerHTML','nYmws','No\x20solution\x20provided','tWTqN','DjhAo','DT1197893','nZJEl','quizSidebar','createElement','3270463UtpSkU','title','bfRtX','JCQmr','width','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2040-year-old\x20man\x20with\x20type\x201\x20diabetes\x20attends\x20a\x20follow-up\x20appointment\x20in\x20the\x20diabetic\x20clinic.\x20He\x20has\x20a\x20blood\x20pressure\x20of\x20145/86\x20mmHg.\x20There\x20is\x20no\x20evidence\x20of\x20diabetic\x20retinopathy\x20or\x20neuropathy.\x20He\x20has\x20an\x20elevated\x20albumin:\x20creatinine\x20ratio\x20in\x20his\x20urine.\x20Creatinine\x20is\x201.01\x20mg/dl.\x20Which\x20of\x20the\x20following\x20should\x20be\x20done?</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Thyroxine</span></p>','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','<p><span\x20style=\x22font-size:12.0pt;\x22>Hb\x20of\x2012\x20g/dl</span></p>','CAtwE','timed_study','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','ArrowLeft','dnLWf','<p><span\x20style=\x22font-size:12.0pt;\x22>IgA\x20nephropathy</span></p>','totalTime','<p><span\x20style=\x22font-size:12.0pt;\x22>Increased\x20dialysis</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Glucose\x20metabolism\x20is\x20impaired\x20in\x20CKD.</span></p>','DT1219943','lTgIu','eBxSU','gmSLl','yhMDf','ZJfeB','location','<p><strong>Explanation:</strong></p>\x0a<p>This\x20patient\x20with\x20progressive\x20dementia\x20after\x20long-term\x20hemodialysis\x20likely\x20has\x20<strong>aluminium\x20toxicity</strong>,\x20especially\x20if\x20exposed\x20to\x20aluminium-containing\x20phosphate\x20binders\x20or\x20non-deionised\x20water.\x20Aluminium\x20accumulation\x20in\x20the\x20brain\x20can\x20cause\x20<strong>dialysis\x20dementia</strong>,\x20a\x20known\x20complication\x20of\x20chronic\x20dialysis\x20in\x20earlier\x20eras.</p>\x0a<p><strong>Aluminium\x20encephalopathy</strong>\x20(dialysis\x20dementia):</p>\x0a<ul>\x0a<li>Occurs\x20in\x20patients\x20on\x20long-term\x20dialysis</li>\x0a<li>Associated\x20with\x20progressive\x20dementia,\x20speech\x20disturbances,\x20myoclonus,\x20seizures,\x20and\x20behavioural\x20changes</li>\x0a</ul>\x0a<p><strong>Pathophysiology:</strong></p>\x0a<ul>\x0a<li>Aluminium\x20crosses\x20the\x20<strong>blood-brain\x20barrier</strong>\x20and\x20accumulates\x20in\x20the\x20<strong>grey\x20matter</strong>,\x20especially\x20the\x20<strong>hippocampus\x20and\x20cortex</strong>.</li>\x0a<li>Leads\x20to\x20<strong>neuronal\x20degeneration</strong>,\x20demyelination,\x20and\x20spongiform\x20changes.</li>\x0a<li>Associated\x20with\x20<strong>microglial\x20activation</strong>\x20and\x20<strong>astrocyte\x20dysfunction</strong>.</li>\x0a</ul>\x0a<p><strong>Diagnosis:</strong></p>\x0a<ul>\x0a<li><strong>Clinical\x20suspicion</strong>\x20in\x20long-term\x20dialysis\x20patients\x20with\x20neurologic\x20symptoms</li>\x0a<li><strong>History\x20of\x20aluminium\x20exposure</strong></li>\x0a<li><strong>Serum\x20aluminium\x20levels</strong></li>\x0a<li><strong>MRI\x20brain</strong>:\x20nonspecific\x20atrophy;\x20sometimes\x20cortical\x20signal\x20changes</li>\x0a<li><strong>Bone\x20biopsy</strong>:\x20evidence\x20of\x20aluminium\x20accumulation</li>\x0a</ul>\x0a<p><strong>Treatment:</strong></p><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250917cbfb08f7-1ba1-47b3-b968-18071ba12999.png\x22>\x0a<p><strong>Prevention:</strong></p>\x0a<ul>\x0a<li>Avoid\x20aluminium-based\x20phosphate\x20binders</li>\x0a<li>Use\x20<strong>aluminium-free\x20dialysate</strong></li>\x0a<li>Routine\x20monitoring\x20of\x20<strong>serum\x20aluminium</strong>\x20in\x20dialysis\x20patients</li>\x0a<li>Education\x20on\x20<strong>medication\x20safety</strong></li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Urea\x20disequilibrium\x20(Option\x20A)\x20</strong>occurs\x20immediately\x20after\x20dialysis,\x20not\x20years\x20later;\x20presents\x20with\x20acute\x20cerebral\x20oedema,\x20nausea,\x20and\x20confusion</p>\x0a<p><strong>Small\x20vessel\x20ischaemia\x20(Option\x20B)\x20</strong>can\x20cause\x20dementia,\x20but\x20not\x20the\x20most\x20characteristic\x20or\x20expected\x20in\x20this\x20dialysis\x20context.</p>\x0a<p><strong>Amyloidosis\x20(Option\x20D)\x20</strong>can\x20occur\x20with\x20long-term\x20dialysis\x20(&gt;10\x20years),\x20but\x20it\x20typically\x20affects\x20joints,\x20bones,\x20and\x20heart,\x20not\x20predominantly\x20dementia</p>','No\x20questions\x20available\x20for\x20this\x20quiz.','bzmAO','rIOLk','navBtn_','timeDisplay','reload','index.html','GhDHP','UAusJ','MvGxh','<p><span\x20style=\x22font-size:12.0pt;\x22>Hypermobility</span></p>','name','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','bJSIX','<p><strong>Explanation:</strong></p>\x0a<ul>\x0a<li><strong>Metformin</strong>\x20is\x20contraindicated\x20or\x20used\x20with\x20extreme\x20caution\x20when\x20eGFR\x20&lt;\x2030\x20ml/min/1.73\x20m&#178;</li>\x0a<li><strong>Risk:\x20</strong>Lactic\x20acidosis,\x20a\x20rare\x20but\x20potentially\x20fatal\x20complication</li>\x0a<li>Guidelines\x20recommend:\x0a<ul>\x0a<li>Stop\x20metformin\x20if\x20eGFR\x20&lt;\x2030</li>\x0a<li>Reduce\x20dose\x20if\x20eGFR\x20is\x20between\x2030-45,\x20and\x20reassess</li>\x0a</ul>\x0a</li>\x0a<li>The\x20drugs\x20that\x20should\x20be\x20avoided\x20in\x20renal\x20failure\x20are\x20<strong>Metformin,\x20Meperidine,\x20NSAIDs</strong>,\x20and<strong>\x20OHAs\x20</strong>that\x20are\x20eliminated\x20by\x20the\x20kidneys.</li>\x0a<li><strong>Sulfonyl\x20ureas\x20</strong>should\x20be\x20avoided\x20only\x20in\x20advanced\x20renal\x20failure.</li>\x0a<li><strong>ACE\x20inhibitors\x20or\x20ARBs\x20</strong>should\x20be\x20stopped\x20if\x20there\x20is\x20a\x20&gt;30%\x20rise\x20in\x20serum\x20creatinine\x20within\x202\x20weeks\x20of\x20initiation\x20or\x20dose\x20increase,\x20or\x20if\x20hyperkalemia\x20develops.</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Gliclazide\x20(Option\x20A)</strong>,\x20a\x20sulfonylurea,\x20can\x20be\x20used\x20in\x20CKD\x20with\x20caution\x20and\x20dose\x20adjustment\x20due\x20to\x20increased\x20hypoglycemia\x20risk\x20in\x20reduced\x20GFR.\x20It\x20is\x20safer\x20than\x20other\x20sulfonylureas\x20like\x20glibenclamide,\x20which\x20are\x20contraindicated\x20in\x20advanced\x20renal\x20failure.</p>\x0a<p><strong>Atenolol\x20(Option\x20C)</strong>\x20is\x20a\x20beta\x20blocker.\x20Dose\x20adjustment\x20may\x20be\x20needed\x20in\x20CKD,\x20but\x20not\x20contraindicated</p>','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','timerContainer','559740rRbMXB','toString','<p><span\x20style=\x22font-size:12.0pt;\x22>None\x20of\x20the\x20above</span></p>','UAOaD','DT1197928','\x20>\x20','wJebP','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2065-year-old\x20lady\x20has\x20investigations\x20for\x20renal\x20impairment\x20(creatinine\x202.4\x20mg/dl).\x20She\x20has\x20a\x20previous\x20history\x20of\x20hypertension,\x20peripheral\x20vascular\x20disease,\x20and\x20osteoarthritis.\x20She\x20has\x20been\x20taking\x20diclofenac\x20for\x206\x20years\x20and\x20penicillamine\x20for\x20the\x20past\x202\x20years\x20(the\x20drug\x20was\x20stopped\x201\x20year\x20ago).\x20Investigations\x20show:\x20Urine:\x20protein\x20+,\x20blood\x20-ve.\x20Ultrasound\x20of\x20kidneys:\x20right\x206\x20cm,\x20left\x208\x20cm\x20in\x20length.\x20What\x20is\x20the\x20likely\x20diagnosis?</span></p>','OuDlG','accuracy','CkXyv','DXlHr','<p><span\x20style=\x22font-size:12.0pt;\x22>Diabetic\x20nephropathy</span></p>','getElementById','UHlPf','<p><strong>Explanation:</strong></p>\x0a<p>The\x20low\x20PTH\x20in\x20the\x20presence\x20of\x20hypercalcemia\x20and\x20hyperphosphatemia\x20indicates\x20oversuppression\x20of\x20parathyroid\x20activity,\x20likely\x20due\x20to\x20excessive\x20calcium\x20and\x20vitamin\x20D\x20(alfacalcidol)\x20intake,\x20leading\x20to\x20<strong>adynamic\x20bone\x20disease\x20</strong>characterized\x20by\x20low\x20bone\x20turnover\x20and\x20increased\x20fracture\x20risk.</p>\x0a<p><strong>Adynamic\x20Bone\x20Disease:</strong></p>\x0a<ul>\x0a<li>A\x20form\x20of\x20renal\x20osteodystrophy\x20characterised\x20by\x20low\x20bone\x20turnover\x20due\x20to\x20suppressed\x20parathyroid\x20hormone\x20(PTH)\x20activity.</li>\x0a<li><strong>Pathophysiology:</strong>\x0a<ul>\x0a<li><strong>Suppressed\x20PTH\x20levels</strong>\x20&rarr;\x20&darr;\x20osteoblast\x20and\x20osteoclast\x20activity</li>\x0a<li>Leads\x20to\x20<strong>low\x20bone\x20formation</strong>,\x20<strong>reduced\x20remodelling</strong>,\x20and\x20<strong>bone\x20fragility</strong></li>\x0a<li>Bone\x20becomes\x20structurally\x20weak,\x20even\x20though\x20mineralisation\x20may\x20be\x20normal</li>\x0a</ul>\x0a</li>\x0a<li><strong>Clinical\x20Features:</strong>\x0a<ul>\x0a<li>Diffuse\x20bone\x20pain</li>\x0a<li>Fractures\x20(especially\x20non-traumatic)</li>\x0a<li>Muscle\x20weakness</li>\x0a<li>Increased\x20vascular\x20calcification\x20(due\x20to\x20excess\x20calcium\x20and\x20phosphate)</li>\x0a<li>Often\x20asymptomatic\x20early</li>\x0a</ul>\x0a</li>\x0a<li><strong>Lab\x20Findings:</strong>\x0a<ul>\x0a<li>PTH:\x20Low\x20or\x20low-normal</li>\x0a<li>Calcium:\x20Normal\x20or\x20mildly\x20elevated</li>\x0a<li>Phosphate:\x20Low\x20or\x20normal</li>\x0a<li>Alkaline\x20phosphatase:\x20Normal\x20or\x20low</li>\x0a<li>Bone\x20biopsy:\x20Low\x20or\x20absent\x20osteoblasts/osteoclasts;\x20low\x20bone\x20turnover</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Aluminium\x20deposition\x20at\x20the\x20osteoid\x20bone\x20interface\x20(Option\x20B):</strong>\x20Aluminium\x20deposited\x20can\x20cause\x20osteomalacia-like\x20picture\x20and\x20is\x20seen\x20with\x20the\x20use\x20of\x20aluminium\x20as\x20a\x20phosphate\x20binder\x20and\x20aluminium\x20in\x20dialysate.</p>\x0a<p><strong>An\x20increase\x20in\x20plasma\x20cells\x20(Option\x20C):</strong>\x20An\x20increase\x20in\x20plasma\x20cells\x20causes\x20hypercalcemia\x20and\x20hypophosphatemia</p>\x0a<p><strong>Osteitis\x20fibrosa\x20cystica\x20(Option\x20D):\x20</strong>Osteitis\x20fibrosa\x20cystica\x20is\x20severe\x20secondary\x20hyperparathyroidism.</p>','FhIdQ','<p><span\x20style=\x22font-size:12.0pt;\x22>Uremic\x20pruritus\x20improves\x20dramatically\x20with\x20dialysis.</span></p>','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','Previous\x20progress\x20cleared.','DT1197837','DT1197955','vNQKX','bLrYT','style','AKAvc','JHHfI','IBmvE','vYMyb','<p><span\x20style=\x22font-size:12.0pt;\x22>Hypophosphatemia</span></p>','KKTGW','yhkNz','markReviewText','SxZoZ','No\x20solution\x20available.','jFlDO','QHZxR','<p><span\x20style=\x22font-size:12.0pt;\x22>Increase\x20the\x20length\x20of\x20haemodialysis</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Lupus\x20nephritis</span></p>','<p><strong>Explanation:</strong></p>\x0a<p><strong>Uremic\x20pruritus</strong>\x20often\x20<strong>persists\x20despite\x20adequate\x20dialysis</strong>\x20and\x20does\x20not\x20improve\x20dramatically,\x20unlike\x20many\x20other\x20skin\x20symptoms\x20in\x20CKD.</p>\x0a<p><strong>Dermatological\x20Manifestations\x20in\x20Chronic\x20Kidney\x20Disease:</strong></p>\x0a<p>Chronic\x20kidney\x20disease\x20affects\x20the\x20skin\x20in\x20multiple\x20ways,\x20due\x20to\x20uremia,\x20electrolyte\x20imbalances,\x20and\x20dialysis-related\x20complications</p>\x0a<ul>\x0a<li><strong>Pruritus\x20(Uremic\x20Pruritus):\x20</strong>The\x20most\x20common\x20skin\x20symptom\x20in\x20CKD;\x20generalized,\x20worse\x20at\x20night,\x20due\x20to\x20uremic\x20toxins,\x20hyperparathyroidism,\x20dry\x20skin,\x20and\x20calcium-phosphate\x20imbalance.</li>\x0a<li><strong>Xerosis\x20(Dry\x20Skin):\x20</strong>Dry,\x20scaly\x20skin\x20from\x20reduced\x20sweat/sebaceous\x20activity;\x20commonly\x20affects\x20trunk\x20and\x20extensor\x20surfaces,\x20worsens\x20itching.</li>\x0a<li><strong>Hyperpigmentation:\x20</strong>Seen\x20in\x20sun-exposed\x20areas\x20due\x20to\x20elevated\x20MSH\x20and\x20urochrome\x20deposition.</li>\x0a<li><strong>Pallor:</strong>\x20Results\x20from\x20anemia\x20and\x20vasoconstriction\x20in\x20CKD,\x20causing\x20pale\x20skin\x20and\x20mucosa.</li>\x0a<li><strong>Calciphylaxis:\x20</strong>Painful\x20skin\x20nodules\x20that\x20ulcerate\x20and\x20necrose;\x20occurs\x20in\x20ESRD\x20with\x20high\x20calcium/phosphate,\x20diabetes,\x20and\x20warfarin\x20use.</li>\x0a<li><strong>Nephrogenic\x20Systemic\x20Fibrosis\x20(NSF):</strong>\x20Scleroderma-like\x20thickening\x20and\x20hardening\x20of\x20the\x20skin\x20after\x20gadolinium\x20exposure\x20in\x20advanced\x20CKD\x20(GFR\x20&lt;30).</li>\x0a<li><strong>Nail\x20Changes:</strong>\x0a<ul>\x0a<li>Half-and-half\x20nails:\x20Proximal\x20white,\x20distal\x20brown\x20band</li>\x0a<li>Muehrcke\x27s\x20lines:\x20Paired\x20white\x20lines\x20from\x20hypoalbuminemia</li>\x0a<li>Terry\x27s\x20nails:\x20White\x20nail\x20beds\x20with\x20pink\x20distal\x20band</li>\x0a</ul>\x0a</li>\x0a<li><strong>Hair\x20and\x20Mucosa:</strong>\x0a<ul>\x0a<li>Hair\x20becomes\x20dry,\x20brittle,\x20and\x20sparse;\x20oral\x20mucosa\x20appears\x20pale,\x20with\x20uremic\x20fetor\x20(ammonia-like\x20breath\x20odor).</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>CKD\x20poses\x20a\x20risk\x20for\x20bleeding\x20as\x20well\x20as\x20thrombosis\x20(Option\x20A):</strong>\x20Chronic\x20kidney\x20disease\x20leads\x20to\x20platelet\x20dysfunction\x20(uremia-induced),\x20causing\x20bleeding,\x20while\x20proteinuria\x20and\x20dysregulated\x20coagulation\x20factors\x20increase\x20thrombotic\x20risk,\x20so\x20both\x20bleeding\x20and\x20thrombosis\x20are\x20recognised\x20complications.</p>\x0a<p><strong>Uremic\x20peripheral\x20neuropathy\x20occurs\x20in\x20stage\x204\x20CKD\x20(Option\x20B):</strong>\x20Uremic\x20neuropathy\x20typically\x20develops\x20in\x20advanced\x20CKD\x20(stage\x204\x20or\x20beyond),\x20often\x20presenting\x20as\x20a\x20distal,\x20symmetrical,\x20sensorimotor\x20neuropathy\x20predominantly\x20affecting\x20the\x20lower\x20limbs.</p>\x0a<p><strong>Glucose\x20metabolism\x20is\x20impaired\x20in\x20CKD\x20(Option\x20C):\x20</strong>CKD\x20leads\x20to\x20insulin\x20resistance\x20and\x20glucose\x20intolerance,\x20especially\x20in\x20moderate\x20to\x20advanced\x20stages,\x20although\x20it\x20often\x20doesn\x27t\x20require\x20specific\x20treatment\x20unless\x20overt\x20diabetes\x20is\x20present.</p>','lCuyZ','NcRaV','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2030-year-old\x20woman\x20presents\x20with\x20seizures,\x20hypertension,\x20and\x20photosensitivity.\x20Bloods\x20show:\x20Hb\x2011\x20g/dl,\x20WBC\x208000/&mu;L,\x20platelets\x20180000/&mu;L,\x20urea\x2098\x20mg/dl,\x20creatinine\x203.2\x20mg/dl,\x20sodium\x20140\x20mmol/l,\x20potassium\x205\x20mmol/l,\x20ESR\x20100\x20mm/hr,\x20CRP\x2025\x20mg/l.\x20Urine\x20showing\x203+\x20protein\x20and\x20hematuria.\x20What\x20is\x20the\x20most\x20likely\x20diagnosis?</span></p>','DYMlx','Factual','DT1197850','JiQNM','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2065-year-old\x20man,\x20who\x20has\x20been\x20on\x20haemodialysis\x20for\x2012\x20years,\x20presents\x20with\x20gradually\x20increasing\x20bone\x20pain.\x20He\x20underwent\x20a\x20subtotal\x20parathyroidectomy\x204\x20years\x20ago.\x20Current\x20medications\x20include\x20alfacalcidol\x201\x20mg/day\x20and\x20calcium\x20carbonate\x20500\x20mg\x20three\x20times\x20daily.\x20His\x20serum\x20calcium\x20concentration\x20is\x2010.6\x20mg/dl,\x20and\x20phosphate\x20is\x202.8\x20mg/dl.\x20What\x20is\x20the\x20most\x20probable\x20cause\x20of\x20his\x20symptoms?</span></p>','LNknB','wfVff','wnjHP','WpCoh','OyCNs','data-option-index','solutionImages','Lzpch','agKBO','<p><span\x20style=\x22font-size:12.0pt;\x22>Diabetes\x20Mellitus</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Interstitial\x20nephritis</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Hypokalaemia</span></p>','GkriK','hZelW','solution','zNWFL','dnErJ','border-green-500','TEIAB','ueHNL','OFsir','totalQuestionsResult','xBydl','oLVeT','<p><span\x20style=\x22font-size:12.0pt;\x22>Osteitis\x20fibrosa\x20cystica</span></p>','xQWgM','DT1197923','YDqos','forEach','KFdsj','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20is\x20a\x20leading\x20cause\x20of\x20chronic\x20kidney\x20disease?</span></p>','CJYFt','<p><strong>Explanation:</strong></p>\x0a<p>Despite\x20previous\x20subtotal\x20parathyroidectomy,\x20ongoing\x20bone\x20pain\x20in\x20a\x20dialysis\x20patient\x20with\x20high-normal\x20calcium\x20suggests\x20<strong>persistent\x20or\x20recurrent\x20hyperparathyroid\x20bone\x20disease\x20(osteitis\x20fibrosa\x20cystica)</strong>.\x20This\x20condition\x20is\x20common\x20in\x20long-term\x20dialysis\x20due\x20to\x20<strong>secondary\x20or\x20tertiary\x20hyperparathyroidism.</strong></p>\x0a<p><strong>Renal\x20Osteodystrophy\x20(CKD-MBD)</strong></p>\x0a<p>Renal\x20osteodystrophy\x20refers\x20to\x20bone\x20pathology\x20resulting\x20from\x20CKD-related\x20disturbances\x20in\x20calcium,\x20phosphate,\x20PTH,\x20and\x20vitamin\x20D\x20metabolism.</p>\x0a<p><strong>Pathophysiology:</strong></p>\x0a<ul>\x0a<li>&darr;\x20GFR\x20&rarr;\x20&darr;\x20phosphate\x20excretion\x20&rarr;\x20hyperphosphatemia</li>\x0a<li>Hyperphosphatemia\x20+\x20&darr;\x20renal\x201&alpha;-hydroxylase\x20&rarr;\x20&darr;\x20active\x20Vitamin\x20D\x20(calcitriol)\x20&rarr;\x20&darr;\x20calcium\x20absorption</li>\x0a<li>Leads\x20to\x20hypocalcemia\x20&rarr;\x20triggers\x20secondary\x20hyperparathyroidism</li>\x0a<li>Chronic\x20PTH\x20elevation\x20&rarr;\x20bone\x20resorption</li>\x0a<li>Also\x20contributes:\x20metabolic\x20acidosis\x20&rarr;\x20bone\x20buffering\x20&rarr;\x20loss\x20of\x20minerals</li>\x0a</ul>\x0a<p><strong>Types\x20of\x20Bone\x20Disease\x20in\x20CKD-MBD:</strong></p>\x0a<ul>\x0a<li><strong>Osteitis\x20Fibrosa\x20Cystica\x20(High-turnover)</strong>\x0a<ul>\x0a<li>Caused\x20by\x20secondary\x20hyperparathyroidism</li>\x0a<li>&uarr;\x20PTH\x20&rarr;\x20bone\x20resorption,\x20marrow\x20fibrosis</li>\x0a<li>Classic\x20form\x20of\x20renal\x20osteodystrophy</li>\x0a</ul>\x0a</li>\x0a<li><strong>Adynamic\x20Bone\x20Disease\x20(Low-turnover)</strong>\x0a<ul>\x0a<li>Due\x20to\x20over-suppression\x20of\x20PTH\x20(e.g.,\x20excessive\x20vitamin\x20D\x20or\x20calcium)</li>\x0a<li>Minimal\x20bone\x20formation/resorption</li>\x0a<li>Common\x20in\x20the\x20elderly,\x20diabetics,\x20and\x20post-parathyroidectomy</li>\x0a</ul>\x0a</li>\x0a<li><strong>Osteomalacia</strong>\x0a<ul>\x0a<li>Defective\x20bone\x20mineralization\x20due\x20to\x20vitamin\x20D\x20deficiency\x20or\x20aluminium\x20toxicity</li>\x0a<li>Bone\x20is\x20unmineralized\x20&rarr;\x20soft\x20bones,\x20fractures</li>\x0a<li>Mixed\x20Uremic\x20Osteodystrophy:\x20Combination\x20of\x20high\x20and\x20low\x20turnover\x20lesions</li>\x0a</ul>\x0a</li>\x0a<li><strong>Clinical\x20Features:</strong>\x0a<ul>\x0a<li>Bone\x20pain</li>\x0a<li>Fractures\x20(especially\x20vertebral,\x20long\x20bones)</li>\x0a<li>Skeletal\x20deformities</li>\x0a<li>Growth\x20retardation\x20in\x20children</li>\x0a</ul>\x0a</li>\x0a<li><strong>Diagnosis:</strong>\x0a<ul>\x0a<li>&uarr;\x20or\x20&darr;\x20PTH\x20levels\x20(depending\x20on\x20type)</li>\x0a<li>&uarr;\x20serum\x20phosphate,\x20&darr;\x20or\x20normal\x20calcium</li>\x0a<li>&uarr;\x20alkaline\x20phosphatase\x20(esp.\x20in\x20high-turnover\x20disease)</li>\x0a<li>Bone\x20biopsy\x20(gold\x20standard,\x20rarely\x20done)</li>\x0a<li>Imaging:\x20X-rays\x20may\x20show\x20subperiosteal\x20resorption\x20(in\x20osteitis\x20fibrosa),\x20Looser\x20zones\x20(in\x20osteomalacia)</li>\x0a</ul>\x0a</li>\x0a<li><strong>Management:</strong>\x0a<ul>\x0a<li>Phosphate\x20binders\x20(e.g.,\x20sevelamer,\x20calcium\x20acetate)</li>\x0a<li>Vitamin\x20D\x20analogs\x20(e.g.,\x20calcitriol,\x20alfacalcidol)</li>\x0a<li>Calcimimetics\x20(e.g.,\x20cinacalcet\x20-\x20lowers\x20PTH)</li>\x0a<li>Parathyroidectomy\x20in\x20refractory\x20hyperparathyroidism</li>\x0a<li>Dialysis\x20adequacy</li>\x0a<li>Avoid\x20aluminium-based\x20antacids\x20(risk\x20of\x20osteomalacia)</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Adynamic\x20Bone\x20Disease(Option\x20A):</strong>\x20Seen\x20in\x20long-term\x20dialysis\x20patients.\x20Often\x20due\x20to\x20<strong>oversuppression\x20of\x20PTH</strong>\x20by\x20excessive\x20vitamin\x20D\x20and\x20calcium\x20therapy.\x20Usually\x20associated\x20with\x20<strong>low\x20PTH,\x20normal/high\x20calcium,</strong>\x20and\x20<strong>low\x20phosphate,</strong>\x20which\x20may\x20seem\x20similar\x20here,\x20<strong>but\x20PTH\x20level\x20isn&rsquo;t\x20provided</strong>,\x20and\x20he\x20had\x20a\x20<strong>history\x20of\x20subtotal\x20parathyroidectomy,</strong>\x20so\x20persistent\x20PTH\x20production\x20is\x20possible.</p>\x0a<p><strong>Dialysis\x20Amyloid\x20(Option\x20B):</strong>\x20Typically\x20causes\x20<strong>joint-related\x20symptoms,</strong>\x20not\x20isolated\x20bone\x20pain.\x20<strong>Bone\x20pain\x20in\x20dialysis\x20amyloidosis\x20is\x20more\x20localized</strong>\x20and\x20often\x20associated\x20with\x20<strong>pathological\x20fractures</strong>\x20or\x20<strong>carpal\x20tunnel\x20signs.</strong></p>\x0a<p><strong>Vitamin\x20D-induced\x20Hypercalcemia(Option\x20D):\x20Calcium\x20is\x20mildly\x20elevated,</strong>\x20not\x20high\x20enough\x20to\x20cause\x20bone\x20pain\x20alone.\x20Hypercalcemia\x20from\x20vitamin\x20D\x20usually\x20causes\x20<strong>systemic\x20symptoms</strong>\x20like\x20<strong>confusion,\x20nausea,\x20vomiting,\x20polyuria,\x20dehydration,</strong>\x20and\x20not\x20isolated\x20<strong>bone\x20pain.</strong>\x20Vitamin\x20D-induced\x20bone\x20disease\x20would\x20more\x20likely\x20lead\x20to\x20<strong>adynamic\x20bone\x20disease</strong>\x20due\x20to\x20PTH\x20suppression,\x20but\x20again,\x20the\x20symptoms\x20don\x27t\x20match.</p>','tAnOF','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','JqJmq','info','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2030-year-old\x20man\x20attends\x20the\x20transplant\x20clinic\x20with\x20his\x20brother,\x20who\x20has\x20end-stage\x20renal\x20failure\x20due\x20to\x20autosomal\x20dominant\x20polycystic\x20kidney\x20disease\x20(ADPKD).\x20He\x20would\x20like\x20to\x20donate\x20a\x20kidney\x20to\x20his\x20brother\x20if\x20possible.\x20Which\x20of\x20the\x20following\x20is\x20the\x20most\x20appropriate\x20modality\x20for\x20screening?</span></p>','MYUet','<p><span\x20style=\x22font-size:12.0pt;\x22>Sarcoidosis</span></p>','filter','__proto__','<p><span\x20style=\x22font-size:12.0pt;\x22>Iron\x20deficiency</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Analgesic\x20nephropathy</span></p>','ceDXG','totalAttempted','mhiwX','(((.+)+)+)+$','yJnTN','EMIIg','WDvSJ','progressBar','mmjsI','DT1219947','CuFYJ','dataset','<p><span\x20style=\x22font-size:12.0pt;\x22>Vitamin\x20D-induced\x20hypercalcaemia</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2030-year-old\x20man\x20had\x20progressive\x20deafness\x20and\x20hematuria\x20from\x20childhood\x20and\x20had\x20undergone\x20a\x20renal\x20transplant\x20eight\x20years\x20ago\x20for\x20chronic\x20renal\x20failure.\x20Examination\x20revealed\x20perceptual\x20high-tone\x20deafness\x20and\x20anterior\x20lenticonus\x20in\x20both\x20eyes.\x20What\x20is\x20the\x20likely\x20diagnosis?</span></p>','xEYYe','<p><span\x20style=\x22font-size:12.0pt;\x22>Calcium\x20pyrophosphate\x20deposition</span></p>','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>','2068tqrxBt','enSRR','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2055-year-old\x20man\x20who\x20has\x20been\x20on\x20hemodialysis\x20for\x2020\x20years\x20has\x20progressive\x20dementia.\x20Which\x20one\x20of\x20the\x20following\x20is\x20most\x20likely\x20to\x20have\x20caused\x20this?</span></p>','tLSZg','<p><span\x20style=\x22font-size:12.0pt;\x22>Chronic\x20interstitial\x20nephritis</span></p>','ADCiU','<p><span\x20style=\x22font-size:12.0pt;\x22>Alport\x27s\x20syndrome</span></p>','zWSFc','studyModeLegend','jvVET','classList','xIMnY','pOtPy','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','<p><strong>Explanation:</strong></p>\x0a<p>The\x20most\x20likely\x20cause\x20of\x20renal\x20osteodystrophy\x20in\x20this\x20dialysis\x20patient\x20is\x20<strong>diminished\x20activity\x20of\x20renal\x201&alpha;-hydroxylase</strong>,\x20which\x20leads\x20to\x20decreased\x20production\x20of\x20active\x20vitamin\x20D\x20(calcitriol),\x20causing\x20hypocalcemia\x20and\x20secondary\x20hyperparathyroidism.</p>\x0a<p><strong>Renal\x20Osteodystrophy:</strong></p>\x0a<ul>\x0a<li>Refers\x20to\x20skeletal\x20complications\x20of\x20chronic\x20kidney\x20disease\x20(CKD)\x20due\x20to\x20disordered\x20bone\x20and\x20mineral\x20metabolism</li>\x0a</ul>\x0a<p><strong>In\x20CKD:</strong></p>\x0a<ul>\x0a<li>&darr;\x20<strong>1&alpha;-hydroxylase\x20activity</strong>\x20&rarr;\x20&darr;\x20<strong>calcitriol</strong>\x20&rarr;\x20&darr;\x20calcium\x20absorption\x20from\x20gut</li>\x0a<li>&uarr;\x20<strong>phosphate\x20retention</strong>\x20(due\x20to\x20&darr;\x20excretion)</li>\x0a<li>&rarr;\x20<strong>Hypocalcemia</strong>\x20and\x20<strong>hyperphosphatemia</strong></li>\x0a<li>&rarr;\x20Stimulates\x20<strong>parathyroid\x20hormone\x20(PTH)</strong>\x20&rarr;\x20<strong>Secondary\x20hyperparathyroidism</strong></li>\x0a<li>Over\x20time,\x20bone\x20changes\x20due\x20to\x20<strong>PTH,\x20FGF-23,\x20vitamin\x20D\x20imbalance</strong>,\x20etc.</li>\x0a</ul><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250917b390bb10-91dd-49a6-922a-9da9d9efd7c8.png\x22>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Hypophosphatemia\x20(Option\x20B):</strong>\x20Hyperphosphatemia\x20contributes\x20to\x20bone\x20disease,\x20not\x20low\x20phosphate.</p>\x0a<p><strong>Increased\x20intestinal\x20absorption\x20of\x20calcium\x20(Option\x20C)\x20</strong>would\x20raise\x20serum\x20calcium,\x20but\x20here,\x20calcium\x20is\x20low\x20(8\x20mg/dL),\x20and\x20PTH\x20is\x20elevated,\x20which\x20is\x20not\x20consistent\x20with\x20increased\x20calcium\x20absorption.</p>\x0a<p><strong>Hypoalbuminemia\x20(Option\x20D):</strong>\x20While\x20it\x20may\x20lower\x20total\x20calcium,\x20it\x20doesn\x27t\x20directly\x20cause\x20secondary\x20hyperparathyroidism\x20or\x20renal\x20osteodystrophy.</p>','uabtL','<p><strong>Explanation:</strong></p>\x0a<p>The\x20combination\x20of\x20early-onset\x20hematuria,\x20high-frequency\x20sensorineural\x20deafness,\x20and\x20ocular\x20abnormality\x20(anterior\x20lenticonus)\x20strongly\x20suggests\x20<strong>Alport\x27s\x20syndrome</strong>,\x20a\x20hereditary\x20nephritis.</p>\x0a<p><strong>Alport\x27s\x20Syndrome:</strong></p>\x0a<ul>\x0a<li>Genetics:<strong>\x20X-linked\x20inheritance</strong>\x20of\x20mutations\x20in\x20the\x20&alpha;5(IV)\x20collagen\x20chain.</li>\x0a<li>Characterised\x20by\x20a\x20triad\x20of:</li>\x0a<li>Progressive\x20<strong>hematuric\x20nephritis</strong></li>\x0a<li>Progressive\x20perceptive\x20<strong>high-tone\x20hearing\x20loss</strong></li>\x0a<li><strong>Ocular\x20signs\x20</strong>(cataracts,\x20spherophakia,\x20and\x20anterior\x20lenticonus,\x20dot\x20and\x20fleck\x20retinopathy)</li>\x0a<li><strong>Renal\x20Biopsy:</strong>\x0a<ul>\x0a<li><strong>Early\x20features:\x20</strong>thin\x20basement\x20membranes\x20on\x20renal\x20biopsy,\x20which\x20thicken\x20over\x20time\x20into\x20multilamellations\x20surrounding\x20lucent\x20areas\x20that\x20often\x20contain\x20granules\x20of\x20varying\x20the\x20so-called\x20split\x20basement\x20membrane.</li>\x0a<li><strong>Advanced\x20disease:</strong>\x20Tubules\x20drop\x20out,\x20glomeruli\x20scar,\x20and\x20the\x20kidney\x20eventually\x20succumbs\x20to\x20interstitial\x20fibrosis.</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250917af432fb4-a2a2-4d04-819d-6fc3db431c87.png\x22>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Neurofibromatosis\x20type\x20II\x20(Option\x20A)\x20</strong>presents\x20with\x20bilateral\x20vestibular\x20schwannomas\x20causing\x20hearing\x20loss,\x20but\x20no\x20hematuria,\x20no\x20lenticonus.\x20NF\x20is\x20associated\x20with\x20stenosis\x20of\x20renal\x20vessels.</p>\x0a<p><strong>Romano-Ward\x20syndrome\x20(Option\x20B)</strong>\x20is\x20a\x20congenital\x20long\x20QT\x20syndrome\x20without\x20deafness.\x20Jervell\x20and\x20Lange-Nielsen\x20syndrome\x20is\x20another\x20form\x20of\x20long\x20QT\x20syndrome\x20associated\x20with\x20deafness,\x20but\x20it\x20is\x20not\x20relevant\x20here.</p>\x0a<p><strong>Adult\x20polycystic\x20kidney\x20disease\x20(Option\x20D)</strong>\x20is\x20associated\x20with\x20Intracranial\x20aneurysms,\x20hepatic\x20cysts,\x20mitral\x20valve\x20prolapse,\x20abdominal\x20wall\x20hernias,\x20and\x20colonic\x20diverticulae.</p>','VnHzW','study','questionStates','YCjWR','ArrowRight','PqUpb','<p><span\x20style=\x22font-size:12.0pt;\x22>Gliclazide</span></p>','mRFEL','border-gray-600','<p><span\x20style=\x22font-size:12.0pt;\x22>Neurofibromatosis\x20type\x20II</span></p>','siZuR','blGmo','IpiUt','<p><strong>Explanation:</strong></p>\x0a<p><strong>IgA\x20nephropathy</strong>\x20is\x20the\x20most\x20common\x20primary\x20glomerulonephritis\x20worldwide\x20and\x20progresses\x20to\x20CKD\x20in\x2020-40%\x20of\x20cases\x20over\x2020\x20years,\x20particularly\x20in\x20those\x20with\x20heavy\x20proteinuria,\x20hypertension,\x20or\x20renal\x20impairment\x20at\x20presentation.</p>\x0a<p><strong>IgA\x20Nephropathy:</strong></p>\x0a<ul>\x0a<li>A\x20primary\x20glomerulonephritis\x20characterised\x20by\x20IgA\x20immune\x20complex\x20deposition\x20in\x20the\x20mesangium\x20of\x20the\x20glomeruli.</li>\x0a<li><strong>Pathophysiology:</strong>\x0a<ul>\x0a<li>Abnormal\x20glycosylation\x20of\x20<strong>IgA1</strong>\x20&rarr;\x20formation\x20of\x20autoantibodies\x20against\x20galactose-deficient\x20IgA1</li>\x0a<li>Formation\x20of\x20circulating\x20immune\x20complexes</li>\x0a<li><strong>Deposition\x20in\x20mesangium</strong>\x20&rarr;\x20mesangial\x20proliferation\x20and\x20inflammation</li>\x0a</ul>\x0a</li>\x0a<li><strong>Clinical\x20Features:</strong>\x0a<ul>\x0a<li>Recurrent\x20hematuria</li>\x0a<li>Mild\x20proteinuria</li>\x0a<li>Hypertension</li>\x0a<li>Progressive\x20renal\x20dysfunction:\x20in\x2020%\x20to\x2040%\x20over\x2020\x20years</li>\x0a</ul>\x0a</li>\x0a</ul>','KUFCE','<p><span\x20style=\x22font-size:12.0pt;\x22>Increased\x20intestinal\x20absorption\x20of\x20calcium</span></p>','AMPVr','apply','tVUYi','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','ehbsF','JYPxg','Not\x20Attempted','not_attempted','CAcks','pathname','UTvVm','xRtWV','qbYiv','removeItem','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','15eWkCrx','RdzRJ','currentMode','vewQQ','BtUYg','prevBtn','xtxzg','<p><strong>Explanation:</strong></p>\x0a<p><strong>Erythropoietin\x20(EPO)\x20</strong>is\x20commonly\x20used\x20in\x20chronic\x20kidney\x20disease\x20(CKD)\x20to\x20treat\x20anaemia\x20due\x20to\x20reduced\x20endogenous\x20erythropoietin\x20production.</p>\x0a<p><strong>Known\x20Side\x20Effects:</strong></p>\x0a<ul>\x0a<li><strong>Hypertension\x20</strong>(most\x20common)</li>\x0a<li>Seizures\x20(rare\x20but\x20recognised,\x20especially\x20with\x20rapid\x20rise\x20in\x20haemoglobin)</li>\x0a<li>Flu-like\x20symptoms</li>\x0a<li>Thrombosis\x20(including\x20access\x20clotting\x20in\x20dialysis\x20patients)</li>\x0a<li>Pure\x20red\x20cell\x20aplasia\x20(rare,\x20anti-EPO\x20antibodies)</li>\x0a<li>Increased\x20PCV</li>\x0a<li>Thrombocythemia</li>\x0a<li>Thrombosis</li>\x0a<li>Iron\x20deficiency</li>\x0a<li>Urticaria.</li>\x0a</ul>\x0a<p><strong>Indications\x20for\x20Exogenous\x20EPO\x20Therapy:</strong></p>\x0a<ul>\x0a<li>Anaemia\x20in\x20Chronic\x20Kidney\x20Disease\x20(CKD)</li>\x0a<li>Anaemia\x20in\x20cancer\x20patients\x20on\x20chemotherapy</li>\x0a<li>HIV\x20patients\x20on\x20zidovudine</li>\x0a<li>Pre-op\x20use\x20to\x20minimise\x20blood\x20transfusions</li>\x0a<li>Anaemia\x20of\x20chronic\x20disease\x20(select\x20cases)</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Hypokalaemia(Option\x20A):\x20</strong>EPO\x20does\x20not\x20directly\x20cause\x20hypokalaemia;\x20hyperkalaemia\x20is\x20more\x20common\x20in\x20CKD.</p>\x0a<p><strong>Osteoporosis(Option\x20B):\x20</strong>EPO\x20does\x20not\x20affect\x20bone\x20density;\x20osteoporosis\x20is\x20unrelated.</p>\x0a<p><strong>Iron\x20overload(Option\x20D):</strong>\x20EPO\x20can\x20cause\x20iron\x20deficiency,\x20not\x20overload,\x20due\x20to\x20increased\x20erythropoiesis.</p>','HCHdb','RRIII','BZjUb','aLvMz','test','pEKGg','none','currentQuestionIndex','avgTimeResult','Ckd','GqWMo','jssjd','custom_quiz.html','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20drugs\x20are\x20used\x20in\x20CKD\x20to\x20reduce\x20the\x20intraglomerular\x20pressure\x20and\x20proteinuria?<br>1.\x20ACEI<br>2.\x20ARB<br>3.\x20Non\x20dihydropyridine\x20CCBs<br>4.\x20Beta\x20blockers</span></p>','eiVIc','DT1197920','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','BJUEn','OYnnG','DT1197898','oQwsu','choices','</span><span>','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x20haemodialysis\x20patient\x20has\x20recurrent\x20knee\x20and\x20ankle\x20swelling\x20and\x20pain.\x20Aspiration\x20of\x20the\x20knee\x20synovial\x20fluid\x20reveals\x20negatively\x20birefringent\x20crystals.\x20Which\x20one\x20of\x20the\x20following\x20treatments\x20is\x20the\x20least\x20effective\x20either\x20acutely\x20or\x20in\x20a\x20chronic\x20situation?</span></p>','rlTYw','question_audio','NxoiF','xArIW','optionsContainer','<p><strong>Explanation:</strong></p>\x0a<p><strong>Erythropoietin\x20deficiency\x20</strong>is\x20the\x20primary\x20cause\x20of\x20anemia\x20in\x20CKD\x20due\x20to\x20the\x20loss\x20of\x20peritubular\x20cells\x20in\x20the\x20kidneys,\x20which\x20are\x20responsible\x20for\x20EPO\x20production.</p>\x0a<p><strong>Other\x20Contributing\x20Causes\x20of\x20Anaemia\x20in\x20CKD:</strong></p>\x0a<ul>\x0a<li><strong>Reduced\x20red\x20blood\x20cell\x20survival:\x20</strong>Due\x20to\x20uremic\x20toxins\x20and\x20chronic\x20inflammation.</li>\x0a<li><strong>Iron\x20deficiency:\x20</strong>Caused\x20by\x20poor\x20gastrointestinal\x20absorption,\x20blood\x20loss\x20(especially\x20from\x20dialysis),\x20or\x20frequent\x20blood\x20testing.</li>\x0a<li><strong>Bleeding\x20tendency:\x20</strong>Due\x20to\x20platelet\x20dysfunction\x20in\x20uremia.</li>\x0a<li><strong>Hyperparathyroidism-induced\x20bone\x20marrow\x20fibrosis\x20</strong>reduces\x20marrow\x20erythropoiesis.</li>\x0a<li><strong>Nutritional\x20deficiencies:\x20Folate\x20or\x20vitamin\x20B12\x20deficiency</strong>\x20may\x20contribute.</li>\x0a<li><strong>Chronic\x20inflammation\x20</strong>leads\x20to\x20functional\x20iron\x20deficiency\x20and\x20impaired\x20erythropoiesis.</li>\x0a<li><strong>Comorbidities:\x20</strong>Include\x20hypo-/hyperthyroidism,\x20pregnancy,\x20HIV,\x20autoimmune\x20disease,\x20and\x20use\x20of\x20immunosuppressants.</li>\x0a</ul>','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','AjHlC','554IlzjxX','incorrectAnswers','<p><span\x20style=\x22font-size:12.0pt;\x22>1,\x202,\x203\x20and\x204</span></p>','CFzYX','ymIzI','yEqXW','LMpTD','\x22\x20data-src=\x22','intermediate','disabled','hidden','fUNGC','xyFLj','includes','feRCF','error','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2030-year-old\x20female\x20with\x20chronic\x20urinary\x20tract\x20infections\x20presents\x20for\x20investigations.\x20Ultrasound\x20scan\x20reveals\x20scarring\x20over\x20the\x20renal\x20calyces.\x20Which\x20one\x20of\x20the\x20following\x20is\x20most\x20likely?</span></p>','<p><strong>Explanation:</strong></p>\x0a<p>The\x20patient\x27s\x20history\x20of\x20hypertension\x20and\x20peripheral\x20vascular\x20disease,\x20along\x20with\x20asymmetrically\x20small\x20kidneys\x20on\x20ultrasound\x20(right\x206\x20cm,\x20left\x208\x20cm),\x20points\x20toward\x20chronic\x20ischaemic\x20damage\x20due\x20to\x20<strong>renal\x20artery\x20stenosis.</strong>\x20The\x20mild\x20proteinuria\x20without\x20hematuria\x20further\x20supports<strong>\x20ischaemic\x20nephropathy</strong>.</p>\x0a<p><strong>Ischaemic\x20nephropathy:\x20</strong></p>\x0a<ul>\x0a<li>Chronic\x20kidney\x20damage\x20due\x20to\x20progressive\x20narrowing\x20or\x20occlusion\x20of\x20the\x20renal\x20arteries,\x20usually\x20secondary\x20to\x20atherosclerosis.</li>\x0a<li>It\x20results\x20in\x20reduced\x20renal\x20perfusion,\x20ischemia,\x20and\x20loss\x20of\x20kidney\x20mass/function.</li>\x0a</ul><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025091754c71f21-8504-4d0c-9ea2-0c8aaef4e86b.png\x22>\x0a<p><strong>Pathophysiology:</strong></p>\x0a<ul>\x0a<li>&darr;\x20Renal\x20perfusion\x20&rarr;\x20activation\x20of\x20<strong>RAAS</strong>\x20&rarr;\x20<strong>hypertension</strong></li>\x0a<li>Chronic\x20ischemia\x20&rarr;\x20interstitial\x20fibrosis,\x20tubular\x20atrophy,\x20and\x20glomerulosclerosis</li>\x0a<li>Leads\x20to\x20<strong>small,\x20shrunken\x20kidneys</strong>\x20(often\x20<strong>asymmetrical</strong>)</li>\x0a</ul>\x0a<p><strong>Clinical\x20Features:</strong></p>\x0a<ul>\x0a<li>Hypertension</li>\x0a<li>Progressive\x20renal\x20failure</li>\x0a<li>Asymmetrical\x20small\x20kidneys</li>\x0a<li>Flash\x20pulmonary\x20oedema</li>\x0a<li>Abdominal\x20bruit</li>\x0a</ul>\x0a<p><strong>Investigations:</strong></p>\x0a<ul>\x0a<li>Ultrasound\x20KUB:\x20Small\x20kidney(s),\x20asymmetry\x20in\x20size</li>\x0a<li>Doppler\x20Renal\x20USG</li>\x0a<li>CT/MR\x20Angiography:\x20Non-invasive\x20confirmation\x20of\x20stenosis</li>\x0a<li>Renal\x20angiography:\x20Gold\x20standard\x20but\x20invasive</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Analgesic\x20nephropathy\x20(Option\x20B)\x20</strong>is\x20not\x20possible\x20as\x20there\x20is\x20no\x20history\x20of\x20combination\x20pill\x20intake\x20or\x20renal\x20colic\x20and\x20hematuria.</p>\x0a<p><strong>Interstitial\x20nephritis\x20(Option\x20C)\x20</strong>will\x20cause\x20minimal\x20proteinuria,\x20but\x20ultrasound\x20will\x20show\x20symmetric\x20kidneys.</p>\x0a<p><strong>Minimal\x20change\x20nephropathy\x20(Option\x20D):</strong>\x20Minimal\x20change\x20disease\x20presents\x20with\x20nephrotic\x20range\x20proteinuria.</p>','click','Tnwla','AjKJm','BDENH','VmZgN','<p><span\x20style=\x22font-size:12.0pt;\x22>Osteoporosis</span></p>','application/vnd.apple.mpegurl','bookmarked','nMJHs','FOOBm','Rrezo','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2070-year-old\x20woman\x20is\x20referred\x20for\x20investigation\x20of\x20a\x20creatinine\x20of\x202.5\x20mg/dl.\x20She\x20mentioned\x20several\x20episodes\x20of\x20haematuria\x20with\x20symptoms\x20of\x20ureteric\x20colic.\x20She\x20has\x20a\x20long\x20history\x20of\x20low\x20back\x20pain\x20treated\x20with\x20a\x20combination\x20of\x20painkillers.\x20An\x20ultrasound\x20shows\x20two\x20irregularly\x20shaped\x20kidneys,\x20size\x208.5\x20and\x209\x20cm,\x20and\x20renal\x20papillary\x20calcifications.\x20Which\x20of\x20the\x20following\x20is\x20the\x20most\x20likely?</span></p>','Uxhyb','reduce','xddaH','<p><span\x20style=\x22font-size:12.0pt;\x22>An\x20increase\x20in\x20plasma\x20cells</span></p>','qQYXj','hLwLl','<p><span\x20style=\x22font-size:12.0pt;\x22>Chronic\x20tubulointerstitial\x20disease</span></p>','egBcQ','<div\x20class=\x22mt-4\x22><img\x20src=\x22','<p><strong>Explanation:</strong></p>\x0a<p>The\x20patient\x27s\x20symptoms\x20suggest\x20peritonitis,\x20a\x20common\x20complication\x20of\x20<strong>peritoneal\x20dialysis</strong>.\x20The\x20most\x20frequent\x20causative\x20organisms\x20are\x20skin\x20flora,\x20especially\x20<strong>Staphylococcus\x20epidermidis</strong>,\x20introduced\x20during\x20dialysis\x20exchanges.</p>\x0a<p><strong>Peritoneal\x20Dialysis-Associated\x20Peritonitis:</strong></p>\x0a<ul>\x0a<li><strong>Most\x20common\x20cause:</strong>\x20Staphylococcus\x20epidermidis\x20(~40-50%)</li>\x0a<li><strong>Other\x20causes:</strong>\x0a<ul>\x0a<li>coli\x20and\x20other\x20Gram-negative\x20bacilli\x20(~25%)</li>\x0a<li>Staphylococcus\x20aureus\x20(~15%)</li>\x0a</ul>\x0a</li>\x0a<li><strong>Clinical\x20Features:</strong>\x0a<ul>\x0a<li>Abdominal\x20pain\x20(variable\x20severity)</li>\x0a<li>Nausea,\x20vomiting</li>\x0a<li>Cloudy\x20peritoneal\x20dialysis\x20fluid</li>\x0a<li>Peritoneal\x20signs:\x20guarding,\x20rebound\x20tenderness</li>\x0a</ul>\x0a</li>\x0a</ul>','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20statements\x20is\x20false\x20regarding\x20CKD?</span></p>','now','<p><span\x20style=\x22font-size:12.0pt;\x22>Cardiac\x20failure</span></p>','className','PXtwq','DT1197824','hjpEs','<p><span\x20style=\x22font-size:12.0pt;\x22>Multiple\x20myeloma</span></p>','userHistory','TEbxw','UFjbs','qsCrm','timed_exam','wUnLg','<p><strong>Explanation:</strong></p>\x0a<p>The\x20earliest\x20morphologic\x20abnormality\x20in\x20<strong>diabetic\x20nephropathy</strong>\x20is\x20the\x20<strong>thickening\x20of\x20the\x20glomerular\x20basement\x20membrane\x20(GBM)\x20</strong>and\x20<strong>expansion\x20of\x20the\x20mesangium\x20due\x20to\x20accumulation\x20of\x20extracellular\x20matrix</strong>.</p>\x0a<p><strong>Diabetic\x20Nephropathy:</strong></p>\x0a<ul>\x0a<li>A\x20chronic\x20microvascular\x20complication\x20of\x20<strong>diabetes\x20mellitus</strong>\x20affecting\x20the\x20glomeruli,\x20leading\x20to\x20progressive\x20<strong>albuminuria</strong>,\x20<strong>hypertension</strong>,\x20and\x20<strong>renal\x20failure</strong>.</li>\x0a<li><strong>Pathophysiology:</strong>\x0a<ul>\x0a<li><strong>Chronic\x20hyperglycemia</strong>\x20&rarr;\x20non-enzymatic\x20glycation\x20of\x20proteins\x20&rarr;\x20basement\x20membrane\x20damage</li>\x0a<li>Activation\x20of\x20<strong>RAAS</strong>,\x20oxidative\x20stress,\x20and\x20cytokines\x20(TGF-&beta;)\x20&rarr;\x20<strong>mesangial\x20expansion</strong>,\x20GBM\x20thickening</li>\x0a<li>Progressive\x20glomerulosclerosis\x20(esp.\x20<strong>Kimmelstiel-Wilson\x20nodules</strong>)</li>\x0a</ul>\x0a</li>\x0a<li><strong>Stages\x20(Mogensen\x20Classification):</strong><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509175d105f50-c9ed-4b2c-9e46-2c4e9c22e5a6.png\x22></li>\x0a<li><strong>Histopathology:</strong>\x0a<ul>\x0a<li>Light\x20microscopy\x20findings\x20show\x20an\x20increase\x20in\x20the\x20solid\x20spaces\x20of\x20the\x20tuft\x20material\x20(diffuse\x20diabetic\x20glomerulopathy).</li>\x0a<li><strong>Kimmelstiel-Wilson\x20nodules,\x20</strong>which\x20are\x20PAS-positive,\x20contain\x20eosinophilic\x20material.<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22\x20https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20231220ca183a64-ba9b-4089-b244-60076e6c2864.png\x22></li>\x0a</ul>\x0a</li>\x0a<li><strong>Diagnosis:</strong>\x0a<ul>\x0a<li><strong>Urine\x20ACR\x20(Albumin-Creatinine\x20Ratio)</strong>:\x0a<ul>\x0a<li>Microalbuminuria:\x2030-300\x20mg/g</li>\x0a<li>Macroalbuminuria:\x20&gt;300\x20mg/g</li>\x0a</ul>\x0a</li>\x0a<li><strong>Serum\x20creatinine,\x20eGFR</strong></li>\x0a<li><strong>Fundus\x20exam</strong>:\x20Retinopathy\x20supports\x20DN\x20diagnosis</li>\x0a<li><strong>Renal\x20biopsy</strong>:\x20Not\x20routinely\x20done\x20unless\x20atypical\x20features\x20(hematuria,\x20rapid\x20progression)</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p>Explanation\x20of\x20Other\x20Options:</p>\x0a<p><strong>Hyaline\x20thrombus\x20formation\x20(Option\x20A):</strong>\x20Hyaline\x20changes\x20in\x20blood\x20vessels\x20are\x20seen\x20in\x20hypertension\x20and\x20are\x20nonspecific.</p>\x0a<p><strong>Mesangial\x20hypercellularity\x20(Option\x20B)</strong>\x20is\x20seen\x20in\x20glomerular\x20diseases\x20like\x20Ig\x20A\x20nephropathy,\x20Lupus\x20Nephritis,\x20post-streptococcal\x20glomerulonephritis,\x20etc.</p>\x0a<p><strong>Basement\x20membrane\x20spikes(Option\x20C)</strong>\x20are\x20characteristic\x20of\x20membranous\x20nephropathy,\x20which\x20presents\x20with\x20nephrotic\x20syndrome,\x20not\x20the\x20nephritic\x20features\x20seen\x20in\x20diabetic\x20nephropathy.</p>','TGZCz','AavWS','<p><span\x20style=\x22font-size:12.0pt;\x22>Vitamin\x20A</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Mycobacterium\x20tuberculosis</span></p>','NuQIb','rVcPx','MRDel','RbaoM','<p><strong>Explanation:</strong></p>\x0a<p><strong>Hypotension</strong>\x20is\x20the\x20most\x20common\x20acute\x20complication\x20of\x20hemodialysis\x20due\x20to\x20rapid\x20fluid\x20removal.</p>\x0a<p><strong>Hemodialysis:</strong></p>\x0a<p>A\x20form\x20of\x20renal\x20replacement\x20therapy\x20that\x20removes\x20toxins,\x20excess\x20fluid,\x20and\x20electrolytes\x20via\x20diffusion\x20and\x20ultrafiltration\x20across\x20a\x20semipermeable\x20membrane\x20in\x20a\x20dialysis\x20machine.</p>\x0a<p><strong>Acute\x20Complications\x20of\x20Hemodialysis</strong></p><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509173e3064f7-d0a6-494d-a772-5784df319cc2.png\x22>\x0a<p>Long-term\x20(Chronic)\x20Complications\x20of\x20Hemodialysis</p><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250917a99ec4bd-43f3-45f7-8de0-dc13e44de455.png\x22>','MAQmd','<p><span\x20style=\x22font-size:12.0pt;\x22>Mitral\x20stenosis</span></p>','DOMContentLoaded','0|1|3|5|2|4','<p><span\x20style=\x22font-size:12.0pt;\x22>Presence\x20of\x20proteinuria</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20is\x20the\x20commonest\x20cause\x20of\x20death\x20in\x20renal\x20dialysis\x20patients?</span></p>','nwlfd','<p><span\x20style=\x22font-size:12.0pt;\x22>Staphylococcus\x20epidermidis</span></p>','Bookmark','<p><span\x20style=\x22font-size:12.0pt;\x22>Atenolol</span></p>','Biymc','testModeLegend','attachMedia','dAPUq','parse','UrKBk','questionText','DT1197845','EiTbv','add','jFyyl','WbNoQ','quizPerformanceData','TSnxl','fromCharCode','totalTimeResult','<p><span\x20style=\x22font-size:12.0pt;\x22>1\x20and\x202</span></p>','correctAnswers','ofZVK','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','toISOString','querySelectorAll','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','APMzc','quizHierarchy','HcAAj','XLAnR','<p><span\x20style=\x22font-size:12.0pt;\x22>Basement\x20membrane\x20thickening\x20and\x20mesangial\x20widening</span></p>','lksLR','customQuizData','iZIIG','textContent','hduhT','YyhGM','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2050-year-old\x20lady\x20was\x20diagnosed\x20with\x20type\x202\x20diabetes\x20a\x20year\x20ago.\x20Since\x20the\x20diagnosis\x20was\x20made,\x20she\x20was\x20found\x20to\x20have\x20pre-proliferative\x20diabetic\x20retinopathy.\x20She\x20has\x20a\x20history\x20of\x20rheumatoid\x20arthritis\x20and\x20has\x20been\x20taking\x20ibuprofen\x20regularly\x20for\x206\x20years.\x20She\x20was\x20referred\x20for\x20investigation\x20of\x20renal\x20impairment.\x20The\x20HbA1C\x20is\x209%\x20urea\x2035\x20mg/dl,\x20creatinine\x202.0\x20mg/dl,\x20Urine\x20dipstick\x20shows\x20blood\x20+,\x20protein\x20++.\x20What\x20is\x20the\x20likely\x20diagnosis?</span></p>','solutionContainer','AzVHL','questionNav','tYwHa','<p><span\x20style=\x22font-size:12.0pt;\x22>Pulmonary\x20embolism</span></p>','UClJY','pqjdZ','RDLcl','not-attempted','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','xvHfh','key','nav-btn-marked-review','table','SWnXv','DT1197885','XWBoX','BuCyB','video[data-src]','explanation_audio_hin','fJVVH','mAZUb','display','TVuKG','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','<p><span\x20style=\x22font-size:12.0pt;\x22>Romano-Ward\x20syndrome</span></p>','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','rtwWx','.m3u8','\x22\x20data-option-index=\x22','ZloNs','remove','stringify','wgFOA','tygKQ','EWSPJ','Correct','XrEVJ','hCNeF','LGqRz','bsVsm','ftGqv','<p><span\x20style=\x22font-size:12.0pt;\x22>Vancomycin\x20treatment</span></p>','cqMZV','RBNBl','closest','Mark\x20for\x20Review','bookmarkText','<p><span\x20style=\x22font-size:12.0pt;\x22>Polymyalgia\x20rheumatica</span></p>','Marked','Xoyfb','FzCvR','questionIndex','div','FzuRO','<p><span\x20style=\x22font-size:12.0pt;\x22>SLE\x20with\x20Lupus\x20nephritis</span></p>','question_video','DEQXY','XoqzA','foLYG','qwiam','DZEOZ','DT1197938','border-red-500','<p><span\x20style=\x22font-size:12.0pt;\x22>Calcium\x20acetate</span></p>','incorrect','explanation_images','WCkhL','contains','<p><span\x20style=\x22font-size:12.0pt;\x22>Muscle\x20cramps</span></p>','fdTCK','keydown','Option\x20','selected','solutionText','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','ZQtvB','flex','vwWSL','correctResult','jMyIb','<p><span\x20style=\x22font-size:12.0pt;\x22>Probenecid</span></p>','qXgKf','IErWD','qJazT','-600\x20text-white\x22>','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2060-year-old\x20lady\x20has\x20been\x20noted\x20for\x20the\x20first\x20time\x20to\x20have\x20renal\x20impairment.\x20Which\x20of\x20the\x20following\x20features\x20is\x20most\x20useful\x20in\x20determining\x20whether\x20the\x20renal\x20failure\x20is\x20acute\x20or\x20chronic?</span></p>','quizFile','ZZFen','\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>','xOiaA','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','DT1197866','setItem','kdnjw','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','onclick','VRgon','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x20patient\x20with\x20chronic\x20renal\x20failure\x20presents\x20with\x20anaemia.\x20What\x20is\x20the\x20most\x20likely\x20cause?</span></p>','qBank','<p><span\x20style=\x22font-size:12.0pt;\x22>Dialysis\x20amyloid</span></p>','GQKbt','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','<p><strong>Explanation:</strong></p>\x0a<p>All\x20of\x20the\x20features\x20mentioned\x20strongly\x20suggest\x20<strong>Dialysis-Related\x20Amyloidosis\x20(DRA)\x20</strong>due\x20to<strong>\x20&beta;2-microglobulin\x20deposition.</strong></p>\x0a<p><strong>Key\x20Features:</strong></p>\x0a<ul>\x0a<li>Amyloid\x20deposits\x20are\x20composed\x20of\x20&beta;2\x20microglobulin</li>\x0a<li>Develop\x20approximately\x20<strong>&gt;\x2012\x20years</strong>\x20of\x20dialysis.</li>\x0a<li><strong>Carpal\x20Tunnel\x20syndrome</strong>\x20is\x20the\x20first\x20presentation.</li>\x0a<li><strong>Joints</strong>\x20involved\x20are\x20bilateral\x20and\x20symmetrical,\x20and\x20large\x20joints.</li>\x0a<li>Joint\x20effusions\x20are\x20non-inflamed\x20and\x20contain\x20&beta;2\x20microglobulin\x20on\x20<strong>Congo\x20red.</strong></li>\x0a<li>There\x20will\x20be\x20visceral\x20deposits\x20of\x20<strong>&beta;2\x20microglobulin.</strong></li>\x0a<li>The\x20incidence\x20of\x20&beta;2-microglobulin\x20amyloidosis\x20is\x20now\x20reduced\x20due\x20to\x20improvements\x20in\x20dialysis\x20membranes.</li>\x0a</ul>\x0a<p><strong>Diagnosis:</strong></p>\x0a<ul>\x0a<li>Clinical\x20+\x20confirmed\x20via\x20biopsy\x20(Congo\x20red\x20staining,\x20&beta;2-microglobulin\x20immunostaining)</li>\x0a</ul>\x0a<p><strong>Treatment:</strong></p>\x0a<ul>\x0a<li>High-flux\x20dialysis,\x20renal\x20transplant\x20(definitive),\x20symptomatic\x20relief\x20for\x20joint\x20issues</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Gout\x20(Option\x20A)\x20</strong>typically\x20affects\x20the\x20first\x20MTP\x20joint,\x20not\x20large\x20joints\x20like\x20shoulders;\x20associated\x20with\x20elevated\x20uric\x20acid,\x20which\x20is\x20not\x20seen\x20here;\x20not\x20linked\x20to\x20long-term\x20dialysis.</p>\x0a<p><strong>Polymyalgia\x20Rheumatica\x20(Option\x20B)\x20</strong>causes\x20muscle\x20stiffness,\x20especially\x20in\x20the\x20shoulders\x20and\x20hips,\x20with\x20very\x20high\x20ESR\x20(&gt;100\x20mm/hr);\x20it\x20does\x20not\x20cause\x20carpal\x20tunnel\x20syndrome\x20or\x20occur\x20due\x20to\x20dialysis.</p>\x0a<p><strong>Calcium\x20Pyrophosphate\x20Deposition\x20(Option\x20C)\x20</strong>affects\x20knees\x20and\x20wrists,\x20may\x20show\x20chondrocalcinosis,\x20but\x20is\x20not\x20related\x20to\x20dialysis\x20or\x20carpal\x20tunnel\x20syndrome;\x20&beta;2-microglobulin\x20deposition\x20is\x20not\x20a\x20feature.</p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Mesangial\x20hypercellularity</span></p>','map','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22','uFUlR','SoNAI','questionMedia','statsBar','YUVPE','biexf','DT1197819','<p><strong>Explanation:</strong></p>\x0a<p><strong>Cardiovascular\x20disease</strong>\x20is\x20the\x20<strong>most\x20common\x20cause\x20of\x20death</strong>\x20in\x20dialysis\x20patients.</p>\x0a<ul>\x0a<li>It\x20includes:\x0a<ul>\x0a<li>Sudden\x20cardiac\x20death</li>\x0a<li>Ischemic\x20heart\x20disease</li>\x0a<li>Heart\x20failure\x20(often\x20from\x20left\x20ventricular\x20hypertrophy)</li>\x0a<li>Arrhythmias</li>\x0a<li>Vascular\x20calcification</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p><strong>Other\x20leading\x20causes\x20of\x20death\x20in\x20renal\x20dialysis\x20patients:</strong></p>\x0a<ul>\x0a<li><strong>Infections:\x20The\x202nd\x20most\x20common\x20cause\x20of\x20death</strong>\x0a<ul>\x0a<li>Vascular\x20access\x20infections\x20(e.g.,\x20catheter-related)</li>\x0a<li>Peritonitis\x20(in\x20peritoneal\x20dialysis)</li>\x0a<li>Pneumonia,\x20sepsis</li>\x0a</ul>\x0a</li>\x0a<li><strong>Malignancy</strong>\x0a<ul>\x0a<li>Uremia\x20and\x20chronic\x20inflammation\x20increase\x20cancer\x20risk</li>\x0a<li>Renal\x20cell\x20carcinoma\x20(especially\x20in\x20acquired\x20cystic\x20kidney\x20disease)</li>\x0a<li>Lymphomas,\x20GI\x20cancers</li>\x0a</ul>\x0a</li>\x0a<li><strong>Withdrawal\x20from\x20dialysis:\x20</strong>Voluntary\x20cessation\x20in\x20terminal\x20or\x20elderly\x20patients\x20due\x20to\x20poor\x20quality\x20of\x20life\x20or\x20complications</li>\x0a<li><strong>Electrolyte\x20disturbances:\x20Hyperkalemia</strong>\x20causing\x20fatal\x20arrhythmias,\x20<strong>Calcium-phosphate\x20imbalance</strong>\x20causing\x20vascular\x20calcification</li>\x0a<li><strong>Hemorrhage:\x20</strong>Due\x20to\x20uremic\x20platelet\x20dysfunction\x20or\x20anticoagulation\x20during\x20dialysis</li>\x0a</ul>','No\x20question\x20text\x20available','<p><span\x20style=\x22font-size:12.0pt;\x22>Metformin</span></p>','QKEoG','whHeU','<p><span\x20style=\x22font-size:12.0pt;\x22>Ischaemic\x20nephropathy</span></p>','zpLXs','iXxKG','qccOC','<p><span\x20style=\x22font-size:12.0pt;\x22>Escherichia\x20coli</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Gout</span></p>','join','<p><strong>Explanation:</strong></p>\x0a<ul>\x0a<li>A\x20history\x20of\x20recurrent\x20urinary\x20tract\x20infections\x20with\x20renal\x20scarring\x20over\x20the\x20renal\x20calyces\x20is\x20typical\x20of<strong>\x20Reflux\x20Nephropathy</strong>.</li>\x0a<li>It\x20is\x20a\x20type\x20of\x20chronic\x20interstitial\x20nephritis.</li>\x0a<li>It\x20is\x20due\x20to\x20<strong>Vesico\x20Ureteral\x20reflux\x20(VUR</strong>),\x20from\x20the\x20bladder\x20to\x20one\x20or\x20both\x20of\x20the\x20ureters,\x20due\x20to\x20an\x20incompetent\x20vesicoureteral\x20valve.</li>\x0a<li>VUR\x20causes\x20renal\x20scarring,\x20tubular\x20dysfunction,\x20and\x20secondary\x20FSGS.</li>\x0a<li>Often\x20associated\x20with\x20<strong>recurrent\x20urinary\x20tract\x20infections.</strong></li>\x0a<li>VUR\x20is\x20often\x20<strong>asymptomatic\x20</strong>and\x20is\x20common\x20in\x20<strong>females\x20</strong>and\x20is\x20diagnosed\x20during\x20pregnancy\x20or\x20other\x20routine\x20evaluation.\x20Hypertension\x20is\x20common.\x20Proteinuria\x20may\x20be\x20moderate.</li>\x0a<li>Ultrasound\x20shows\x20<strong>focal\x20scarring\x20</strong>over\x20areas\x20of\x20calyces\x20with\x20areas\x20of\x20<strong>compensatory\x20hypertrophy</strong>.</li>\x0a<li>Confirmation\x20is\x20by<strong>\x20DMSA\x20scan</strong>,<strong>\x20MRI,\x20or\x20CT.</strong></li>\x0a<li><strong>Reimplantation\x20of\x20ureters</strong>\x20is\x20indicated\x20if\x20renal\x20scarring\x20has\x20not\x20occurred\x20and\x20with\x20high-grade\x20reflux.</li>\x0a<li>Maintenance\x20of\x20sterile\x20urine\x20with\x20<strong>prophylactic\x20antibiotics</strong>\x20and\x20<strong>ACEI\x20or\x20ARBs\x20</strong>for\x20proteinuria\x20may\x20retard\x20the\x20progression.</li>\x0a</ul><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250917bc9dc1ca-c7f5-4427-b2ec-26d91e7612e3.png\x22>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Analgesic\x20nephropathy\x20(Option\x20A)\x20</strong>is\x20associated\x20with\x20chronic\x20NSAID\x20use.\x20Causes\x20papillary\x20necrosis,\x20not\x20necessarily\x20focal\x20calyceal\x20scarring.\x20Typically\x20seen\x20in\x20older\x20patients,\x20especially\x20females\x20with\x20chronic\x20pain\x20disorders.</p>\x0a<p><strong>Polycystic\x20kidney\x20disease\x20(Option\x20B)\x20</strong>causes\x20bilateral\x20kidney\x20enlargement\x20and\x20multiple\x20cysts,\x20not\x20focal\x20calyceal\x20scarring.</p>\x0a<p><strong>Nephrotic\x20syndrome\x20(Option\x20C)\x20</strong>is\x20characterized\x20by\x20heavy\x20proteinuria,\x20oedema,\x20and\x20hypoalbuminemia.</p>','qMidA','<p><span\x20style=\x22font-size:12.0pt;\x22>Hyperparathyroid\x20bone\x20disease</span></p>','MFnsX','correct','<p><strong>Explanation:</strong></p>\x0a<ul>\x0a<li>The\x20clinical\x20clues\x20to\x20<strong>chronicity\x20of\x20renal\x20impairment\x20</strong>are\x20symptoms\x20of\x20azotemia\x20for\x20&gt;\x203\x20months,\x20renal\x20osteodystrophy,\x20bilaterally\x20scarred\x20kidneys,\x20and\x20broad\x20casts\x20in\x20urinary\x20sediments.</li>\x0a<li>Ultrasonically,\x20the\x20normal\x20size\x20of\x20kidneys\x20is<strong>\x2010-12\x20cms</strong>.\x20<strong>Kidneys\x20&lt;\x208\x20cm</strong>\x20with\x20destroyed\x20parenchyma\x20and\x20increased\x20echogenicity\x20are\x20seen\x20in\x20CKD.</li>\x0a<li><strong>Renal\x20osteodystrophy\x20</strong>and\x20a<strong>\x20small-sized\x20kidney\x20</strong>with\x20destroyed\x20renal\x20parenchyma,\x20characterised\x20by\x20increased\x20echogenicity\x20and\x20a\x20thinned-out\x20cortex,\x20along\x20with\x20isosthenuria\x20and\x20broad\x20casts,\x20are\x20the\x20only\x20conclusive\x20findings\x20of\x20chronicity.</li>\x0a</ul>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250917cae727b5-1e4b-43c4-984d-03005dacbe9a.png\x22>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Haemoglobin\x20of\x2012\x20g/dl\x20(Option\x20B)\x20</strong>is\x20only\x20mildly\x20reduced\x20and\x20can\x20be\x20seen\x20in\x20both\x20AKI\x20and\x20CKD,\x20or\x20even\x20in\x20non-renal\x20conditions,\x20making\x20it\x20less\x20specific\x20for\x20determining\x20chronicity\x20compared\x20to\x20small\x20renal\x20size.</p>\x0a<p><strong>Blood\x20pressure\x20of\x20160/90\x20(Option\x20C):</strong>\x20Hypertension\x20can\x20be\x20a\x20consequence\x20of\x20CKD,\x20but\x20it\x20is\x20not\x20specific\x20to\x20CKD;\x20It\x20may\x20be\x20a\x20primary\x20disorder\x20itself\x20contributing\x20to\x20CKD</p>\x0a<p><strong>Presence\x20of\x20proteinuria\x20(Option\x20D):\x20</strong>Proteinuria\x20can\x20be\x20present\x20in\x20several\x20acute\x20as\x20well\x20as\x20chronic\x20conditions.\x20E.g.,\x20vigorous\x20exercise,\x20acute\x20tubulointerstitial\x20disease,\x20nephritic\x20syndrome,\x20etc<br\x20/>\x20</p>','round','fHVoI','<p><strong>Explanation:</strong></p>\x0a<p>In\x20young\x20potential\x20donors\x20(&lt;30\x20years)\x20with\x20a\x20family\x20history\x20of\x20ADPKD,\x20particularly\x20Type\x202\x20(PKD2),\x20ultrasound\x20may\x20miss\x20small\x20cysts\x20due\x20to\x20lower\x20sensitivity\x20and\x20the\x20late\x20onset\x20of\x20cyst\x20formation.\x20<strong>Genetic\x20screening\x20</strong>for\x20PKD1\x20and\x20PKD2\x20mutations\x20provides\x20definitive\x20exclusion\x20of\x20ADPKD,\x20ensuring\x20the\x20donor\x20does\x20not\x20carry\x20the\x20disease.</p>\x0a<p>There\x20may\x20be\x20cysts\x20that\x20are\x20below\x20the\x20detection\x20threshold\x20of\x20ultrasound.\x20So,\x20before\x20donating\x20kidney\x20to\x20a\x20family\x20member\x20with\x20ADPKD,\x20genetic\x20testing\x20has\x20to\x20be\x20done</p>\x0a<p><strong>Investigations\x20in\x20ADPKD:</strong></p>\x0a<p><strong>Ultrasound\x20(USG\x20Abdomen):</strong></p>\x0a<ul>\x0a<li>First-line\x20and\x20most\x20commonly\x20used.</li>\x0a<li>Shows\x20multiple\x20bilateral\x20renal\x20cysts.</li>\x0a<li>Diagnostic\x20criteria\x20depend\x20on\x20age\x20and\x20the\x20number\x20of\x20cysts.</li>\x0a<li>Although\x20ultrasound\x20has\x20a\x20high\x20degree\x20of\x20sensitivity\x20for\x20ADPKD\x20type\x201,\x20the\x20sensitivity\x20for\x20ADPKD\x20type\x202\x20is\x20much\x20lower\x20because\x20of\x20the\x20late\x20age\x20of\x20onset,\x20and\x20a\x20subject\x20may\x20be\x20cleared\x20to\x20donate\x20a\x20kidney,\x20yet\x20still\x20have\x20the\x20disease.\x20<strong>(Option\x20D\x20ruled\x20out)</strong></li>\x0a</ul>\x0a<p><strong>CT/MRI\x20Abdomen:</strong></p>\x0a<ul>\x0a<li>More\x20sensitive\x20than\x20USG.</li>\x0a<li>Detects\x20smaller\x20cysts,\x20hemorrhage,\x20infection,\x20and\x20extrarenal\x20involvement\x20(e.g.,\x20liver\x20cysts).</li>\x0a<li>MRI\x20is\x20best\x20for\x20monitoring\x20total\x20kidney\x20volume\x20(TKV)\x20progression.</li>\x0a<li>However,\x20a\x20CT\x20scan\x20exposes\x20the\x20patient\x20to\x20radiation\x20and\x20radiocontrast,\x20which\x20may\x20cause\x20serious\x20allergic\x20reactions\x20and\x20nephrotoxicity\x20in\x20patients\x20with\x20renal\x20insufficiency.\x20<strong>(Option\x20B\x20ruled\x20out)</strong></li>\x0a</ul>\x0a<p><strong>Genetic\x20Testing:</strong></p>\x0a<ul>\x0a<li>Detects\x20mutations\x20in\x20PKD1\x20or\x20PKD2\x20genes.</li>\x0a<li>Useful\x20for\x20Early\x20diagnosis\x20(especially\x20in\x20potential\x20transplant\x20donors),\x20Equivocal\x20imaging\x20findings,\x20and\x20Family\x20screening.</li>\x0a</ul>\x0a<p><strong>Intravenous\x20urography:\x20</strong>Intravenous\x20urography\x20has\x20a\x20poor\x20sensitivity\x20compared\x20to\x20all\x20the\x20investigations\x20mentioned\x20above,\x20so\x20not\x20preferred\x20<strong>(Option\x20A\x20ruled\x20out)</strong></p>','markedForReview','cbZFl','YZezQ','SJxrF','log','strokeDasharray','hWowA','<p><span\x20style=\x22font-size:12.0pt;\x22>Aluminum\x20phosphate\x20binders</span></p>','ExJQt','get','moJwt','HAxkG','<p><span\x20style=\x22font-size:12.0pt;\x22>&beta;2\x20microglobulin\x20amyloidosis</span></p>','notAttempted','yaFIH','POYxm','<p><span\x20style=\x22font-size:12.0pt;\x22>Renal\x20calculi</span></p>','aMXJT','BPULF','nav-btn-current','<p><span\x20style=\x22font-size:12.0pt;\x22>Amyloidosis</span></p>','rSeue','answered','<p><span\x20style=\x22font-size:12.0pt;\x22>Consider\x20an\x20islet\x20cell\x20transplant</span></p>','qwYdW','qWlWY','<p><span\x20style=\x22font-size:12.0pt;\x22>Cystic\x20kidney\x20disease</span></p>','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','DT1197934','<p><span\x20style=\x22font-size:12.0pt;\x22>CKD-EPI</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>1,\x202\x20and\x204</span></p>','endsWith','4|0|2|1|5|3','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','pkliv','isSupported','<p><span\x20style=\x22font-size:12.0pt;\x22>Alfacalcidol\x20supplements</span></p>','getAttribute','correct_choice_id','green','QXvev','ccQze','UilXE','<p><span\x20style=\x22font-size:12.0pt;\x22>Intravenous\x20urography</span></p>','zcjXS','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','<p><span\x20style=\x22font-size:12.0pt;\x22>Gastrointestinal\x20haemorrhage</span></p>','KfsNr','Xwnaq','eAisO','bookmarkedQuestions','DT1197863','solutionAudio','jzwds','solutionVideo','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20is\x20the\x20best\x20equation\x20to\x20determine\x20eGFR?</span></p>','LgZTy','bnqlt','DT1197881','FZuXv','EWBWK','notAttemptedResult','submitSection','xlNyp','eVcvk','warn','explanation_audio_eng','MUWsP','DDafD','pAlti','nVQuK','LqwgR','aPUmx','<p><span\x20style=\x22font-size:12.0pt;\x22>Aluminium\x20deposition\x20at\x20the\x20osteoid\x20bone\x20interface</span></p>','fill','modeModal','review-question\x20','Hgmbp','addEventListener','push','<p><span\x20style=\x22font-size:12.0pt;\x22>Occult\x20malignancy</span></p>','totalQuestions','<p><span\x20style=\x22font-size:12.0pt;\x22>Genetic\x20screening</span></p>','616564UcplBo','lAFno','SguSf','text','Incorrect','getItem','<p><span\x20style=\x22font-size:12.0pt;\x22>Adynamic\x20bone\x20disease</span></p>','JAJLj','bookmarkBtn','22swoXsP','<p><span\x20style=\x22font-size:12.0pt;\x22>Minimal\x20change\x20nephropathy</span></p>','NfxPz','NgWEk','GwkIV','hilgO','vRKZN','dbfNo','dRrsq','21160asmzLi','CpbPT','INstO','DT1197809','hMCEc','replace','<p><span\x20style=\x22font-size:12.0pt;\x22>Hypotension</span></p>','qFFZn','hierarchy','AQyaE','mFmPK','EQEQG','IVUOg','appendChild','CuoRt','fGKwX','DT1197815','performanceModal','JofhD','oscKp','open','preventDefault','rESZJ','vqeqF','1|3|0|4|5|2','wZoAl','<p><strong>Explanation:</strong></p>\x0a<ul>\x0a<li><strong>ACEIs\x20and\x20ARBs</strong>\x20lower\x20intraglomerular\x20pressure\x20by\x20dilating\x20the\x20efferent\x20arteriole,\x20reducing\x20proteinuria.</li>\x0a<li><strong>Non-dihydropyridine\x20CCBs</strong>\x20(like\x20verapamil,\x20diltiazem)\x20also\x20have\x20antiproteinuric\x20effects.</li>\x0a<li><strong>Beta\x20blockers</strong>\x20control\x20BP\x20but\x20do\x20not\x20reduce\x20intraglomerular\x20pressure\x20or\x20proteinuria.</li>\x0a</ul>\x0a<p><strong>ACE\x20inhibitors\x20(ACEI):</strong></p>\x0a<ul>\x0a<li><strong>Mechanism:</strong>\x20Dilate\x20efferent\x20arterioles\x20&rarr;\x20reduce\x20glomerular\x20capillary\x20pressure</li>\x0a<li><strong>Effect:</strong>\x20&darr;\x20Proteinuria,\x20&darr;\x20GFR\x20decline</li>\x0a<li><strong>Used\x20in\x20CKD\x20and\x20diabetic\x20nephropathy</strong></li>\x0a</ul>\x0a<p><strong>Angiotensin\x20receptor\x20blockers\x20(ARB):</strong></p>\x0a<ul>\x0a<li><strong>Mechanism:</strong>\x20Similar\x20to\x20ACEI,\x20but\x20blocks\x20angiotensin\x20II\x20receptor</li>\x0a<li><strong>Effect:</strong>\x20&darr;\x20Intraglomerular\x20pressure,\x20&darr;\x20Proteinuria</li>\x0a<li>Alternative\x20in\x20<strong>ACEI-intolerant\x20patients</strong></li>\x0a</ul>\x0a<p><strong>Non-dihydropyridine\x20calcium\x20channel\x20blockers\x20(e.g.,\x20verapamil,\x20diltiazem)</strong></p>\x0a<ul>\x0a<li><strong>Mechanism:</strong>\x20Reduce\x20proteinuria\x20independently\x20of\x20BP-lowering\x20effect</li>\x0a<li><strong>Additional\x20benefit:</strong>\x20Especially\x20in\x20diabetics,\x20when\x20RAS\x20blockers\x20are\x20insufficient</li>\x0a<li><strong>Note:</strong>\x20Dihydropyridine\x20CCBs\x20(e.g.,\x20amlodipine)\x20<strong>do\x20not</strong>\x20reduce\x20proteinuria.</li>\x0a</ul>\x0a<p><strong>Beta-blockers:</strong></p>\x0a<ul>\x0a<li><strong>Mechanism:</strong>\x20Primarily\x20reduces\x20systemic\x20BP\x20and\x20heart\x20rate</li>\x0a<li><strong>Effect:</strong>\x20<strong>No\x20direct\x20effect</strong>\x20on\x20intraglomerular\x20pressure\x20or\x20proteinuria</li>\x0a<li><strong>Used\x20for\x20cardiovascular\x20protection</strong>,\x20not\x20for\x20nephroprotection\x20directly.</li>\x0a</ul>','JKVJw','UlQXe','pSAOy','iwoSE','PwsSR','wDVlB','iFwND','fiEjv','console','<p><span\x20style=\x22font-size:12.0pt;\x22>Urea\x20disequilibrium</span></p>','bind','DT1197954','<p><span\x20style=\x22font-size:12.0pt;\x22>Kidney\x20Failure\x20Risk\x20(KFR)\x20equation</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Renal\x20tuberculosis</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Computed\x20tomography(CT)\x20scan</span></p>','bottom','markReviewBtn','scVyZ','accuracyScore','toggle','{}.constructor(\x22return\x20this\x22)(\x20)','dfEnX','<p><strong>Explanation:</strong></p>\x0a<p>A\x20young\x20female\x20with\x20a\x20history\x20of\x20seizures,\x20hypertension,\x20and\x20photosensitivity\x20rash,\x20who\x20has\x20renal\x20impairment\x20with\x20hematuria\x20and\x20proteinuria,\x20high\x20ESR\x20points\x20to\x20the\x20diagnosis\x20of\x20<strong>SLE\x20with\x20Lupus\x20nephritis</strong>.</p>\x0a<p><strong>Lupus\x20Nephritis:</strong></p>\x0a<ul>\x0a<li>Serious\x20complication\x20of\x20<strong>Systemic\x20Lupus\x20Erythematosus\x20(SLE)</strong>\x20that\x20involves\x20inflammation\x20of\x20the\x20kidneys\x20due\x20to\x20immune\x20complex\x20deposition.</li>\x0a<li><strong>Pathophysiology:</strong>\x0a<ul>\x0a<li>Immune\x20complex\x20deposition\x20(mainly\x20anti-dsDNA\x20antibodies)\x20in\x20the\x20glomeruli.</li>\x0a<li>Leads\x20to\x20complement\x20activation\x20&rarr;\x20glomerular\x20inflammation\x20and\x20damage.</li>\x0a<li>Commonly\x20associated\x20with\x20<strong>low\x20complement\x20levels\x20(C3,\x20C4)</strong>\x20and\x20<strong>positive\x20ANA,\x20anti-dsDNA</strong>.</li>\x0a</ul>\x0a</li>\x0a<li><strong>Classification:</strong><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250917997bde39-d693-427e-ae2e-7d40b20847a3.png\x22></li>\x0a<li><strong>Investigations:</strong>\x0a<ul>\x0a<li><strong>Urinalysis</strong>:\x20proteinuria,\x20hematuria,\x20RBC\x20casts</li>\x0a<li><strong>Serum\x20creatinine</strong>:\x20elevated\x20in\x20advanced\x20stages</li>\x0a<li><strong>Serology</strong>:\x0a<ul>\x0a<li>ANA:\x20positive</li>\x0a<li>Anti-dsDNA:\x20high</li>\x0a<li>Low\x20complement\x20(C3,\x20C4)</li>\x0a</ul>\x0a</li>\x0a<li><strong>Renal\x20biopsy</strong>:\x20gold\x20standard\x20for\x20diagnosis\x20and\x20classification<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025091749229af3-54a9-439c-932c-d76258c17e7e.png\x22></li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p>Explanation\x20of\x20Other\x20Options:</p>\x0a<p><strong>Anti-GBM\x20disease\x20(Option\x20A)</strong>\x20is\x20a\x20cause\x20of\x20rapidly\x20progressive\x20glomerulonephritis,\x20which\x20presents\x20as\x20an\x20acute\x20nephritic\x20syndrome\x20leading\x20to\x20renal\x20failure\x20and\x20may\x20also\x20affect\x20the\x20lungs,\x20causing\x20diffuse\x20alveolar\x20haemorrhage,\x20which\x20presents\x20with\x20hypoxemia\x20and\x20haemoptysis.</p>\x0a<p><strong>Multiple\x20myeloma\x20(Option\x20B)</strong>\x20causes\x20renal\x20impairment,\x20but\x20the\x20patient\x20profile\x20will\x20be\x20an\x20elderly\x20patient\x20with\x20skeletal\x20pains,\x20hypercalcemia,\x20and\x20renal\x20impairment.\x20There\x20will\x20be\x20anaemia,\x20high\x20ESR,\x20albumin-globulin\x20ratio\x20reversal,\x20and\x20hypercalcemia.\x20Skeletal\x20survey\x20shows\x20a\x20lytic\x20lesion.</p>\x0a<p><strong>Granulomatosis\x20with\x20polyangiitis\x20(Option\x20D)</strong>\x20is\x20a\x20small\x20vessel\x20vasculitis\x20which\x20causes\x20rapidly\x20progressive\x20glomerulonephritis\x20(RPGN)\x20along\x20with\x20pulmonary\x20cavities\x20&amp;\x20infiltrates\x20and\x20is\x20characterised\x20by\x20cANCA\x20positivity.</p>','referrer','length','canPlayType','<p><span\x20style=\x22font-size:12.0pt;\x22>Allopurinol</span></p>','frJnX','CAJVV','ExevM','bcqXb','toLowerCase','PeBmF','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','CNfSk','resume','IfaFp','<p><span\x20style=\x22font-size:12.0pt;\x22>Blood\x20pressure\x20of\x20160/90</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>What\x20is\x20the\x20most\x20common\x20acute\x20complication\x20of\x20hemodialysis?</span></p>','MmdrG','scoreCircle','<p><span\x20style=\x22font-size:12.0pt;\x22>Haemolytic\x20Uraemic\x20Syndrome</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Hypertension</span></p>','red','gitBr','mhGrn','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2057-year-old\x20man\x20with\x20diabetic\x20nephropathy\x20has\x20a\x20plasma\x20creatinine\x20of\x204.3\x20mg/dl\x20(NR\x200.6-1.4\x20mg/dl),\x20potassium\x205.2\x20mmol/l,\x20calcium\x208.8\x20mg/dl,\x20albumin\x204.2\x20g/dl,\x20phosphate\x204.4\x20mg/dl,\x20and\x20PTH\x201.6\x20pmol/l\x20(NR\x201.4-6.8).\x20Which\x20of\x20the\x20following\x20should\x20be\x20commenced?</span></p>','block','1791EMbALE','status','6314730vrZEAB','ahNsP','DT1197951','<p><span\x20style=\x22font-size:12.0pt;\x22>Uremic\x20peripheral\x20neuropathy\x20occurs\x20in\x20stage\x204\x20CKD</span></p>','selectedAnswer','TVuXc','zUeml','<p><strong>Explanation:</strong></p>\x0a<p>This\x20elderly\x20woman\x20with\x20long-term\x20analgesic\x20use,\x20renal\x20impairment,\x20hematuria,\x20and\x20papillary\x20calcifications\x20has\x20classic\x20features\x20of\x20<strong>analgesic\x20nephropathy</strong>,\x20a\x20form\x20of\x20chronic\x20tubulointerstitial\x20nephritis.</p>\x0a<p><strong>Analgesic\x20Nephropathy:\x20</strong></p>\x0a<ul>\x0a<li>Result\x20of\x20prolonged\x20or\x20chronic\x20ingestion\x20of\x20combination\x20analgesics\x20that\x20contain\x20<strong>phenacetin\x20or\x20acetaminophen\x20</strong>and\x20<strong>nonsteroidal\x20anti-inflammatory\x20drugs\x20(NSAIDs)</strong>,\x20including\x20aspirin\x20and\x20caffeine.</li>\x0a<li>Usual\x20NSAIDs(ibuprofen,\x20diclofenac)\x20do\x20not\x20cause\x20Analgesic\x20nephropathy</li>\x0a</ul>\x0a<h3>Pathophysiology:</h3>\x0a<ul>\x0a<li><strong>Direct\x20tubular\x20toxicity</strong>\x20from\x20analgesic\x20metabolites.</li>\x0a<li><strong>Papillary\x20ischemia\x20and\x20necrosis</strong>\x20due\x20to\x20inhibition\x20of\x20prostaglandin\x20synthesis\x20&rarr;\x20reduced\x20renal\x20blood\x20flow.</li>\x0a<li>Chronic\x20use\x20&rarr;\x20repeated\x20insults\x20&rarr;\x20<strong>chronic\x20tubulointerstitial\x20inflammation</strong>\x20&rarr;\x20fibrosis\x20and\x20<strong>renal\x20papillary\x20necrosis</strong>.</li>\x0a</ul>\x0a<p><strong>Clinical\x20Features:</strong></p>\x0a<ul>\x0a<li><strong>Flank\x20pain:\x20</strong>From\x20papillary\x20necrosis\x20or\x20obstructive\x20debris</li>\x0a<li><strong>Hematuria:\x20</strong>Often\x20microscopic,\x20may\x20be\x20gross\x20during\x20necrosis</li>\x0a<li><strong>Polyuria,\x20nocturia:</strong>\x20Due\x20to\x20impaired\x20concentrating\x20ability\x20(tubular\x20damage)</li>\x0a<li><strong>Chronic\x20renal\x20insufficiency:\x20</strong>Slowly\x20progressive</li>\x0a<li><strong>Hypertension</strong></li>\x0a</ul>\x0a<p><strong>Investigations:</strong></p>\x0a<ul>\x0a<li><strong>Urine\x20analysis:</strong>\x20Hematuria,\x20sterile\x20pyuria,\x20mild\x20proteinuria</li>\x0a<li><strong>Serum\x20creatinine/urea:</strong>\x20Raised\x20(chronic\x20kidney\x20disease)</li>\x0a<li><strong>Ultrasound:\x20</strong>Small,\x20<strong>shrunken\x20kidneys</strong>,\x20<strong>irregular\x20contour</strong>,\x20<strong>papillary\x20calcifications</strong></li>\x0a<li><strong>CT\x20KUB:\x20</strong>Better\x20for\x20visualising\x20<strong>papillary\x20necrosis,\x20calcifications</strong></li>\x0a<li><strong>Biopsy\x20(rarely\x20needed):\x20</strong>Interstitial\x20fibrosis,\x20tubular\x20atrophy,\x20necrotic\x20papillae</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Chronic\x20tubulointerstitial\x20disease\x20(Option\x20A):\x20</strong>NSAID-induced\x20tubulointerstitial\x20disease\x20will\x20not\x20present\x20with\x20colic\x20and\x20hematuria.</p>\x0a<p><strong>Chronic\x20Obstructive\x20Uropathy\x20(Option\x20B):\x20</strong>Usually\x20associated\x20with\x20hydronephrosis\x20or\x20post-void\x20residual\x20urine.\x20No\x20evidence\x20of\x20bladder\x20outlet\x20obstruction\x20or\x20prostate\x20issues\x20in\x20this\x20elderly\x20woman.</p>\x0a<p><strong>Multiple\x20myeloma\x20(Option\x20C):\x20</strong>There\x20is\x20no\x20other\x20information\x20given\x20in\x20the\x20question\x20that\x20suggests\x20a\x20myeloma\x20other\x20than\x20low\x20back\x20pain.\x20Myeloma\x20does\x20not\x20produce\x20colic\x20and\x20hematuria.\x20It\x20will\x20not\x20cause\x20shrunken\x20kidneys.\x20Myeloma\x20causes\x20CKD\x20with\x20normally\x20sized\x20kidneys.</p>','search','ucLgY','VsMcW','Progress\x20loaded.','src'];_0x4075=function(){return _0x3c0996;};return _0x4075();}function reviewQuestions(){const _0x53418b=_0x578afd,_0x27aa35={'VgMKq':'performanceModal','ouBua':function(_0x2ee43e,_0x4cdb57){return _0x2ee43e+_0x4cdb57;},'wnjHP':function(_0x247516,_0xd3542d){return _0x247516*_0xd3542d;},'Biymc':function(_0x57a906,_0x5ac7fa){return _0x57a906*_0x5ac7fa;},'JKVJw':'scoreCircle','Tnwla':function(_0x1aacdf,_0x385f05){return _0x1aacdf-_0x385f05;},'GqWMo':function(_0x24e891,_0x19456c){return _0x24e891*_0x19456c;},'hCNeF':function(_0x249e0b,_0x40ac1a){return _0x249e0b/_0x40ac1a;},'yaFIH':_0x53418b(0x178),'zcjXS':'incorrectResult','cNvCT':_0x53418b(0x1ed),'GkriK':function(_0x1dcf0b,_0xb098ee){return _0x1dcf0b/_0xb098ee;},'jpZzh':function(_0x268b2a,_0x31d9a2){return _0x268b2a/_0x31d9a2;},'ueHNL':function(_0x51ba10,_0xf98434){return _0x51ba10%_0xf98434;},'FzuRO':'totalTimeResult','agKBO':function(_0x39d905,_0xf1b348){return _0x39d905/_0xf1b348;},'SWnXv':_0x53418b(0x3a1),'VsMcW':_0x53418b(0x3c3),'qMidA':function(_0x119571,_0x24a5e3){return _0x119571!==_0x24a5e3;},'fGKwX':function(_0x490269,_0xad11a9){return _0x490269===_0xad11a9;},'UAOaD':function(_0x2ee5f5,_0x477f0e){return _0x2ee5f5===_0x477f0e;},'siZuR':function(_0x53c811,_0x433ce7){return _0x53c811+_0x433ce7;},'CNfSk':'correct','mRFEL':_0x53418b(0x20b),'jfycZ':_0x53418b(0x158),'frJnX':'gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','zWSFc':'Bookmarked','nwlfd':_0x53418b(0x131),'wEJTp':function(_0x582f90,_0x15b83e){return _0x582f90!==_0x15b83e;},'TEbxw':_0x53418b(0x38e),'APMzc':_0x53418b(0x14d),'CAJVV':_0x53418b(0x3dc),'ceDXG':'incorrect','vNQKX':_0x53418b(0x207),'xGQmW':function(_0x106e3f,_0x25b30a){return _0x106e3f===_0x25b30a;},'SoNAI':_0x53418b(0x1d7),'vRKZN':_0x53418b(0x25b),'mmjsI':'gray','pxaUQ':_0x53418b(0x316),'Xoyfb':_0x53418b(0x2ac),'BDENH':'reviewQuestionsContainer','vwWSL':function(_0x5c3f0a){return _0x5c3f0a();}};document[_0x53418b(0x301)](_0x27aa35[_0x53418b(0x15b)])[_0x53418b(0x36b)][_0x53418b(0x148)](_0x27aa35[_0x53418b(0x26c)]);const _0x38a88d=document[_0x53418b(0x301)](_0x27aa35[_0x53418b(0x3ce)]);_0x38a88d[_0x53418b(0x2c0)]='',questionsData[_0x53418b(0x340)]((_0x21b356,_0x5c02b)=>{const _0x50235e=_0x53418b,_0x40fa7d={'jFyyl':_0x27aa35['CNfSk'],'OYnnG':_0x50235e(0x14d),'fJVVH':_0x27aa35[_0x50235e(0x379)],'iFwND':_0x27aa35['jfycZ'],'OuYqa':_0x27aa35[_0x50235e(0x24b)],'feRCF':_0x27aa35[_0x50235e(0x368)],'ZJfeB':_0x50235e(0x401)},_0x11c52e=questionStates[_0x5c02b],_0xe9156=_0x21b356[_0x50235e(0x1d6)];let _0x58a7af=_0x27aa35[_0x50235e(0x3ff)],_0x542b29=_0x50235e(0x388);if(_0x27aa35['wEJTp'](_0x11c52e[_0x50235e(0x266)],null)){if(_0x27aa35['TEbxw']===_0x27aa35[_0x50235e(0x3ea)]){const _0x153992=_0x21b356[_0x50235e(0x3ae)][_0x11c52e[_0x50235e(0x266)]];if(_0x27aa35['fGKwX'](_0x153992['id'],_0xe9156))_0x58a7af=_0x27aa35[_0x50235e(0x252)],_0x542b29=_0x27aa35[_0x50235e(0x41a)];else{if(_0x27aa35[_0x50235e(0x224)](_0x27aa35[_0x50235e(0x24c)],_0x50235e(0x3dc)))_0x58a7af=_0x27aa35['ceDXG'],_0x542b29=_0x27aa35[_0x50235e(0x30a)];else{const _0x2fe82c=_0xdbbb9[_0x50235e(0x301)](_0x27aa35['VgMKq']),_0x4569b7=_0x27aa35['ouBua'](_0x30787f,_0x680965)>0x0?_0x4ac0db[_0x50235e(0x1ad)](_0x27aa35[_0x50235e(0x326)](_0x1dccfa/(_0x313352+_0x5cfa8c),0x64)):0x0,_0x71c5f0=_0x27aa35[_0x50235e(0x326)](_0x27aa35[_0x50235e(0x403)](0x2,_0x3b263b['PI']),0x41),_0x256473=_0xff6b2b[_0x50235e(0x301)](_0x27aa35[_0x50235e(0x230)]);_0x256473[_0x50235e(0x30c)]['strokeDasharray']=_0x71c5f0+'\x20'+_0x71c5f0,_0x256473['style'][_0x50235e(0x2a8)]=_0x27aa35[_0x50235e(0x3cc)](_0x71c5f0,_0x27aa35[_0x50235e(0x3a3)](_0x27aa35['hCNeF'](_0x4569b7,0x64),_0x71c5f0)),_0x297d9d[_0x50235e(0x301)](_0x50235e(0x242))[_0x50235e(0x125)]=_0x4569b7+'%',_0x453585['getElementById']('totalQuestionsResult')['textContent']=_0x2150bb[_0x50235e(0x248)],_0x202dcf['getElementById'](_0x27aa35[_0x50235e(0x1be)])[_0x50235e(0x125)]=_0x404a30,_0x7444['getElementById'](_0x27aa35[_0x50235e(0x1dc)])[_0x50235e(0x125)]=_0x535823,_0x24ec82[_0x50235e(0x301)](_0x27aa35['cNvCT'])[_0x50235e(0x125)]=_0x3d0b03;const _0x47641a=_0x381d3f[_0x50235e(0x28d)](_0x27aa35[_0x50235e(0x330)](_0x12aa30,0xea60)),_0x5d452c=_0x3c471a[_0x50235e(0x28d)](_0x27aa35['jpZzh'](_0x27aa35[_0x50235e(0x337)](_0x1054c9,0xea60),0x3e8));_0x4211cb[_0x50235e(0x301)](_0x27aa35[_0x50235e(0x15f)])['textContent']=_0x47641a+':'+_0x5d452c[_0x50235e(0x2f5)]()[_0x50235e(0x274)](0x2,'0');const _0x573b63=_0x27aa35[_0x50235e(0x32c)](_0x32e542,_0x1f37c8[_0x50235e(0x248)]),_0x23358b=_0x5073b0[_0x50235e(0x28d)](_0x27aa35[_0x50235e(0x14f)](_0x573b63,0xea60)),_0x100b1e=_0x296336['floor'](_0x27aa35[_0x50235e(0x14f)](_0x573b63%0xea60,0x3e8));_0x2fc587[_0x50235e(0x301)](_0x27aa35[_0x50235e(0x137)])[_0x50235e(0x125)]=_0x23358b+':'+_0x100b1e[_0x50235e(0x2f5)]()['padStart'](0x2,'0'),_0x2fe82c[_0x50235e(0x36b)][_0x50235e(0x148)](_0x27aa35[_0x50235e(0x26c)]);}}}else _0xc96f05=_0x40fa7d[_0x50235e(0x40d)],_0x538e35=_0x40fa7d[_0x50235e(0x3ab)];}const _0x3c5748=document[_0x50235e(0x2c8)](_0x50235e(0x15e));_0x3c5748[_0x50235e(0x3e4)]=_0x50235e(0x1fc)+_0x58a7af;let _0x400907=(_0x21b356[_0x50235e(0x3ae)]||[])[_0x50235e(0x192)]((_0x468afc,_0x229f38)=>{const _0x19d388=_0x50235e;if(_0x27aa35[_0x19d388(0x1a8)](_0x19d388(0x3a4),_0x19d388(0x30e))){const _0xe28523=_0x27aa35[_0x19d388(0x224)](_0x11c52e[_0x19d388(0x266)],_0x229f38),_0x196cac=_0x27aa35[_0x19d388(0x2f7)](_0x468afc['id'],_0xe9156);let _0x34f5f4=_0x19d388(0x37a);if(_0x196cac)_0x34f5f4=_0x19d388(0x335);else{if(_0xe28523)_0x34f5f4=_0x19d388(0x168);}return _0x19d388(0x346)+_0x34f5f4+_0x19d388(0x1dd)+String[_0x19d388(0x411)](_0x27aa35[_0x19d388(0x37c)](0x41,_0x229f38))+_0x19d388(0x3af)+_0x468afc[_0x19d388(0x206)]+'</span></div>';}else{const _0x11ceb6=_0x490e50[_0x19d388(0x301)](_0x40fa7d[_0x19d388(0x13d)]),_0x474903=_0xde25ed[_0x19d388(0x301)](_0x40fa7d[_0x19d388(0x236)]),_0x569229=_0x3af8d9[_0x5537c6][_0x19d388(0x3d2)];_0x11ceb6[_0x19d388(0x3e4)]=_0x569229?_0x40fa7d['OuYqa']:_0x19d388(0x419),_0x474903[_0x19d388(0x125)]=_0x569229?_0x40fa7d[_0x19d388(0x3c7)]:_0x40fa7d[_0x19d388(0x2e0)];}})[_0x50235e(0x1a6)]('');const _0x4dc775=_0x21b356['explanation_video']?'<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-'+_0x5c02b+_0x50235e(0x3c0)+_0x21b356[_0x50235e(0x2be)]+'\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>':'';let _0x14945e='';if(_0x21b356[_0x50235e(0x1f2)])_0x14945e+=_0x50235e(0x36e)+_0x21b356['explanation_audio_eng']+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';if(_0x21b356[_0x50235e(0x13c)])_0x14945e+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22'+_0x21b356[_0x50235e(0x13c)]+_0x50235e(0x385);let _0x2453a2=(_0x21b356['explanation_images']||[])[_0x50235e(0x192)](_0x561978=>_0x561978?_0x50235e(0x3df)+_0x561978+'\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>':'')['join']('');_0x3c5748['innerHTML']='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20'+_0x27aa35['ouBua'](_0x5c02b,0x1)+_0x50235e(0x143)+(_0x27aa35['xGQmW'](_0x58a7af,_0x27aa35[_0x50235e(0x252)])?_0x27aa35[_0x50235e(0x195)]:_0x27aa35[_0x50235e(0x224)](_0x58a7af,_0x27aa35[_0x50235e(0x350)])?_0x27aa35[_0x50235e(0x212)]:_0x27aa35[_0x50235e(0x358)])+_0x50235e(0x17e)+_0x542b29+_0x50235e(0x188)+_0x21b356[_0x50235e(0x206)]+_0x50235e(0x184)+_0x400907+_0x50235e(0x416)+(_0x21b356[_0x50235e(0x332)]||_0x27aa35['pxaUQ'])+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20'+_0x4dc775+_0x50235e(0x18f)+_0x14945e+_0x50235e(0x18f)+_0x2453a2+_0x50235e(0x360),_0x38a88d[_0x50235e(0x222)](_0x3c5748);}),_0x27aa35[_0x53418b(0x177)](initializeReviewVideos);}function _0x53de(_0x522fa2,_0x2d7dd0){const _0x3e7a36=_0x4075();return _0x53de=function(_0x1aa54c,_0x2c6725){_0x1aa54c=_0x1aa54c-0x11f;let _0x423d74=_0x3e7a36[_0x1aa54c];return _0x423d74;},_0x53de(_0x522fa2,_0x2d7dd0);}function initializeReviewVideos(){const _0x1f3f35=_0x578afd,_0x3e9761={'POYxm':_0x1f3f35(0x39f),'ADCiU':function(_0x54fea6){return _0x54fea6();},'MAQmd':function(_0x464bea,_0x211b3a){return _0x464bea===_0x211b3a;},'XrEVJ':_0x1f3f35(0x410),'scVyZ':_0x1f3f35(0x145),'lAFno':function(_0x17f4ba,_0x2b2f95,_0x2e93b3){return _0x17f4ba(_0x2b2f95,_0x2e93b3);},'ZloNs':_0x1f3f35(0x31d),'mhiwX':_0x1f3f35(0x13b)};document[_0x1f3f35(0x418)](_0x3e9761[_0x1f3f35(0x352)])[_0x1f3f35(0x340)](_0x12525a=>{const _0x1ea5ee=_0x1f3f35,_0x556c61={'OuDlG':function(_0x2803f8){return _0x2803f8();},'mAZUb':_0x3e9761[_0x1ea5ee(0x1bf)],'BPULF':_0x1ea5ee(0x1fb),'buRHt':_0x1ea5ee(0x176)};if(_0x3e9761[_0x1ea5ee(0x3f9)](_0x1ea5ee(0x410),_0x3e9761[_0x1ea5ee(0x14e)])){const _0x44982c=_0x12525a[_0x1ea5ee(0x35b)][_0x1ea5ee(0x26e)];if(_0x44982c&&_0x44982c[_0x1ea5ee(0x3c6)](_0x3e9761[_0x1ea5ee(0x241)]))_0x3e9761[_0x1ea5ee(0x204)](setupVideo,_0x12525a,_0x44982c);else _0x44982c&&(_0x3e9761[_0x1ea5ee(0x3f9)](_0x1ea5ee(0x382),_0x3e9761[_0x1ea5ee(0x147)])?(_0x1e10a9[_0x1ea5ee(0x301)](_0x1ea5ee(0x1fb))['style'][_0x1ea5ee(0x13f)]=_0x3e9761[_0x1ea5ee(0x1bf)],_0x3e9761[_0x1ea5ee(0x366)](_0x139dab)):_0x12525a['src']=_0x44982c);}else _0x556c61['OuDlG'](_0x5d60c4)?(_0x4c6b20[_0x1ea5ee(0x301)](_0x1ea5ee(0x1fb))[_0x1ea5ee(0x30c)]['display']=_0x556c61[_0x1ea5ee(0x13e)],_0x556c61[_0x1ea5ee(0x2fc)](_0x115f48)):(_0x556c61['OuDlG'](_0x4a6f6),_0x119946[_0x1ea5ee(0x301)](_0x556c61[_0x1ea5ee(0x1c2)])[_0x1ea5ee(0x30c)][_0x1ea5ee(0x13f)]=_0x556c61['buRHt']);});}function retakeQuiz(){const _0x5d1784=_0x578afd,_0x319f4b={'KFdsj':function(_0x203de6,_0x3374ce){return _0x203de6(_0x3374ce);},'JqJmq':_0x5d1784(0x251),'GcbDj':_0x5d1784(0x3a5),'jcyot':function(_0x5a57e5){return _0x5a57e5();}};_0x319f4b[_0x5d1784(0x341)](confirm,_0x319f4b[_0x5d1784(0x347)])&&(window[_0x5d1784(0x2e1)][_0x5d1784(0x38b)][_0x5d1784(0x1cf)](_0x319f4b['GcbDj'])&&localStorage[_0x5d1784(0x38f)](_0x5d1784(0x123)),_0x319f4b[_0x5d1784(0x288)](clearProgress),location[_0x5d1784(0x2e8)]());}function loadBookmarkedQuestions(){const _0x3fcb65=_0x578afd,_0x54c241={'SPuWE':function(_0x562aa5,_0x2e3306){return _0x562aa5!==_0x2e3306;},'QasEG':_0x3fcb65(0x122),'tbOGF':function(_0x2b9325,_0x204332){return _0x2b9325<_0x204332;}},_0x8df991=JSON[_0x3fcb65(0x407)](localStorage[_0x3fcb65(0x208)](_0x3fcb65(0x1e2)))||[];_0x8df991[_0x3fcb65(0x340)](_0x5ed081=>{const _0x59a2a7=_0x3fcb65;if(_0x5ed081[_0x59a2a7(0x180)]['includes'](quizName[_0x59a2a7(0x24f)]()['replace'](/ /g,'-'))){if(_0x54c241[_0x59a2a7(0x292)](_0x54c241['QasEG'],_0x54c241['QasEG'])){if(_0x30a48e)_0x12770c+=_0x59a2a7(0x174)+_0x47b42d+'\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';}else _0x54c241['tbOGF'](_0x5ed081[_0x59a2a7(0x15d)],questionsData[_0x59a2a7(0x248)])&&(questionStates[_0x5ed081[_0x59a2a7(0x15d)]]['bookmarked']=!![]);}});}function toggleBookmark(){const _0x5b08e3=_0x578afd,_0x2e26fb={'OzCtt':_0x5b08e3(0x240),'OStLP':_0x5b08e3(0x2d0),'pkliv':_0x5b08e3(0x390),'tYwHa':_0x5b08e3(0x15a),'urMnK':function(_0x149b9c,_0x2ff180){return _0x149b9c===_0x2ff180;},'mjbgj':'rUpPe','XLAnR':'bookmarkedQuestions','moJwt':function(_0x4d3f4a){return _0x4d3f4a();}},_0x716383=!questionStates[currentQuestionIndex][_0x5b08e3(0x3d2)];questionStates[currentQuestionIndex][_0x5b08e3(0x3d2)]=_0x716383;let _0x361233=JSON[_0x5b08e3(0x407)](localStorage['getItem']('bookmarkedQuestions'))||[];if(_0x716383){if(_0x2e26fb['urMnK'](_0x2e26fb['mjbgj'],'YkzCL')){const _0x56a519=_0x5b94a3[_0x5b08e3(0x301)](_0x2e26fb[_0x5b08e3(0x273)]),_0x39c0ae=_0x4626b0[_0x5b08e3(0x301)](_0x5b08e3(0x314)),_0x447047=_0x152b2c[_0x1ba35d][_0x5b08e3(0x1b0)];_0x56a519['className']=_0x447047?_0x2e26fb['OStLP']:_0x2e26fb[_0x5b08e3(0x1d2)],_0x39c0ae[_0x5b08e3(0x125)]=_0x447047?_0x2e26fb[_0x5b08e3(0x12c)]:_0x5b08e3(0x157);}else{const _0x3ef284={'quizName':quizName,'quizFile':window['location'][_0x5b08e3(0x38b)][_0x5b08e3(0x29f)]('/')['pop'](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date['now']()};_0x361233[_0x5b08e3(0x1ff)](_0x3ef284);}}else _0x361233=_0x361233[_0x5b08e3(0x34c)](_0xcefd47=>!(_0xcefd47['quizFile'][_0x5b08e3(0x3c6)](quizName[_0x5b08e3(0x24f)]()[_0x5b08e3(0x21a)](/ /g,'-'))&&_0xcefd47[_0x5b08e3(0x15d)]===currentQuestionIndex));localStorage['setItem'](_0x2e26fb[_0x5b08e3(0x120)],JSON['stringify'](_0x361233)),_0x2e26fb[_0x5b08e3(0x1ba)](updateBookmarkButton),_0x2e26fb[_0x5b08e3(0x1ba)](updateQuestionNav);}function updateBookmarkButton(){const _0x233881=_0x578afd,_0x1a6a93={'ZQtvB':_0x233881(0x20b),'ZZFen':_0x233881(0x3a9),'vwzfL':_0x233881(0x419),'UilXE':'Bookmarked','qccOC':_0x233881(0x401)},_0x48157f=document[_0x233881(0x301)](_0x1a6a93[_0x233881(0x175)]),_0x3f0953=document[_0x233881(0x301)]('bookmarkText'),_0x216cfe=questionStates[currentQuestionIndex][_0x233881(0x3d2)];_0x48157f[_0x233881(0x3e4)]=_0x216cfe?_0x1a6a93[_0x233881(0x181)]:_0x1a6a93['vwzfL'],_0x3f0953[_0x233881(0x125)]=_0x216cfe?_0x1a6a93[_0x233881(0x1da)]:_0x1a6a93[_0x233881(0x1a3)];}function toggleMarkForReview(){const _0x5b4c38=_0x578afd,_0x3eab18={'pEKGg':function(_0x4da00d){return _0x4da00d();},'hZelW':function(_0x12ee25){return _0x12ee25();}};questionStates[currentQuestionIndex][_0x5b4c38(0x1b0)]=!questionStates[currentQuestionIndex]['markedForReview'],_0x3eab18[_0x5b4c38(0x39e)](updateMarkReviewButton),_0x3eab18[_0x5b4c38(0x331)](updateQuestionNav);}function updateMarkReviewButton(){const _0x32594c=_0x578afd,_0x57c3e3={'NgWEk':'markReviewText','JofhD':'gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','iwoSE':_0x32594c(0x15a)},_0x18be10=document[_0x32594c(0x301)](_0x32594c(0x240)),_0x54bfc6=document[_0x32594c(0x301)](_0x57c3e3[_0x32594c(0x20f)]),_0x579a28=questionStates[currentQuestionIndex][_0x32594c(0x1b0)];_0x18be10[_0x32594c(0x3e4)]=_0x579a28?_0x57c3e3[_0x32594c(0x227)]:_0x32594c(0x390),_0x54bfc6[_0x32594c(0x125)]=_0x579a28?_0x57c3e3[_0x32594c(0x233)]:'Mark\x20for\x20Review';}function previousQuestion(){const _0x33f840=_0x578afd,_0x304de1={'fdTCK':function(_0x24c7de){return _0x24c7de();},'WbNoQ':function(_0x2457e2,_0x51f0e7){return _0x2457e2<=_0x51f0e7;},'bsVsm':function(_0x425ed2,_0x377ad8){return _0x425ed2(_0x377ad8);},'qXgKf':function(_0x31a966,_0x24af7e){return _0x31a966===_0x24af7e;},'DcQSh':_0x33f840(0x3ed),'PtSoR':function(_0x29e150){return _0x29e150();},'VVqKw':function(_0x570d9d){return _0x570d9d();},'hilgO':function(_0x36430e,_0x29f9){return _0x36430e>_0x29f9;},'skJpg':_0x33f840(0x18a),'wUnLg':'ltzGg'};_0x304de1[_0x33f840(0x211)](currentQuestionIndex,0x0)&&(_0x304de1[_0x33f840(0x276)]===_0x304de1[_0x33f840(0x3ee)]?(_0x3474c2--,_0x304de1[_0x33f840(0x16f)](_0x157428),_0x304de1[_0x33f840(0x40e)](_0x1852bf,0x0)&&(_0x304de1[_0x33f840(0x151)](_0x368ad3,_0x458b6f),_0x304de1[_0x33f840(0x17b)](_0x42e66e,_0x304de1['DcQSh'])?_0x304de1[_0x33f840(0x2b1)](_0x22d1df):_0x304de1[_0x33f840(0x275)](_0x39fad9))):(questionStartTime&&(questionStates[currentQuestionIndex][_0x33f840(0x272)]+=Date['now']()-questionStartTime),currentQuestionIndex--,displayQuestion(),_0x304de1['fdTCK'](saveProgress)));}function nextQuestion(){const _0x2f554b=_0x578afd,_0x560024={'bcqXb':function(_0x139c16){return _0x139c16();},'abHZF':_0x2f554b(0x1fb),'MZZXX':_0x2f554b(0x176),'aPUmx':function(_0x229c74,_0x59f0a9){return _0x229c74<_0x59f0a9;},'oZNAI':function(_0x567e76,_0x5ecf44){return _0x567e76-_0x5ecf44;},'SQEEQ':function(_0x42ae88){return _0x42ae88();},'bJSIX':function(_0x14fec2,_0x1c3465){return _0x14fec2===_0x1c3465;},'NWKvp':function(_0x1897ad,_0x42b15b){return _0x1897ad===_0x42b15b;},'XoqzA':_0x2f554b(0x3ed),'BZjUb':function(_0x4551f1,_0x4fe317){return _0x4551f1(_0x4fe317);},'ZHmrc':function(_0x39c750,_0x50b88f){return _0x39c750===_0x50b88f;},'cjsOS':_0x2f554b(0x164),'szpww':_0x2f554b(0x1e1),'DXlHr':function(_0x4c1640){return _0x4c1640();},'HcAAj':_0x2f554b(0x141),'cYliE':function(_0x1d0edf){return _0x1d0edf();}};questionStartTime&&(questionStates[currentQuestionIndex][_0x2f554b(0x272)]+=Date['now']()-questionStartTime),_0x560024[_0x2f554b(0x1f8)](currentQuestionIndex,_0x560024[_0x2f554b(0x28e)](questionsData['length'],0x1))?(currentQuestionIndex++,_0x560024['SQEEQ'](displayQuestion),saveProgress()):_0x560024[_0x2f554b(0x2f0)](currentMode,_0x2f554b(0x39d))||_0x560024[_0x2f554b(0x27b)](currentMode,_0x560024[_0x2f554b(0x163)])?_0x560024[_0x2f554b(0x39b)](confirm,'You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?')&&(_0x560024['ZHmrc'](_0x560024['cjsOS'],_0x560024['szpww'])?(_0x560024[_0x2f554b(0x24e)](_0xd9bef6),_0x2c5d40[_0x2f554b(0x301)](_0x560024['abHZF'])[_0x2f554b(0x30c)][_0x2f554b(0x13f)]=_0x560024['MZZXX']):_0x560024[_0x2f554b(0x2ff)](submitQuiz)):confirm(_0x560024[_0x2f554b(0x11f)])&&(currentQuestionIndex=0x0,_0x560024['cYliE'](displayQuestion),saveProgress());}function startTimer(){const _0x5e0152=_0x578afd,_0x6ce73b={'xlNyp':function(_0x384daf,_0x4480df){return _0x384daf-_0x4480df;},'ykCcf':function(_0x1c5b1a,_0x3ad317){return _0x1c5b1a===_0x3ad317;},'eBKpr':_0x5e0152(0x34a),'jzwds':'JdGjl','aMXJT':function(_0x52bb65){return _0x52bb65();},'GwkIV':function(_0xe36207,_0x5329cc){return _0xe36207<=_0x5329cc;},'FzCvR':function(_0x3156f2,_0x4ec55d){return _0x3156f2(_0x4ec55d);},'MWOkf':function(_0x47a64c,_0xd94c02){return _0x47a64c!==_0xd94c02;},'JiQNM':_0x5e0152(0x150),'oscKp':function(_0x302773,_0x140e04){return _0x302773(_0x140e04);},'bnqlt':function(_0x3a6a95,_0xad37d1,_0x58535a){return _0x3a6a95(_0xad37d1,_0x58535a);}};if(timer)_0x6ce73b[_0x5e0152(0x228)](clearInterval,timer);timeRemaining=0x78,_0x6ce73b[_0x5e0152(0x1c1)](updateTimerDisplay),timer=_0x6ce73b[_0x5e0152(0x1e9)](setInterval,()=>{const _0x26e10b=_0x5e0152;if(_0x6ce73b['ykCcf'](_0x6ce73b[_0x26e10b(0x2a5)],_0x6ce73b[_0x26e10b(0x1e5)])){if(_0x5c5449)_0x1da653[_0x26e10b(0x2c0)]+=_0x26e10b(0x3df)+_0x74aed7+_0x26e10b(0x2d4);}else timeRemaining--,_0x6ce73b[_0x26e10b(0x1c1)](updateTimerDisplay),_0x6ce73b[_0x26e10b(0x210)](timeRemaining,0x0)&&(_0x6ce73b[_0x26e10b(0x15c)](clearInterval,timer),currentMode===_0x26e10b(0x3ed)?_0x6ce73b[_0x26e10b(0x29c)](_0x6ce73b[_0x26e10b(0x322)],_0x6ce73b[_0x26e10b(0x322)])?(_0x3ea6fa[_0x5eade9]['timeSpent']+=_0x6ce73b[_0x26e10b(0x1ef)](_0x1e104a[_0x26e10b(0x3e2)](),_0x50ed5c),_0x5aad41=_0x13d1d7[_0x26e10b(0x3e2)]()):submitQuiz():_0x6ce73b[_0x26e10b(0x1c1)](nextQuestion));},0x3e8);}function updateTimerDisplay(){const _0x180f4e=_0x578afd,_0x2e6bfe={'YUVPE':function(_0xcc3656,_0x2c761d){return _0xcc3656/_0x2c761d;},'dnErJ':function(_0x15d0eb,_0xd44d4e){return _0x15d0eb%_0xd44d4e;},'rmskN':function(_0xbb2e56,_0x525a13){return _0xbb2e56+_0x525a13;}},_0x4e0879=Math[_0x180f4e(0x28d)](_0x2e6bfe[_0x180f4e(0x198)](timeRemaining,0x3c)),_0x1b5ddb=_0x2e6bfe[_0x180f4e(0x334)](timeRemaining,0x3c);document['getElementById'](_0x180f4e(0x2e7))[_0x180f4e(0x125)]=_0x2e6bfe['rmskN'](_0x2e6bfe['rmskN'](_0x4e0879,':'),_0x1b5ddb[_0x180f4e(0x2f5)]()[_0x180f4e(0x274)](0x2,'0'));}function toggleSidebar(){const _0x295073=_0x578afd,_0x10abfa={'jFlDO':_0x295073(0x2c7),'Hgmbp':_0x295073(0x229)};document[_0x295073(0x301)](_0x10abfa[_0x295073(0x317)])['classList'][_0x295073(0x243)](_0x10abfa[_0x295073(0x1fd)]);}document[_0x578afd(0x1fe)](_0x578afd(0x3fb),()=>{const _0x51ce48=_0x578afd,_0x294bb2={'dnLWf':function(_0x347a5b,_0x5def82){return _0x347a5b%_0x5def82;},'rESZJ':_0x51ce48(0x2e7),'eVcvk':function(_0x76dd5f,_0x3e7f19){return _0x76dd5f+_0x3e7f19;},'nYmws':function(_0x276a1d,_0x20a21e){return _0x276a1d+_0x20a21e;},'DYMlx':_0x51ce48(0x353),'CAcks':function(_0x38d1bb,_0x1d2463){return _0x38d1bb+_0x1d2463;},'XsbgY':function(_0x2b156d,_0x3d0a2d){return _0x2b156d===_0x3d0a2d;},'HbawY':_0x51ce48(0x15e),'BmWWg':function(_0x4d1611,_0xed5fff){return _0x4d1611+_0xed5fff;},'aLvMz':_0x51ce48(0x171),'LlASV':function(_0x38db9a,_0x8d1bc2){return _0x38db9a+_0x8d1bc2;},'xQWgM':_0x51ce48(0x3cb),'IfaFp':_0x51ce48(0x2b6),'lTgIu':function(_0x2e77e8){return _0x2e77e8();},'NfElz':function(_0x43e44b,_0x3455d0){return _0x43e44b!==_0x3455d0;},'UAusJ':'mpzZo','MFnsX':_0x51ce48(0x1fb),'PeBmF':_0x51ce48(0x39f),'YCjWR':function(_0x47fd4d){return _0x47fd4d();},'HWuZH':_0x51ce48(0x2aa),'YyhGM':'HTAQb','xArIW':function(_0x456d0f){return _0x456d0f();},'FOOBm':_0x51ce48(0x176),'UYbjA':_0x51ce48(0x3a5)};if(resume){if(_0x294bb2[_0x51ce48(0x254)]!==_0x294bb2['IfaFp']){const _0x30bbd=_0x32cc31['floor'](_0x59385d/0x3c),_0x2888ec=_0x294bb2[_0x51ce48(0x2d6)](_0x1b0e8c,0x3c);_0xe30567[_0x51ce48(0x301)](_0x294bb2[_0x51ce48(0x22b)])[_0x51ce48(0x125)]=_0x294bb2[_0x51ce48(0x1f0)](_0x294bb2[_0x51ce48(0x2c1)](_0x30bbd,':'),_0x2888ec[_0x51ce48(0x2f5)]()[_0x51ce48(0x274)](0x2,'0'));}else{if(_0x294bb2[_0x51ce48(0x2dc)](loadProgress)){if(_0x294bb2['NfElz'](_0x294bb2[_0x51ce48(0x2eb)],_0x294bb2[_0x51ce48(0x2eb)]))return _0xb40628[_0x51ce48(0x2f5)]()[_0x51ce48(0x26a)](jkGrFI[_0x51ce48(0x31f)])['toString']()[_0x51ce48(0x29b)](_0x4e0777)['search'](jkGrFI['DYMlx']);else document['getElementById'](_0x294bb2[_0x51ce48(0x1aa)])[_0x51ce48(0x30c)][_0x51ce48(0x13f)]=_0x294bb2[_0x51ce48(0x250)],_0x294bb2[_0x51ce48(0x375)](initializeQuiz);}else _0x294bb2['HWuZH']===_0x294bb2[_0x51ce48(0x127)]?(_0x15a2be[_0x51ce48(0x3ae)]['forEach']((_0x56c2b1,_0x54f914)=>{const _0xe9e533=_0x51ce48,_0x883a7b=_0x35d2a9[_0xe9e533(0x411)](_0x294bb2[_0xe9e533(0x38a)](0x41,_0x54f914)),_0x169811=_0x294bb2['XsbgY'](_0x234d45,_0x54f914),_0x19222e=_0x3ef8f7['createElement'](_0x294bb2[_0xe9e533(0x295)]);_0x19222e['innerHTML']=_0xe9e533(0x3b7)+(_0x169811?_0xe9e533(0x172):'')+_0xe9e533(0x146)+_0x54f914+'\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>'+_0x883a7b+_0xe9e533(0x306)+(_0x56c2b1[_0xe9e533(0x206)]||_0x294bb2['BmWWg'](_0x294bb2[_0xe9e533(0x39c)],_0x294bb2['LlASV'](_0x54f914,0x1)))+_0xe9e533(0x132),_0x2e72a4[_0xe9e533(0x222)](_0x19222e);}),_0x3fb2d4[_0x51ce48(0x1fe)](_0x294bb2[_0x51ce48(0x33d)],function(_0x516fdf){const _0x509021=_0x51ce48,_0x31db28=_0x516fdf['target'][_0x509021(0x156)]('.option-button');if(_0x31db28){const _0x1bf159=_0x5e86f5(_0x31db28[_0x509021(0x1d5)]('data-option-index'));_0x2a15ce(_0x1bf159);}})):(_0x294bb2[_0x51ce48(0x3b4)](clearProgress),document[_0x51ce48(0x301)](_0x51ce48(0x1fb))['style']['display']=_0x294bb2['FOOBm']);}}else!window[_0x51ce48(0x2e1)][_0x51ce48(0x38b)][_0x51ce48(0x1cf)](_0x294bb2['UYbjA'])?(clearProgress(),document[_0x51ce48(0x301)](_0x294bb2[_0x51ce48(0x1aa)])[_0x51ce48(0x30c)][_0x51ce48(0x13f)]=_0x294bb2[_0x51ce48(0x3d4)]):initializeQuiz();}),document['addEventListener'](_0x578afd(0x170),function(_0xe9f212){const _0x97db9b=_0x578afd,_0x387a99={'wfVff':_0x97db9b(0x3c3),'NRGfA':_0x97db9b(0x3e9),'MRDel':_0x97db9b(0x1d0),'BJsrx':_0x97db9b(0x26d),'yEqXW':'Incorrect','EfnXm':_0x97db9b(0x172),'qWlWY':function(_0x48ea56,_0x4fc0be){return _0x48ea56===_0x4fc0be;},'BMlWz':'correct','JYPxg':function(_0x25b680,_0x215ffd){return _0x25b680===_0x215ffd;},'hRjhA':function(_0x39328,_0x500c2d){return _0x39328!==_0x500c2d;},'dRrsq':'none','qsCrm':function(_0x1e8fae,_0x33a40e){return _0x1e8fae===_0x33a40e;},'hjpEs':_0x97db9b(0x226),'pqjdZ':function(_0x3f0287,_0x42af6d){return _0x3f0287>=_0x42af6d;},'GSvPM':function(_0x4fc69e,_0x2807a3){return _0x4fc69e<=_0x2807a3;},'mRdFB':'kpIJk','RsbxX':_0x97db9b(0x17d),'OyCNs':function(_0x28ca2b,_0x4b6e3f){return _0x28ca2b-_0x4b6e3f;},'RdzRJ':function(_0x303d4a,_0x4348ca){return _0x303d4a(_0x4348ca);},'qifst':function(_0x26b4df,_0x1feddf){return _0x26b4df<_0x1feddf;},'xddaH':_0x97db9b(0x2d5),'qQYXj':_0x97db9b(0x1f5),'xRtWV':function(_0x345f11){return _0x345f11();},'rtwWx':function(_0x4c74b9,_0x5a3720){return _0x4c74b9===_0x5a3720;},'PqUpb':_0x97db9b(0x376),'QKEoG':function(_0x5595d5,_0x254736){return _0x5595d5===_0x254736;},'tygKQ':function(_0x13485c,_0x25fa9c){return _0x13485c!==_0x25fa9c;},'xXHds':_0x97db9b(0x1f7),'xOiaA':function(_0x395418,_0x46964e){return _0x395418===_0x46964e;},'XaoYw':function(_0xf9c116,_0xbdac9a){return _0xf9c116===_0xbdac9a;},'jMyIb':_0x97db9b(0x373),'ZHYNb':_0x97db9b(0x2d3),'QgPlB':function(_0x2b1883,_0xb6dc4){return _0x2b1883!==_0xb6dc4;},'eBxSU':_0x97db9b(0x3b1),'Rrezo':function(_0x29c8e3,_0x2f74b5){return _0x29c8e3===_0x2f74b5;},'FPRIP':_0x97db9b(0x39d),'BuCyB':function(_0x19768b,_0x5be05e){return _0x19768b===_0x5be05e;},'VmZgN':_0x97db9b(0x3ed),'onisd':_0x97db9b(0x1f6),'RDLcl':function(_0x4accde){return _0x4accde();}};if(_0x387a99['hRjhA'](document[_0x97db9b(0x301)](_0x97db9b(0x1fb))[_0x97db9b(0x30c)][_0x97db9b(0x13f)],_0x387a99[_0x97db9b(0x214)]))return;if(_0x387a99[_0x97db9b(0x3ec)](document['getElementById'](_0x387a99[_0x97db9b(0x3e7)])[_0x97db9b(0x36b)][_0x97db9b(0x16d)](_0x97db9b(0x3c3)),![]))return;if(_0x387a99[_0x97db9b(0x12f)](_0xe9f212['key'],'1')&&_0x387a99['GSvPM'](_0xe9f212[_0x97db9b(0x134)],'4')){if(_0x387a99[_0x97db9b(0x3ec)](_0x387a99['mRdFB'],_0x387a99['RsbxX']))_0xd61912[_0x97db9b(0x301)](_0x97db9b(0x2f3))['classList'][_0x97db9b(0x148)](_0x387a99[_0x97db9b(0x325)]);else{const _0x5c8506=_0x387a99[_0x97db9b(0x328)](_0x387a99[_0x97db9b(0x392)](parseInt,_0xe9f212[_0x97db9b(0x134)]),0x1),_0x2846d0=document['querySelectorAll'](_0x97db9b(0x27d));if(_0x387a99['qifst'](_0x5c8506,_0x2846d0['length']))_0x387a99[_0x97db9b(0x392)](selectOption,_0x5c8506);}}else{if(_0x387a99[_0x97db9b(0x387)](_0xe9f212[_0x97db9b(0x134)],_0x387a99[_0x97db9b(0x3d9)])){if(_0x387a99['qWlWY'](_0x387a99[_0x97db9b(0x3db)],_0x97db9b(0x1f5)))_0x387a99[_0x97db9b(0x38d)](previousQuestion);else{const _0x4c3a1a=_0x252638['parse'](_0xb09945['getItem'](_0x387a99['NRGfA']))||{},_0x118c40=_0x4c3a1a[_0x4c3bee];if(_0x118c40){const _0x5037cd=_0x387a99[_0x97db9b(0x3f6)]['split']('|');let _0x492ec5=0x0;while(!![]){switch(_0x5037cd[_0x492ec5++]){case'0':_0x4bc317=_0x118c40[_0x97db9b(0x27c)];continue;case'1':_0x411df7=_0x118c40[_0x97db9b(0x393)];continue;case'2':_0x151bd1=_0x118c40[_0x97db9b(0x3a0)];continue;case'3':return!![];case'4':_0x146660=_0x118c40[_0x97db9b(0x374)];continue;case'5':_0x3d3e89[_0x97db9b(0x1b4)](_0x387a99['BJsrx']);continue;}break;}}return![];}}else{if(_0x387a99[_0x97db9b(0x144)](_0xe9f212['key'],_0x387a99[_0x97db9b(0x377)])||_0x387a99[_0x97db9b(0x19e)](_0xe9f212[_0x97db9b(0x134)],'\x20'))_0x387a99[_0x97db9b(0x14b)](_0x97db9b(0x2b7),_0x387a99['xXHds'])?(_0xe9f212[_0x97db9b(0x22a)](),_0x387a99[_0x97db9b(0x38d)](nextQuestion)):(_0x4fb679=_0x97db9b(0x16a),_0x4907d6=_0x387a99[_0x97db9b(0x3be)]);else{if(_0x387a99[_0x97db9b(0x183)](_0xe9f212[_0x97db9b(0x134)][_0x97db9b(0x24f)](),'b')&&(_0x387a99['XaoYw'](currentMode,_0x387a99[_0x97db9b(0x179)])||_0x387a99['qWlWY'](currentMode,_0x387a99['ZHYNb']))){if(_0x387a99[_0x97db9b(0x291)]('UYokx',_0x387a99[_0x97db9b(0x2dd)]))toggleBookmark();else{_0x413f38[_0x97db9b(0x36b)]['remove'](_0x387a99[_0x97db9b(0x2a4)]);if(_0x387a99[_0x97db9b(0x1c9)](_0x70bde1,_0x3b7ff8))_0x175c50[_0x97db9b(0x36b)][_0x97db9b(0x40c)](_0x387a99['BMlWz']);else{if(_0x387a99[_0x97db9b(0x387)](_0x86942d,_0x353800)&&!_0x46d30e)_0x3f1903[_0x97db9b(0x36b)][_0x97db9b(0x40c)]('incorrect');}}}else{if(_0x387a99[_0x97db9b(0x183)](_0xe9f212[_0x97db9b(0x134)][_0x97db9b(0x24f)](),'m')&&(_0x387a99[_0x97db9b(0x3d5)](currentMode,_0x387a99['FPRIP'])||_0x387a99[_0x97db9b(0x13a)](currentMode,_0x387a99['VmZgN'])))_0x387a99['onisd']===_0x97db9b(0x139)?_0x47f332=_0x46f812[_0x97db9b(0x34c)](_0x15d26f=>!(_0x15d26f['quizFile'][_0x97db9b(0x3c6)](_0x87ceae[_0x97db9b(0x24f)]()[_0x97db9b(0x21a)](/ /g,'-'))&&_0x15d26f[_0x97db9b(0x15d)]===_0xcd2f5b)):toggleMarkForReview();else _0x387a99['JYPxg'](_0xe9f212[_0x97db9b(0x134)][_0x97db9b(0x24f)](),'s')&&(currentMode==='test'||currentMode===_0x387a99[_0x97db9b(0x3cf)])&&_0x387a99[_0x97db9b(0x130)](submitQuiz);}}}}});</script>

</body></html>